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ABSTRACT 
 
 
 
THE RELEVANCE OF INTERDEPENDENCIES BETWEEN 
HEADQUARTER AND SUBSIDIARY ORGANISATIONS FOR A PRODUCT 
LAUNCH 
 
An in-depth analysis of the launch of Xarelto® in the Bayer Healthcare 
organisation 
 
 
KEY WORDS: Interdependence, Headquarter Subsidiary Relationships,  
Product launch, Network Theory, Bayer AG, Xarelto® 
 
 
Modern management literature highlights the importance of headquarter and 
country organisations working together in an interdependent fashion to 
improve their performance. However, empirical support for this link is scarce; 
moreover, the theoretical framework on the factors that may affect these 
relationships and the prerequisites for fostering them is limited. Current 
literature highlights the importance of high levels of interdependency between 
HQs and subsidiaries for the performance of the subsidiary, but a direct 
relationship has not been established. In this research, the link between 
headquarter-subsidiary interdependence and subsidiary-level performance is 
empirically probed and explored, using a longitudinal, multi-method approach 
that combines quantitative and qualitative data. Responses to surveys from 
53 marketing and business managers are used to describe the 
interdependence levels, which are then combined with actual launch 
outcomes data for Xarelto® in their respective countries.  
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Based on the survey results, a direct link between headquarter and 
subsidiary interdependence and the launch success of Xarleto® could not be 
established and subsidiary interdependence and uptake levels were used to 
select 10 countries for further explorative interviews. The results of these 
highlighted that, through fully collaborative and supportive headquarter 
subsidiary relationships, improved knowledge transfer, avoidance of 
duplication and leveraging of materials and expertise, product launch 
outcomes in the subsidiary could be enhanced. Moderators to these 
relationships and factors to maintain these relationships will be presented 
and this research and a link to network theory and social capital will be made. 
 
This research provides several practical recommendations that can be taken 
into consideration when planning future launches to enhance product uptake 
in subsidiary markets. 
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1. INTRODUCTION 
 
 
The conceptual idea for this research originated from observations within 
Bayer Healthcare AG during preparations of the global launch roll-out of a 
novel oral blood thinner. In 2010, Xarelto® (rivaroxaban) was a new and 
recently approved medication to prevent venous thromboembolism after major 
orthopaedic surgery and launched in over 80 countries worldwide (Bayer A.G., 
2010). Xarelto® represents a major innovation in the pharmaceutical industry 
and has the potential to become a multi-billion dollar drug by the middle of the 
next decade (Arnold, 2009). 
 
Xarelto® proved to have a significant competitive advantage, showing superior 
efficacy and equal levels of safety compared with the gold standard treatment 
of Clexane/Lovenox (enoxaparin) in patients after elective hip or knee 
replacement surgery (Lassen et al., 2007). Bayer Healthcare AG rolled out the 
product introduction globally to maximise the value of the product. 
 
Modern literature suggests that subsidiaries should work with headquarters 
and with each other in an interdependent manner to enhance competitiveness 
and performance. This collaboration enables subsidiaries to leverage the 
marketing expertise and competitive information from other subsidiaries, 
thereby, improving their market performance and outcomes (Bartlett and 
Ghoshal, 1989; Roth, 1995; Nohria and Ghoshal, 1997; O'Donnell, 2000; 
Birkinshaw et al., 2005; Porter, 1986). 
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1.1 Problem Definition 
 
The task of the global marketing organisation is to conduct and manage the 
successful global launch together with the country subsidiary organisations. 
Global product launches of new and innovative products are resource 
intensive endeavours. These launches need to be carefully orchestrated, 
unification of branding, messaging and pricing are key factors for success 
(MacCarthy and Gascoigne, 2007).  This harmonisation often leads to tension 
with local subsidiaries that have local ideas or want to adapt materials to their 
local markets. This aspect is central in this research and is worth investigating, 
because improving the level of coordination and exchange may have a 
potentially positive influence on the launch performance. 
 
Although a new product launch comprises only a short moment in a life cycle 
of approximately 20 years, this period is of the highest importance, and can 
determine the success of both product and the organisation (MacCarthy and 
Gascoigne, 2007)  
 
In the past Bayer Healthcare has had lacklustre performance on global 
launches, especially with respect to brand uptake in the local markets and 
absolute sales and market share level compared to competitive products.  
One example of this is the launch of Levitra®; better sales could have been 
expected based on its clinical profile. “The messages on the benefits were not 
harmonised globally and sold properly to the target audience” (Salz, 2008), 
which may have contributed to poor international coordination. In the end, the 
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full potential of the product performance was not realised and global product 
uptake and market share were below the corporate expectations.  
 
The literature points towards interdependent working relationships (O'Donnell, 
2000), which may lead to improved coordination, knowledge exchange and 
resource sharing between headquarter and country organisations as a 
possible solution.  
 
One of the issues, on the Levitra case study may have been the fact that the 
subsidiary organisations acted quite autonomously and therefore the brand 
had fragmented product messaging across the world. The headquarter 
organisation needs the cooperation of the subsidiaries to implement a 
successful launch; however strict direction and centralised global mandates 
from headquarters have also not always worked in the past, as seen in the 
launch of Levitra®. Launch success or failure has many contributing factors or 
reasons. The literature suggests that improved working relationships and 
communication between headquarters and subsidiaries may be the foundation 
for improved subsidiary performance and therefore potentially improve launch 
outcomes (Bartlett and Ghoshal, 1989;  Birkinshaw et al., 2005; O'Donnell and 
Jeong, 2000).  
 
As a result many corporations, as well as the Bayer Healthcare AG., have set 
up a network structure similar to models proposed by Ghoshal and Norhia and 
others to manage interdependence and value creation (Nohria and Ghoshal, 
1997). As Bartlett and Ghoshal (1989) put it:  
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“[P]erhaps the most important requirement of the transnational 
organization is the need for organizational configuration to be based 
on a principle of reciprocal dependence among units. Such an 
interdependence of resources and responsibilities breaks down the 
hierarchy between local and global interests by making the sharing 
of resource, ideas, and opportunities a self-enforcing norm." 
 
1.1.1 Definition of Interdependence  
 
The conceptualisation of interdependence describes the dependence of the 
headquarter organisation on subsidiaries, the subsidiaries dependence on the 
headquarter organisation, other subsidiaries dependence on the local 
subsidiary and the local subsidiaries on other subsidiaries (O'Donnell, 2000). 
Interdependence is defined by O’Donnell (2000) as:  
“The reliance of each sub-unit of the multinational corporation, including 
corporate head office, on other sub-units for its operations”.  
 
It takes into account the scope of the flow of organisational resources from and 
to headquarters and subsidiaries. These can vary from broad to narrow. It also 
recognises the reciprocity of this relationship. 
 
According to the literature, interdependence across subsidiaries can enhance 
competitiveness and subsidiary performance as it enables the subsidiaries to 
leverage the marketing expertise and competitive information from other 
subsidiaries, thereby making better strategic competitive brand decisions 
(Porter, 1990). 
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Further literature recognises a positive correlation on an organisational level 
between the interdependency and subsidiary performance (Subramaniam and 
Watson, 2006). It is postulated that a high degree of interdependent working 
relationships with subsidiaries may have its merits.  
 
The limitation of existing research is that it investigated interdependency on a 
global organisational level and is focused on the benefits of interdependency 
for the organisation as a whole. However the issue of how interdependence 
influences subsidiary performance in particular is often overlooked  
(Subramaniam and Watson, 2006).  A direct relationship between the degree 
interdependence and increase in revenue has not been demonstrated and has 
certainly not been brought in relation to any marketing or product launch 
outcomes. In addition, moderating factors and subsidiary reactions to 
interdependency were not taken into consideration in the current published 
literature.  
 
Interdependent working relationships can be contentious as the subsidiary has 
to give up their local interest for global corporate concepts (Bartlett and 
Ghoshal, 1992). Power struggles or turf wars may erupt between subsidiary 
and headquarter organisations (Subramaniam and Watson, 2006). If we see 
the subsidiaries as economic rent-seeking units, they will only be interested in 
how to best apply their resources in their local markets (Makadok, 2001) and 
not be told by headquarters or other subsidiaries how to best apply these 
resources or even share them with other subsidiaries or headquarters. 
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Furthermore, the increased sharing of information and coordination associated 
with increased interdependency is costly to the subsidiaries (Van der Vegt et 
al., 1999).  This leads to the question: Are the subsidiaries willing to make the 
extra efforts in terms of resources and costs? These ambiguities could lead to 
counter pressures within the subsidiaries and adversely affect the strength of 
the subsidiaries in the individual markets as well as the competitiveness of the 
organisation as a whole. 
 
As the literature points out: “interdependence as a concept useful in 
organisational design and management is more problematic than many 
researchers currently acknowledge” (McCann and Ferry, 1979).  
 
While existing research often focuses on the positive effects, the existence of 
countervailing forces may be the reason for the ambiguity of existing empirical 
findings on the effects of interdependence on performance. 
 
A deeper analysis is needed in order to understand the concept of 
interdependency better and its potential role in the success of global product 
launches. Now that Bayer Healthcare is conducting the global launch roll-out 
of the potential new blockbuster drug, Xarelto®, it is possible to obtain 
empirical insights into the benefits of integrated interdependent relationships 
on product launch performance.   
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1.2 Research Objective  
 
There is already some degree of interdependence between the global and 
subsidiary marketing groups in place from the integration of global marketing 
operations (Bartlett and Ghoshal, 1989).  Therefore the central question which 
is being addressed throughout the research is:  
 
Is the Bayer Healthcare subsidiary’s new product launch performance of 
Xarelto® associated with interdependence between the headquarter and 
subsidiary organisations?  
 
The objective of this research is to explore whether subsidiaries with a high 
degree of interdependent working relationships with headquarters achieve 
better product launch outcomes. 
 
Secondary questions that will be explored are moderating factors that affect 
the interdependent performance relationships. 
This research provides the opportunity to evaluate the interdependent working 
relationships to obtain objective outcomes and improve future launch 
performance.  
 
The relevant insights could then be taken into account or considered for future 
launches within the Bayer Healthcare organisation to make them even more 
effective. There are multiple product launches anticipated for the near future 
within Bayer Healthcare organisation. Therefore this research has practical 
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relevance and is necessary due to the constantly changing environment in the 
pharmaceutical industry. To better understand the contextual background of 
the product and the associated launch, a short overview of the Xarelto® and its 
potential on patient care will be provided. 
 
1.3 Xarelto® Product Background  
 
 
Xarelto® is a novel oral anti-coagulant or blood thinner which acts by 
intervening selectively in the process of blood coagulation and prevents the 
activation of the enzyme Factor Xa (pronounced ten A), which plays a key role 
in the development of a blood clot after injury (Perzborn et al., 2007).  
 
Though needed in healthy patients, unwanted blood clots (or thrombi) 
secondary to other clinical disorders are life-threatening disorders which affect 
millions of people every year. In the UK, blood clots are one of the most 
common causes of preventable in-hospital deaths, killing up to 25,000 people 
every year – more people than HIV/AIDS, breast cancer and road traffic 
accidents combined (Cohen, 2008). Orthopaedic surgery, particularly hip and 
knee replacement, are common elective procedures worldwide but are 
associated with a high risk of hospital-acquired clots. Without preventive 
treatment, between forty and sixty percent of the patients undergoing elective 
hip or knee replacement surgery may develop an unwanted, dangerous blood 
clot (Warwick, 2007).   
 
After hip or knee replacement, Xarelto® (rivaroxaban) offers patients, a drug 
that combines a novel mechanism of action with superior efficacy and 
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comparable safety profile to the current standard therapy in the UK (B. I. 
Eriksson et al., 2009).  
Some other new oral agents, such as dabigatran have also shown to be 
effective, but unlike Xarelto® have not consistently demonstrated superior 
efficacy over the current standard of care enoxaparin (Eriksson et al., 2007). 
The results of these landmark Phase III trials known as the RECORD 
programme were published in prestigious peer-reviewed journals such as the 
New England Journal of Medicine and The Lancet. 
 
This new medicine offers patients and doctors some major advantages over 
the current standard therapies, most importantly, Xarelto® can be administered 
in tablet form, and there is no need for heparin injections allowing 
straightforward administration and thromboprophylaxis to continue in the home 
setting after discharge from hospital (Xarelto SmPC, 2011).  
 
Xarelto® was granted its first marketing license in September 2008 for the 
prophylaxis of venous thromboembolism VTE in adults following elective hip or 
knee replacement surgery (Bayer Press Server, 2008). To date, Xarelto® has 
also received regulatory approval for use in stroke prevention in atrial 
fibrillation and the treatment of deep vein thrombosis. Xarelto® has the 
potential to improve the lives of millions of patients in the UK (Rawlings, 2010).  
 
Since its first launch in October 2008 Xarelto® has been approved in more than 
hundred countries world-wide for the prevention of venous thromboembolism 
following elective hip or knee surgery” (Bayer A.G., 2010).   
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It is clear from the product profile, that Xarelto® has the potential to significantly 
affect patient care and potentially revolutionise anticoagulant treatment in the 
future. As this represents a major opportunity for the improvement in patient 
care, the emphasis and investment for the company to implement the 
launches successfully becomes ever more present. 
 
Over the past decade advances in technology and innovation, particularly in 
the pharmaceutical industry has increased. In this industry the external 
competitive pressures, restricted governmental healthcare budgets and 
healthcare spending limits, necessitate the need for pharmaceutical 
organisations to increase their internal skills, competencies and overall 
competitiveness to survive in a challenging market environment.  
 
 
1.4 Research Approach 
 
An exploratory, in-depth case study research approach is used to answer the 
research objective. The research will be conducted as a single case study, in 
order to apply the relating theoretical work on interdependency to a specific 
empirical situation. The aim is to address the “how” and “why” questions, which 
will be central in the research and are typically best addressed by an 
exploratory case study (Yin, 2003).  
 
As the launch is well underway there are enough subsidiaries, within Bayer 
Healthcare AG to generate launch data within the first year of the launch, 
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therefore, a multi-method case based study approach using data from a 
multitude of subsidiaries in the same company provides the optimal 
environment to conduct the research. As the nature of the problem is complex 
and multifactorial, multiple research methods will be used to answer the 
research objective, as well as different data collection methods. These include 
observations and a subsidiary survey, as well as in-depth interviews. The 
survey will provide the necessary background information and characterise the 
subsidiary relationships.  
Observational methods will collect the subsidiary’s actual launch outcome 
data. A selection will then be made for the in-depth interviews where the 
interdependent relationships and outcomes will be explored and any new and 
important factors identified. 
 
1.5 Organisational Background – Bayer Healthcare. 
 
The research will take place within the pharmaceuticals group of the Bayer 
Healthcare A.G. To understand the research setting better as short 
organisational background will be provided. 
 
On the first of August 1863, Friedrich Bayer, a merchant and Johan Friedrich 
Weskott, a textile colourist founded Bayer A.G. as a joint manufacturing 
company for the production and sales of synthetic dyestuffs for colouring 
textiles. The company was located on the banks of river Wupper in Germany 
(Verg et al., 1988). Contrary to the natural dyes, which were difficult to make 
and also very expensive, making dyes out of tar products was one of the 
innovations at the time. International expansion followed rapidly, already in 
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1865 Bayer had participation in dye factories in the US due to the excellent 
connections of Friedrich Bayer. In 1881 the financial foundation was laid as 
Bayer transformed into a joint stock company (Verg et al., 1988).  
The founders anticipated that the only way to stay in business was to build 
their own laboratory to continue to develop new derivatives from tar products. 
It was in these laboratories in 1899 that Bayer Invented Aspirin® which was 
the first medication to be in tablet form on the market, the competition 
proclaimed that this was only done so the Bayer cross could be embossed in 
the tablet (Verg et al., 1988).  
The invention of Aspirin® by Thomas Hoffmann in 1899, lead the way for the 
company’s foray into the pharmaceutical business. Other milestones in the 
pharmaceutical inventions of Bayer AG include Adalat® (nifidipine), a calcium 
channel blocker, which led to the development of a whole new class of blood 
pressure reducing medications (Pickel, 2009). Bayer A.G. has been a 
pharmaceutical chemical conglomerate for more than 125 years, which was 
celebrated in 1988 (Verg et al., 1988).  
 
 
In January of 2005 the base chemical business was split from the company in 
a separate entity called Lanxess (Lanxess, 2005). This was transformational 
as the company grew into a life-science company with a management holding 
structure and three independent different subgroups, Crop Science, Specialty 
Chemicals and Healthcare businesses  (Bayer A.G., 2010). 
 
The healthcare group is divided into two segments: Pharmaceuticals and 
Consumer Health segments. The pharmaceutical segment concentrates on 
prescription based pharmaceutical products in the fields of General Medicine, 
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Specialty Medicine, Women’s Healthcare and Diagnostic imaging. The 
Consumer Health segment contains the Consumer Care, Healthcare and 
Animal Health Divisions.  
 
Figure 1: Bayer Group Corporate Structure-2010 
 
The research will be conducted in the Pharmaceuticals Division of the Bayer 
Healthcare subgroup.  In this subgroup, the Bayer Schering Pharma (BSP) 
entity was integrated after Bayer purchased Schering Pharma in June of 2006 
(Investor Relations, 2006). Immediately after the merger, there were six 
business units within the Bayer Schering Pharma AG. This was later 
consolidated to four subunits, including General Medicine, Specialty Medicine, 
Women’s Healthcare and Diagnostic Imaging. The actual research took place 
in the General Medicine subunit.  
 
Since the research took place in the same organisation, no differentiation is 
made by culture or by country origin.  
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1.6 Definition of the Global Team 
 
For the purpose of this research the definition of the global team includes not 
just the marketing colleagues in headquarters, but a larger extended team. 
One of the unique aspects of the Xarelto® launch was the integration of the 
global marketing team in what was called ‘The Core Team’. The core team 
consisted of all the members directly involved with the development of 
Xarelto®: Global Medical department, Drug Safety, Toxicology, Health 
Economic and Outcomes Research, Pharmacokinetics & Pharmacodynamics 
group, Regulatory and Global Marketing.  
 
This group set the phase III clinical studies strategy for Xarelto® as well as the 
clinical and economic outcome parameters. This group was also responsible 
for the initial, publication and symposia plans. During the pre-launch and 
launch period of Xarelto®  all these groups were in the same offices located at 
the headquarters and pharmaceutical research centre in Wuppertal, 
Germany, this was quite unique to this specific launch. The relevant brand 
knowledge was developed centrally and decisions about the brand were 
made centrally with the collective involvement of this group. In this research 
when reference is made to headquarters or the headquarter group it is defined 
as the larger core team and not just the global marketing colleagues. 
 
 
1.7 Research Initiated During Late Stage Clinical Development 
 
 
The research was initiated during the late stage or Phase III clinical 
development and the first year of commercialisation of the product. To explain 
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the clinical research cycles and the background and the timing of launch 
preparation and actual launch the clinical stages of development will be 
highlighted in the next paragraph.  
 
The phase III development period is the time in the product life cycle of a 
pharmaceutical product when the large clinical trials are conducted to 
demonstrate the clinical efficacy and safety in clinical studies that involve 
thousands of patients worldwide. The outcomes of these studies represent the 
confirmation of a pharmaceutical product profile in terms of efficacy and side 
effects, and an overall clinical benefit of the pharmaceutical product is 
established. 
 
The data are submitted after successful completion studies to the local 
regulatory authorities. In Europe, for example, the European Medicines 
Agency (EMA) reviews the application for a licence to use the drug in clinical 
practice. If the review is positive, than the pharmaceutical manufacturer will 
obtain a marketing authorisation and the clinical product is allowed to be sold 
commercially. This process often takes twelve to fourteen month before the 
product is then allowed to be launched in a particular market in which the 
licence is granted. Launch timings may therefore vary from country to country 
 
On the next page, is a schematic overview of the different clinical development 
stages a pharmaceutical product goes through (Ruh-Pohlenz, 2010). 
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Figure 2: Research and Development Process in Pharmaceutical Industry 
 
 
1.8 Structure of the thesis 
 
The thesis will commence with a literature review on interdependence and will 
also cover topics that are related to interdependence such as subsidiary-
headquarter relationships, subsidiary typology, knowledge transfer as well as 
subsidiary influence. The literature review will be used to guide the research, 
uncovering gaps, and limitations of the existing knowledge base and to build 
the case for this exploratory research project. The existing literature on 
marketing performance will also be reviewed as it plays a central role in this 
research project.  
 
In chapter three a guiding conceptual background will be provided and the 
theoretical arguments for increased and multidirectional relationships between 
headquarters and subsidiaries, and their potential contributions to 
organisational success, will be presented. Many aspects of interdependent 
relationships are not yet understood and both the supporting and detracting 
factors are going to be discussed. This will provide the research questions to 
be included in the research methodology chapter. 
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In chapter four, the multi-method research approach and methodology for an 
exploratory case study research approach will be provided as well as a 
description of the empirical framework in which the research is taking place. 
Both quantitative and qualitative research methods in the form of a survey and 
interviews are used to explore the interdependent headquarter – subsidiary 
relationships. 
 
Chapter five will present the quantitative data from the country survey as well 
as the results of the subsidiary survey capturing the interdependence score 
and link these with the actual launch outcomes of each of the subsidiaries. 
From this analysis, the subsidiaries will be identified for in-depth interviews. 
 
Chapter six will provide the rationale for the selection of subsidiaries used for 
qualitative data analysis and describe the interview set-up, conduct and 
analysis approach of the interview data.  
 
In chapter seven, the results of the interviews will be presented. Themes 
evolving relevant to the interdependence performance link will be described 
and subsequently analysed in a cross cluster analysis. The similarities and 
differences of these themes across the high and low interdependent 
subsidiaries are explored for their role as moderators within the 
interdependence-performance link. 
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Chapter eight contains the concluding remarks including practical 
recommendations from the research conducted for the Bayer organisation to 
potentially improve the outcomes of future launches. This is followed by the 
limitations of study conducted and suggestions for further research. 
 
A schematic overview of the thesis is provided below:  
 
 
Figure 3: Schematic Overview of Thesis 
 
 
 31 
 2. LITERATURE REVIEW 
 
This chapter will review the literature on the concept of interdependence as 
well as subsidiary performance measures and product launch outcomes. The 
literature in several associated fields, such as subsidiary typology and 
subsidiary influence in organisations will also be briefly highlighted as it bears 
relevance to the research topic and is used in the guiding conceptual 
framework. In addition, knowledge exchange is a central topic in 
interdependence and therefore this topic will also briefly be addressed in the 
literature review. The chapter will conclude with literature on launch 
performance, particularly in the pharmaceutical industry.  
 
2.1 The concept of interdependence 
 
The concept of interdependence, started out as a transactional approach, 
between units within one organisation (McCann and Ferry, 1979). The focus 
was on resource utilization and resource transactions, such as funds, 
products, clients, support services. What only counted were the number and 
amount of resources exchanged between the sub-units of an organisation as 
well as the frequency and amount of resources. The direction of the resource 
flow, into or out the organisational subunit, or multidirectional, both ways, were 
deemed relevant dimensions of interdependence. It was just volume based on 
measurable resource flows. This concept has been relatively recently used in 
a paper by Anne-Will Harzing (2000) who defined interdependence as the 
percentage of purchases (incl. part/semi-manufactured articles) from 
headquarters or other subsidiaries in relation to the total amount of purchases 
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of this subsidiary as well as the sales to headquarters and other subsidiaries 
(Harzing, 2000). 
 
Victor and Blackburn (Victor and Blackburn, 1987) had an alternative concept 
of interdependence which looked more at relationship aspects, rather than 
resource transaction units. This takes different relationship aspects into 
consideration such as, coordination and inter-unit cooperation and conflict. 
The main criticism of the original concept of interdependence was that 
workflow patterns which are cycled through the organisation are not precise 
and exclusive and do not include reciprocity. Therefore, Victor and Blackburn 
(1987) proposed a matrix structure with two arms. The first arm was 
designated as the relative dependence on other organisation’s actions, the 
second arm the relative dependence on joint actions. The latter, describes a 
potential reciprocity in interdependence, which was initially proposed by 
Thompson (Thompson, 1967), who introduced a concept of mutual 
dependence rather than resource transactions going back and forth between 
headquarters and subsidiaries.  
 
Thompson (1967) also argued that both the direction, as well as the scope of 
the resource flows, are relevant parts of interdependent relationships. The 
subsidiary’s interdependent relationships were characterized by the level of 
scope and the direction of the resources. For example, a subsidiary with a 
narrow scope has a unilateral direction of limited resource flow, from 
headquarters to subsidiary in just one direction.  
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Recently the concept has been defined more clearly by O'Donnell (2000) as a 
mutual reliance of subsidiaries and headquarter organisations on each to 
effectively conducts its operations. Both flow of resource packets as well the 
direction of resource flow are included in this concept. This was the basis for 
further research into interdependence. Neither of the authors tested their 
theoretical concepts with subsidiary or product launch outcomes. 
 
2.2 Interdependence and performance 
 
 
Interdependence in relationship with performance was only recently 
established in a research paper by Subramanian and Watson (2006). Their 
contribution was to demonstrate that a simple high or low metric of 
interdependence did not exhibit a significant relationship with subsidiary 
performance. This is a relevant finding, but fails to capture the intricacies of 
any underlying interdependent relationships in the multinational corporation. It 
also points out that the scope and direction may be relevant. In previous 
literature this was just theoretically postulated. The hypothesis the authors 
tested was that subsidiary performance will not differ across the four 
interdependence profiles. The authors provided their viewpoint in the analysis 
and argued that if the subsidiaries each have a level of interdependence that 
fits their role overall organisational performance is improved. Their analysis of 
115 headquarter subsidiary pairs demonstrated that if the level of 
interdependence, both direction and flow, matched the level necessary for the 
subsidiary or subsidiary role or characterization, performance may be 
enhanced. This is the first paper, aside from the theoretical aspects of 
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interdependence, which contains actual empirical research at the subsidiary 
level. Their biggest contribution is a new framework to examine how 
interdependence influences subsidiary performance and initial evidence on 
subsidiary interdependence-performance linkage.  
 
There are, however, several limitations to the research conducted by 
Subramaniam and Watson (2006).  
First, the performance measures used are based on subjective subsidiary 
manager’s assessment of profit improvement, cash flow from operations, 
return on investment and cost control, but not with real measured, outcomes 
data. A response bias cannot be excluded as it is conceivable that managers 
subjectively think they do better than in reality or over exaggerate outcomes.  
Second, the authors failed to directly link performance to the level of subsidiary 
interdependence. What was proven was the level of ‘fit’ of the subsidiary’s 
ideal interdependence profile based on a pre-defined subsidiary typology and 
its perceived organisational performance. This is a supportive finding that there 
is a linkage between interdependence and better organisational performance, 
but it does not follow through with final proof that there is a direct link to 
performance. 
Third, the prerequisites for the different levels of interdependent relationships 
are not evaluated in the paper. The authors argue that the reactions of the 
subsidiaries are important and relevant but do not give a clear indication what 
they are and how they influenced the outcomes. Hence, it provides a good 
basis to continue and expand the research and look at the performance more 
closely in this field. 
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2.3 Subsidiary Typology 
 
Since subsidiary characteristics, including size or role, may affect the 
interdependence fit and or subsidiary performance, the literature on subsidiary 
typology will be reviewed. A number of researchers have described subsidiary 
typologies. Typology is often done to identify certain subsidiary characteristics 
or features that distinguish them so they can be used in research. “Such 
approaches assume that the typologies are empirically verified phenomena 
that are now appropriate for further theoretical development” (Enright, 2005). 
There have been several different approaches to the typology or classification 
of subsidiaries depending on the research streams. Subsidiary typologies will 
be offered and evaluated as they are relevant to the level of interdependence. 
Early literature focussed on strategy at headquarter levels and centralised 
dyadic headquarter-subsidiary relationships, which were more structurally 
based with very formal coordination and control mechanisms (Chandler, 
1962). Perlmutter looked more at geographical development and describes 
subsidiaries as geocentric, ethnocentric or polycentric based on their structure 
and strategy (Perlmutter, 1969). These typology models essentially represent 
centralised and decentralised approaches, with the main differences being 
their primary organising principles and management systems for establishing 
worldwide operations (Perlmutter, 1969).  
 
The literature also describes subsidiary roles more from a process perspective 
and on how they develop over time as part of a multinational evolution 
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(Stopford and Wells, 1972; Malnight, 1996), Initially, organisations sell single 
products developed and produced by headquarters. The subsidiary units act 
as sales organisation of the multinational corporation and its headquarters. As 
the product diversification increases, and the sales percentage of total sales 
increases, these organisations will establish area divisional structures, 
ultimately leading to a global matrix structure with differentiated subsidiary 
roles and typologies.  
An alternative typology or subsidiary categorisation has their origin in the 
international strategy process and the need for national responsiveness while 
simultaneously having global integration (Prahalad and Doz, 1987). This has 
led to different frameworks to typecast subsidiaries focussing on local needs or 
on global integration (Bartlett and Ghoshal, 1989; Gupta and Govindarajan, 
1991; Roth and Morrison, 1992). Bartlett and Ghoshal categorise different 
roles of a subsidiary according to strategic importance of the nation's sub-
sidiaries environment, and its own internal resources competence and 
availability of local resources (Bartlett and Ghoshal, 1989; Nohria and 
Ghoshal, 1997). Difference from the early research is that they focussed on 
the subsidiary role rather than the headquarter view. Their view is that the 
subsidiary is fits an integrated network with different roles of the subsidiary 
along geographical, product and strategic importance characteristics.  
 
Most of subsidiary conceptualization has been conducted along a two 
dimensional framework, resulting in four different subsidiary types which are 
laid out in a two by two matrix. This is done in the literature in multiple ways: In 
terms of capabilities and importance of the subsidiary (Bartlett and Ghoshal, 
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1989), Integration and responsiveness (Gupta and Govindarajan, 1991), 
knowledge inflows or outflows (Birkinshaw and Morrison, 1995), autonomy and 
decision making (Doz and Prahalad, 1981).  
Harzing (2000) conducted an in-depth review of subsidiary typologies offering 
a three part subsidiary typology called: “Multidomestic”, “Global” and 
“Transnational” based on an empirical study using a sample of 287 
subsidiaries.  
 
Enright and Subramanian have attempted to harmonise the different 
directional subsidiary typologies in an organising framework along four 
dimensions: Capability Creation, Capability Utilization, Product Scope and 
Geographic scope (Enright and Subramanian, 2007). This captures the 
evolutionary role of the subsidiary which has been a gap in the literature and 
shows that most of the research has been conducted from a headquarter view 
(Birkinshaw et al., 2005).  
 
In the paper of Subramanian and Watson (2006) where subsidiary and 
interdependence performance is described on a subsidiary level, a 
classification or typology of the subsidiaries is provided in terms of scope, 
directionality and level of interdependence as such that they correspond to the 
profiles of “lone stars”, “passive stars”, “dominant stars” or “constellation stars”. 
These subsidiary typologies will be shortly reviewed and compared to the 
literature. 
The lone stars are subsidiaries characterised by low degree and narrow scope 
of interdependence, with no significant influence directed at another subunit. 
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These subsidiaries would primarily be sales organisations in a country where 
products & marketing concepts are provided. Therefore there is little need for 
interdependency. This characterisation is conform the “black hole” or “local 
observer” (Bartlett and Ghoshal, 1989;  Gupta and Govindarajan, 1991).  
A moderate degree of interdependence which is narrow in scope, typically 
limited to headquarters indicates a passive star, however passive stars exhibit 
bi-directional interdependence with headquarters (Subramaniam and Watson, 
2006). From an agency theory perspective, passive stars can be viewed as 
agents of the parent organisation (Roth, 1995).  
Dominant stars on the other hand are characterised as having moderate 
degree of interdependence, which consist of a broad scope and unidirectional 
influence to other subsidiaries and to headquarters (Roth, 1995). These are 
subsidiaries, which have some special competencies or entrepreneurial 
capacities and can make contributions to headquarters or to other subsidiaries 
(Birkinshaw et al., 2005). Finally, constellation stars are subsidiaries 
characterised by a high degree of interdependence and a broad scope and 
multidirectional influence, with influence also flowing from other subunits (Roth, 
1995). This would be typical of a subsidiary in the transnational organisation 
we previously described and is consistent with other empirical studies (Bartlett 
and Ghoshal, 1986;  Enright, 2005).  
 
The criticism that can be made is that the typology offered by Subramaniam 
and Watson (2000) only look at the level and direction of interdependence. 
While this is helpful, essential subsidiary characteristics, such as capabilities of 
the subsidiary and or the desire to participate in the interdependent network 
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are not addressed. This represents a gap in the literature, warranting a need 
for further investigation.  
 
2.4 Interdependence and Knowledge Exchange 
 
According to the literature there is a high degree of knowledge and information 
exchange across interdependent networks (Bartlett and Ghoshal, 1989) and  
competitive environments increasingly require cross-border knowledge 
networks that are denser, more widely dispersed, more complex and more 
differentiated than those that were adequate in an earlier era (Robbins, 1987).  
It is relevant to review the literature on knowledge exchange, given the well 
documented act that efficient knowledge transfer within the organisation does 
have an effect on performance (Inkpen and Tsang, 2005; Watson and Hewitt, 
2006). Also frequency of knowledge transfer has been demonstrated in the 
literature to impact on performance (Watson and Hewitt, 2006). 
 
Early theories subscribed to the notion that knowledge is at the headquarter 
level and is bestowed upon the subsidiary (O'Donnell, 2000). The agency 
theory (Jensen and Meckling, 1976; Eisenhardt and Martin, 2000) has often 
been the basis for research in knowledge transfer which describes 
headquarters and subsidiaries as a principle-agent relationship. A number of 
publications emphasize the importance of inter-unit communication for 
effective control or management (Galbraith, 1977; Gupta and Govindarajan, 
1991).  
In contrast to using knowledge exchange as headquarter control function, 
several papers in the literature focus on the viewpoint that for the multinational 
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corporation to run efficiently it is also of interest to the headquarter 
organisation that the subsidiary, with its valuable capabilities and knowledge, 
contributes to the competency development of other parts of the multinational 
organisation (Frost et al., 2002; Bjoerkman et al., 2004).   
 
To some extent, this aspect of reciprocity existent in knowledge exchange is 
also highlighted in the literature from a socialisation perspective (Inkpen and 
Tsang, 2005). Here the social relationship is the basis for the transfer of 
knowledge with other individuals or organisational structures and is discussed 
along several dimensions, such as the structural dimension i.e. structure or 
network formation, cognitive dimension, representing shared goals and shared 
culture, and relationship dimensions such as trust and sharing of norms 
(Gupta and Govindarajan, 1991; Nahapiet and Ghoshal, 1998).   
The main point made in the literature is that different network types require 
different social dimensions to make the knowledge flow work (Nahapiet and 
Ghoshal, 1998).  
 
Knowledge transfer is also born out of the recourse theory which reveals that 
subsidiaries are exposed to unique cultural, technological, societal and political 
environments in which they encounter different market conditions, competitive 
situations, resource availability and management practices (Anderson et al., 
2002). In these subsidiaries, local innovations making use of resources and 
entrepreneurship of the national units or subsidiaries, work to their advantage. 
The literature supports the idea that subsidiaries have potential for 
independent and entrepreneurial behaviour (Doz et al., 2001; Birkinshaw et al., 
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2005). Often local circumstances surrounding the subsidiary, begin the “self-
improvement” process of the subsidiary (Birkinshaw et al., 2005). Some 
subsidiaries emerge with an organisation and are recognised to have a unique 
or leadership position. Such subsidiaries have a set of capabilities that has 
been explicitly recognized by the firm as an important source of value creation 
which can or have to be leveraged by and/or disseminated to other parts of the 
firm (Frost et al., 2002).  
 
In the literature, several limiting aspects of knowledge transfer are discussed 
such as the potential differences in mode of knowledge transfer, the 
preferences for how knowledge is coded and transferred, and the frequency by 
which they are transferred between headquarters and subsidiaries. (Kogut and 
Zander, 1993; Watson and Hewitt, 2006). In addition, motivational factors, 
such as the loss of a position of superiority (Bjoerkman et al., 2004) and the 
cost involved have been identified as limiting the process of knowledge 
transfer  (Frost et al., 2002).  
Several of the themes in the literature pertinent to the research in knowledge 
transfer have been discussed. There is a lack of research in the 
operationalisation of the knowledge transfer. Aspects such as what factors 
make subsidiaries accept knowledge from headquarters or factors that 
improve the willingness to share knowledge are underemphasized in the 
literature. Although and in-depth analysis of knowledge transfer would go 
above and beyond the structure of this research, operational and mechanistic 
aspects of knowledge exchange in an empirical setting may provide additional 
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insights to the subsidiary’s willingness to share information with headquarter 
organisation. 
 
2.5 Social Capital 
 
 
It is recognised in the literature that there are interdependent networks 
between headquarter and subsidiary organisations, as just reviewed. 
Therefore it is important to review the current level research on creation of 
informal coordination and knowledge exchange networks as defined by social 
capital. The literature on social capital discusses the role of informal networks 
on a personal, individual network member as well as on an organisational 
level that will inform the data collection as well as the analysis in this thesis.  
 
The origins of research in social capital focussed on the individual and social 
capital was seen as a private good, where it primarily benefitted the individual 
who possessed or was connected through the social network (Burt, 1992). 
This individual was able to get better position or benefitted otherwise from the 
improved knowledge or connections of his network. 
A contrasting view by Putnam (1993) considers social capital a public good. 
His research was  originally community based and social capital would 
represent a successful communities based on trust, reciprocity and strong 
normative values that provide a means of cooperation and effective regulation 
(Putman, 1993).  
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Kostova and Roth (2003) have argued that it is important for the multinational 
entity to build social capital both as a private and public good, because they 
see it as facilitating the coordination of headquarter and subsidiary activities. 
They argue that the required levels and form of social capital are determined 
by the nature of interdependence between headquarters and subunits. 
They both acknowledge in their model of social capital a structural and 
relational aspects, such as motivation to maintain relationship with 
headquarters, felt obligation to do favours for headquarters, expectation that 
headquarters will reciprocate and perceived likelihood of providing, asking 
and receiving help from headquarters (Kostova and Roth, 2003) . 
Their main argument is that as interdependence between headquarter and 
subsidiaries increase and become more complex, the subunits will need 
higher levels of social capital. Their proposed model includes qualitative 
factors and that interactions among participants across subsidiaries and 
headquarter organisations should be meaningful and directed towards 
mutually beneficial work related objectives. The authors have not conducted 
empirical studies in their research to actually link social capital to work related 
projects. This represents a gap in the literature which needs to be addressed.  
 
Nahapiet and Ghoshal (1998) have attempted to link social capital to added 
value creation for the organisation. They argue that social capital can have 
organisational advantage as is facilitates the creation of new intellectual 
capital. Their thesis is that the denser the network of the multinational 
organisation is, the more they see an advantage in sharing this intellectual 
capital. The relationship is central to the competitive advantage. The authors 
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consider three dimensions to create new intellectual capital, structural i.e. 
physical network configuration and cognitive, i.e. shared codes and language 
and relational i.e. trust, obligation and norms. They argue along the resource 
based theory that competitive advantage of a firm is based in their "unique 
constellation of resources" which if accessible can be used to create a 
competitive advantage (Nahapiet and Ghoshal, 1998).  
Their definition of social capital is:  
 
"The sum of the actual and potential resources embedded within, 
available through and derived from the network of relationships 
possessed by and individual or social unit" 
 
The drawback of this literature is that the authors offer very little to explain 
how informal networks are build and evidence that knowledge creation indeed 
creates improved outcomes. 
 
Adler and Kwon (2002) provide a concept for social capital including market 
relations, social relations and hierarchal relations and how these bring value 
to the organisation. The social capital ties in the organisation, creates 
opportunities for social capital transactions. The authors argue for this to 
manifest itself, there needs to be opportunity for the actors in the social 
relational network to interact, they need to have the motivation and the ability 
for the benefits of social capital to become evident.  
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Benefits the authors ascribe to social capital are facilitating access to broader 
sources of knowledge in particular, better and more timely knowledge 
exchange, less need formal control and increased solidarity. 
In the previous section, knowledge exchange could be linked to better 
competitive position and potentially better outcomes. The authors do not 
postulate this, but merely refer to “value” to the organisation. 
 
Some of the risks of social capital are highlighted by the authors as the 
considerable investment in building and maintaining social relationships, the 
overembeddedness of the network, can reduce the flow of new ideas into the 
group and the network actors may slow to seek out new ways and resource 
opportunities. The authors have not addressed in empirical research whether 
the benefits outweigh the risk and indeed confirmed that social capital leads to 
better value creation. 
 
In the literature the link between establishing networks for the individual and 
organisation and potentially creating value for the organisation through 
improved knowledge creation and transfer has been established (Nahapiet 
and Ghoshal, 1998; Kostova and Roth, 2003). However, aspects such a 
building and sustaining these social networks and how they are tied to various 
tasks the organisation faces has not really been highlighted in the literature or 
supported by empirical data. Furthermore aspects such as trust, reciprocity 
and motivation have been mentioned in the literature in association with 
building social capital (Adler and Kwon, 2002; Kostova and Roth, 2003) but 
have not been empirically evaluated. In addition, the literature makes a 
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general statement that social capital leads to better value for the organisation, 
but this has not been empirically proven. This research project offers the 
opportunity to research headquarter and subsidiary interaction related to a 
work project i.e. the preparation of a product launch and aspects such as 
trust, reciprocity, network establishment can be closer evaluated as well as 
overall value creation for the subsidiary in the form of product launch success.  
 
2.6 Subsidiary Influence  
 
 
One aspect on interdependent relationships has not been adequately 
addressed in the literature, namely the recognition of the subsidiary by 
headquarters and other subsidiaries. Before interdependent relationships are 
established the subsidiary needs to be recognised by the headquarter 
organisation. 
 
Bouquet and Birkinshaw (2008) have provided a theoretical framework for this 
topic. For subsidiaries to participate in an interdependent manner, the 
subsidiaries need to gain legitimacy within the organisation:  
 
“They must also find ways to translate corporate ideals into a tangible 
set of local practices that effectively bridge the expectations of head 
office, if they are to exert any influence on the multinational corporation” 
(Bouguet and Birkinshaw, 2008).   
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In their model, possession of critical resources or knowledge help the 
subsidiary gain legitimacy (Birkinshaw et al., 2005) and is generally supported 
in other literature as well (Anderson et al., 2002; Rugman and Verbeke, 2003; 
Bouguet and Birkinshaw, 2008). Another part of their model is gaining 
centrality of the subsidiary within the organisation and they state that it is 
equally important to consider how well connected the actors are to other units 
(Birkinshaw et al., 2005). This is related to the social network theory which was 
previously discussed, whereby the main objective of the subsidiary should be 
to gain influence within the strategic networks within the multinational 
corporation (Bouguet and Birkinshaw, 2008). 
 
2.7 Marketing Performance measures  
 
As performance measurement is a relevant topic in this thesis, a review of 
common performance outcomes in the marketing area is warranted. Several 
literature searches and search terms had to be used to find relating literature 
sources. This was especially true when adding the search term 
“pharmaceutical” to the title search. Only two results were found, one of them 
was a dissertation, illustrating the point that marketing or launch performance 
in the pharmaceutical industry are poorly represented topics in currently 
literature. This points to a clear need for more research in this area (Vorhies 
and Morgan, 2003; Rust et al., 2004; O'Sullivan and Abela, 2007). 
Several recent publications highlight aspects of marketing performance 
measurement in general, which is defined as the: “assessment of the 
relationship between marketing activities and business performance” (Clark 
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and Ambler, 2001). In the literature, three different research approaches can 
be defined.  
 
The first one is the measurement of marketing productivity (Rust et al., 2004). 
Rust and colleagues describe a chain of marketing productivity elements 
which are the marketing activities including advertising, service improvements 
and new product launches that trigger results in the market. These can be 
improved customer thoughts, feelings, knowledge about the product and 
ultimately customer (buying) behaviour, which in turn influence financial 
performance of the firm, such as sales, market share impact and ultimately 
increased shareholder value. This is a practical framework for linking 
marketing performance to overall subsidiary or organisational outcomes 
however it clearly lacks empirical evidence. 
 
The second research approach is metric focused. Especially Clark and Ambler 
(2001) cite examples of metrics companies can use along the productivity 
chain, including financial, non-financial and market based assets, such as the 
firm’s market orientation and competitive position. There is a discussion on 
several of the financial measures in the literature such as return on investment, 
marketing margin, or economic value added (Seggie et al., 2007). The 
criticism in the literature on the financial measures is that these are often 
standalone measures and that marketing entails more than just the existence 
of financial measures (Seggie et al., 2007).   
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The third research approach focuses on exactly this, namely: Sustaining brand 
equity (Aaker, 1991). According to Aaker (1991), the measurements of brand 
equity are: brand loyalty measures, perceived quality or leadership measures, 
associations or differentiations of a brand, and awareness measures. The 
criticism that is often made in the literature is that many of these performance 
measurements come from a consumer psychology and are subjective in 
nature.  
 
As just described, there are several marketing performance measurements 
available in the literature; however, very few studies have been done using 
these measures in an empirical setting. In a study by O’Donnell (2000), 
marketing performance as a result of marketing standardisation was 
investigated. The performance measures were defined by sales volume, 
market share and market development of the subsidiary (O'Donnell and 
Jeong, 2000). However, the measures were subjective responses pertaining to 
the subsidiary performance relative to headquarters’ expectations. No real in-
market performance measures such as actual sales or market share results 
were used in this research. This is a clear gap which this research project 
hopes to address. Interesting in this study and in O’Sullivan’s study (2007) is 
that the subsidiary size and age was used as a control variable on the 
performance measurements as they were proven to be influential. 
 
The only publication using real outcomes data is an industry publication, 
conducted by IMS health, a leading provider of market intelligence to the 
pharmaceutical and healthcare industry. They conducted the largest study in 
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launch performance in pharmaceutical industry by analysing the launch 
performance of 4225 launches of 2470 pharmaceutical products in eight major 
markets between 1994 and 2004. The study ranks the product launch success 
according to three criteria: 
 Market Dominance: Successful products took a dominant share (first or 
second place) in the market within two years. 
 Promotional Effectiveness: Gaining superior market share relative to 
their competitive share. 
 Maximising Opportunity: Achieving a steep launch curve and deep 
market penetration during their brief launch window. The launch 
trajectory is typically set within the first six month of launch. 
 
The market performance measures used here are a mix of market position, 
i.e. market share and market share uptake as well as promotional 
effectiveness, which have not specifically been defined in the literature.  
The outcome measures is a mix of the measurements use by Rust et al, 
(2004) measuring market productivity, such as a launch outcome and are very 
much in line with the metric approach used by Clark and Ambler (2001) using 
purely financial data such sales volume and competitive position. 
IMS Health measures and collects the actual empirical sales data in a given 
market or county of pharmaceutical products for the pharmaceutical industry. 
 
Of the 4225 product launches analysed, only 88 product launches met all 
these three criteria in at least one country and just 35 in two or more countries 
(MacCarthy and Gascoigne, 2007). Reviewing these outcomes, even the new, 
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differentiated pharmaceutical products are not as successful in launching as 
they could be according to the study (MacCarthy and Gascoigne, 2007). 
Questions can be raised if the three criteria for launch success described on 
the previous page were too strict that only so few launched could be defined 
as successful. However these measures match the outcome measures used 
in the literature by O’Donnell and Jeong (2000) very well who used, sales 
volume, market share and market development. Therefore these outcome 
criteria have an overlap in the literature and form a good basis for the 
performance measures evaluate product launch performance in this research.  
 
 
2.8 Summary of Literature 
 
The concept of Interdependence in organisational design and management is 
more widespread and complex than many researchers currently acknowledge 
(McCann and Ferry, 1979). Interdependence contextually has many reference 
points in the literature as proven by the many related fields in the literature. 
This also indicates the complexity of this topic. 
 
There is an evident gap in the literature as there is no direct link between level 
of interdependence and subsidiary outcomes established in empirical studies. 
In particular, the issue how interdependence influences the subsidiary product 
launch performance is not specifically addressed in the literature.   
 
Furthermore, the empirical evidence of marketing performance is 
underdeveloped. The literature indicates that product launch outcomes can be 
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measured, in terms of sales volume, market shares and market uptake. The 
literature indicates that subsidiaries working interdependently with the 
headquarter organisation could lead to better overall company performance, 
however factors between interdependent headquarter-subsidiary relationships 
and subsidiary performance, in particular product launch performance have 
not been adequately addressed in the literature. This exploratory research 
aims to make a contribution in this area. 
 
In the next chapter a concept will be presented, outlining theoretical arguments 
which high level of interdependence between headquarter and subsidiary 
organisation may lead to better subsidiary product launch performance and 
identify factors that may potentially detract from this relationship.    
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3. GUIDING CONCEPTUAL BACKGROUND 
 
 
The conceptual background will synthesise several of the aspects of the 
literature described in the previous chapter and will build a guiding conceptual 
background that provides a rationale for why interdependence could lead to 
better launch outcomes. Counter pressures or detracting factors from the 
subsidiary will also be included. This conceptual foundation will be used as a 
basis for the explorative analysis in this case study.  
 
3.1 Linking Interdependence to product launch outcomes 
 
The literature describes a link to improved performance in relation to 
interdependent working relationships between headquarters and subsidiaries, 
albeit with limitations. In this chapter the argument will be made that there is a 
direct positive relationship between the level of interdependence and 
marketing related outcomes. The conceptual framework of this research is not 
aimed at whether there is interdependence or not between the subsidiaries 
and headquarters, but is more focused on the optimisation of interdependent 
relationships to get buy-in from the subsidiaries in jointly developing global 
marketing concepts. There is recent evidence in the literature that global 
standardisation was positively related to organisational performance in high 
tech industries (O'Donnell and Jeong, 2000). The pharmaceutical industry can 
be defined as high tech industry and there are several arguments which can 
be made why working interdependently can help standardisation and 
furthermore, directly lead to improved marketing or product launch outcomes.  
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First, co-developing global marketing concepts with local subsidiaries will 
facilitate the subsidiary buy-in and adoption of the positioning and messaging 
around the new product. There is ample support in the literature viewing the 
subsidiaries as learning organisations. The leverage of knowledge, can 
enhance the capabilities of the subsidiary (Birkinshaw et al., 2005), which 
supports the fact that subsidiaries can enhance their innovative abilities and 
increases competitiveness. Especially during product launches some 
subsidiaries may benefit from the crosspollination of novel ideas 
(Subramaniam and Watson, 2006) and thereby come to better efficiency in 
approaching the market with better outcomes. 
In addition, the argument is supported that interdependence leads to a better 
pool of cumulative knowledge that can be leveraged worldwide (Doz et al., 
2001; Watson and Hewitt, 2006). This in itself could lead to higher 
performance as it enables the subsidiaries to leverage the market expertise 
and competitive information from other subsidiaries, thereby making better 
strategic competitive brand decisions (Porter, 1990).  
Furthermore, it should make the subsidiaries better equipped to handle 
competition as they have superior information and can react better and faster 
to incumbent threats (Roth, 1995; Porter, 1986) and thereby enhance business 
results. 
 
Second, since the marketing materials are conceptually already made, just 
local adaptations need to be made, as “no total standardization is conceivable” 
(O'Donnell and Jeong, 2000), the argument can be made that this would save 
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duplication of efforts as just minor adaptations have to be implemented instead 
of the development of new marketing materials from the ground up. The 
duplication would be both in product management time as well as marketing 
budget, whereby the local sales should benefit as more marketing funding is 
available to in-market use as it is not spent on advertising concepts and 
agency fees. Therefore, a high degree of interdependency can lead to better 
optimised investment.  
 
The basis for this argument lies in managing along the value chain, if concepts 
are worked out at the global level and not duplicated in the countries, 
resources can be saved or put to better use in the market (Kogut, 1985). 
Furthermore, if the organisation does not duplicate all effort locally it has more 
funds available to shape the customer perception of the superior benefits of 
the product which will then translate to better sales and business results. 
Alternatively, economies of scale can potentially be realised as well, in 
particular if purchases are bundled and coordinated on a global scale for the 
countries. 
 
Third, expertise and specific capabilities can be drawn into the global team. 
Subsidiaries can be given a global mandate to help. Roth and Morrison (1992) 
propose this approach whereby responsibility is decentralised but centrally 
managed. This constitutes an interdependent relationship as the subsidiary is 
now responsible to global projects. Marketing managers with specific skills or 
capabilities can be added as “extended experts” to the global marketing group. 
For example, in the case study, the Bayer UK organisation has to deal with 
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strict health economic requirements from the external governmental groups 
like NICE have advanced capabilities to develop health economic arguments 
that could facilitate the sales force in conveying economic benefits of newer 
oral anticoagulant compounds, such as Xarelto® on the market. In this case 
study, a health economic manual was built with the help of several countries 
that have these capabilities, thereby extending the expertise of the global 
marketing group and obtaining local buy-in and ultimately producing a global 
sales tool that works in local markets. This has created a situation of mutual 
dependence between headquarter and a subsidiary for producing global sales 
arguments and marketing materials.   
 
Fourth, the organisation as a whole can benefit from transferring resources, 
competencies and information to other parts of the organisation (Anderson et 
al., 2002).  
“A firm’s network can be seen as a resource in itself. Through the social 
network, the firm gets access to resources and capabilities outside the 
organisation, such as capital, goods, services, innovations etc”.  
 
Not only the internal network is relevant for the organisation or the subsidiary, 
also the external network that the subsidiaries have may enhance the 
competitiveness and performance. The network can be seen as a strategic 
resource that has both structural as well as relationship dimensions.  
There is wide support in the literature for the notion that subsidiaries can draw 
from specific knowledge or have access to specific resources and become 
better equipped to handle the competition and thereby enhance performance 
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(Kogut, 1985; Porter, 1990). Therefore, it can be argued that if Bayer could 
harness marketing talent from outside the global group and put them to use for 
central concepts, its marketing groups and expertise would be larger or better 
used than that of the competition and could lead to better product launch 
performance. Hence the argument is postulated that there should be a positive 
correlation between product launch success and an interdependent resource 
sharing. 
 
3.1.1 Linking Product Launch Performance to Organisational Performance 
 
The pharmaceutical industry is considered a high-tech industry whose 
lifeblood depends on continuous innovation. New product launches are 
therefore a necessity for the success and growth of the pharmaceutical 
companies. Successful Product launches are therefore high important and can 
function as a proxy for organisational success.  
The advantage of using product launch outcomes data rather than overall 
subsidiary performance measures is that all the subsidiaries have a similar 
starting with the launch of the new product. There are relatively few economic 
or cyclical influences that can skew or bias outcomes results. Since in this 
research real empirical launch data can be captured, this provides a 
measurable alternative to subsidiary success.  
 
Headquarter and subsidiary interdependence is in a sense already present as 
outlined in the introduction, as the product are developed and produced 
centrally, but distributed via the local country subsidiaries. The interaction 
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between headquarter and subsidiary organisation can be observed and 
measured and the arguments made in the literature validated. In particular, 
interdependent working relationships between headquarters and subsidiaries 
can be brought in relation to launch performance. When they work 
interdependently with one another, a certain level of exchange is necessary 
and factors just described such as avoiding duplication of efforts, aligned 
messaging and branding, building a mutual knowledge base and harnessing 
the marketing capabilities of the top performing subsidiaries should enhance 
the product launch performance of the respective subsidiary. The marketing 
teams or capabilities in the team would become significantly larger, when they 
work interdependently together than they currently are and potentially larger 
than the competition leading to a competitive edge as outlined in the literature. 
Furthermore, the subsidiaries could be given partial responsibility to develop 
global marketing materials or activities, alleviating the headquarters’ burden 
and allowing them to focus on other strategic responsibilities, thereby creating 
country buy-in and reciprocity. This will foster a mandatory exchange or 
dialogue as activities are to be executed locally taking the global branding 
guidelines, ideas and standards into consideration. This in turn facilitates the 
knowledge exchange, avoids duplications and harnesses the inputs and 
expertise from the subsidiaries and therefore should enhance product launch 
performance. 
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3.2 Potential Counter Pressures to Headquarter-Subsidiary 
Interdependence 
 
The benefits of headquarter and subsidiaries organisations working in an 
interdependent manner which each other has been theoretically established. 
The question however is why the implementation in practice is lacking. The 
literature, indicates that there are several counter pressures from the 
subsidiaries to potentially work interdependently with the headquarter 
organisation.  
 
First point, the subsidiary has to give up some of their local autonomy or 
interests and be open for global mandates (Bartlett and Ghoshal, 1992).  In 
general the assumption is that the subsidiaries will only be interested in how 
they best apply their own resources in their respective markets (Makadok, 
2001) and not be guided by a headquarter organisation subsidiaries on how to 
best utilise their resources. Political battles could ensue  
 
Second, interdependence can also be source of inter-unit conflict (McCann 
and Ferry, 1979), especially if there is a difference in mutual perceptions of 
interdependence. This may lead to differences in coordinating behaviours, for 
example one subsidiary finds weekly contact enough, and headquarters wants 
a daily update. The conflict is more likely if there is incongruence on this point 
(McCann and Ferry, 1979).  
 
Third, issues with the reciprocity in interdependent relationship or opportunistic 
behaviours of the subsidiary can occur. This is especially true when the 
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subsidiary is shirking their reciprocal responsibility, whereby they take part in 
the transactions, but do not reciprocate to the same level or at all (Watson and 
Hewitt, 2006).  
Collaborative intent and trust development can therefore be seen as important 
antecedents to a productive collaboration between headquarter and 
subsidiaries (Tasoluk et al., 2006). “Convincing both parties of the expertise of 
the other party” is deemed essential for effective collaboration (Tasoluk et al., 
2006) and suggests that communication is the key variable in collaboration 
between headquarters and subsidiary to ensure proper reciprocity is given by 
both parties. 
 
Fourth, high interdependence needs resource investments to coordinate and 
manage interdependent relationship (O'Donnell, 2000). This increased sharing 
of information and coordination associated with increased interdependency is 
costly to the subsidiaries (Van der Vegt et al., 1999). There may be differing 
views on what is needed to support the interdependent relationships and the 
level of investment needed. Again conflicts may arise if the subsidiary is not 
able or willing to support the communication efforts to the same degree as 
other subsidiaries. 
 
Fifth, there is also evidence that unmanaged interdependence leads to higher 
administrative turnover due to the turbulence and difficulty of managing these 
relationships (Salancik et al., 1980). Therefore subsidiaries must have the 
capabilities of the subsidiary to maintain and support these relationships and 
this is highlighted in the literature as moderating effect if they do not (McCann 
 61 
and Ferry, 1979; Roth, 1995). Controversially, the subsidiaries with high 
capabilities seem to be less likely to work on an interdependent level as they 
deem themselves to be more autonomous and less in need to headquarter 
assistance or support (Roth, 1995).  
 
Several additional moderating factors on interdependent relationships can be 
rationalised.  
Sixth, imperfect information (McCann and Ferry, 1979), when the subsidiary is 
not aware of the potential benefits of the relationship, or perceives the benefits 
as very different, they may not be willing to support these interdependent 
relationships.  
 
Seven, a moderating effect is the variability in the relationship outcome 
(O'Donnell, 2000), variability or uncertainty in the outcome or benefit of the 
relationship, may also lead to diminished willingness to support these 
interdependent relationships.  
 
The multitude of factors, just described, indicate that building and maintaining 
these interdependent working relationships does not go without ambiguities. 
The concept of interdependence presents benefits, but also a lot of detracting 
factors which may create counter pressures from the subsidiary, where the full 
benefit of interdependence will not come to fruition and this may affect 
performance.  
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3.3 Summary and Guiding Conceptual Background 
 
A multitude of factors have been identified in the literature where established 
interdependent working relationships can enhance product launch 
performance on subsidiary level, as well as detract from this performance, 
these are captured in the guiding theoretical background framework 
 
The positive factors are leveraging standardised global marketing materials 
(O'Donnell and Jeong, 2000), avoiding duplication (Kogut, 1985), better 
information and knowledge exchange, which would lead to a better competitive 
position (Porter, 1990; Doz et al., 2001; Watson and Hewitt, 2006), country 
buy-in and reciprocity (Roth and Morrison, 1992) and access to a wider 
organisational resource network (Anderson et al., 2002). 
 
Detracting factors outlined in the framework are local autonomy (Makadok, 
2001),  incongruence in responsiveness and outcomes (McCann and Ferry, 
1979), Necessary collaborative intent or trust (Tasoluk et al., 2006),  Increased 
resources to manage interdependence (O'Donnell, 2000) and potentially 
employee turnover (Roth, 1995). 
 
Figure 4: Guiding Theoretical  Background  
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There are a multitude of factors that support the interdependence performance 
relationship a several that detract from this relationship as outlined in the table 
above. The gap in the literature linking interdependence directly to product 
launch performance was identified and therefore, exploratory research is 
needed to explore if building interdependent working relationships the 
subsidiary marketing teams and headquarter organisation does indeed lead to 
improved launch performance, and which factors moderate this relationship in 
the positive or negative way.   
 
In the next chapter, the methodology this exploratory research will be 
presented. 
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4. METHODOLOGY 
 
 
 
The current chapter describes the research structure, epistemology, 
methodology, methods for data collection and analysis. Due to the complexity 
of the topic of interdependence, a mixed method case study research 
approach is chosen to answer the research objective. “The benefits of a mixed 
method approach is in capturing a holistic picture of the subject matter and 
possibly uncover surprising features” (Jick, 1979). Additionally using multiple 
methods may increase the validity of the findings in an exploratory case study 
(Eisenhardt and Graebner, 2007; Jick, 1979; Yin, 2003).  
In the Bayer organisation, there is now the opportunity to investigate the link 
between the level and direction of interdependence and product launch 
outcomes with Xarelto®, a novel oral anticoagulant.  At of the end of 2008, 
Xarelto® had been launched in all five regions around the world, and an 
estimated thirty subsidiaries have generated launch outcomes data with the 
new introduction of Xarelto® within the first year of launch. Data from a 
multitude of subsidiaries in the same company supports this case based 
exploratory research approach.  
 
4.1 Research Structure 
 
The research is built up in three stages. Stage one started with the results of a 
country survey of the Bayer Healthcare subsidiaries involved in the launch of 
Xarelto®. The country survey captured background data of the subsidiary and 
established an interdependency rating of each of the launching subsidiaries at 
the time when the first countries are launching. Also, questions pertaining to 
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lateral integration and information flows between headquarters, regional 
headquarters and subsidiaries were asked in the survey, as well as 
relationship aspects. The reason the research commenced with the survey 
instrument was to obtain the relationship aspects unbiased from launch results 
at the time point of the first country launch. This is highly relevant as political 
power plays often arise if and when launch results are not satisfactory as 
outlined in the literature (Subramaniam and Watson, 2006). This may bias the 
subsidiaries’ feedback on the interdependence rating in the interviews. In order 
to avoid this, a survey captures a base-line status of the interdependent 
working relationship at the time of launch. 
 
In the second stage, the launch results were tracked and collected from the 
subsidiaries after the launch of Xarelto®. Both the interdependency score as 
well as the actual launch results helped to identify the subsidiaries for 
subsequent analysis through in-depth interviews. The interviews were 
conducted with the subsidiaries after real launch results were collected for a 
minimum of six-month period of actual in-market sales after the subsidiary 
launched of Xarelto®.    
 
Conducting the survey before the launch outcomes were known is relevant as 
it will help to select the appropriate subsidiaries and frame the subsequent 
interviews. Having this data before conducting the interviews, the relationships 
can be explored much better with the survey data at hand and factors can be 
uncovered that indeed enhance or detract from these interdependent 
relationships. 
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Below is a schematic overview of the research methodology: 
 
 
Figure 5: Methodology Overview 
 
 
4.2 Multi-Method Exploratory Case Study Approach 
 
A case based study is defined by Gillham (2000) as: “A unit of human activity 
embedded in the real world, which can only be studied and understood in 
context, exists in the here and now, and merges in with its context so that 
precise boundaries are difficult to draw”. 
A case study applies very well to analyse the research objective posed, 
because it deals with the Bayer Healthcare organisation as an entity and its 
current organisational development. The research can be defined as a single 
case study, whereby the launch of Xarelto® in the subsidiaries of the Bayer 
Healthcare will form the foundation for this study in which the academic theory 
of interdependency will be explored in an empirical situation (Yin, 2003).  
 
The goal of this case study is to “collect, present and analyse the data fairly 
and provide a compelling report of real events” (Yin, 2003).  
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Supportive argumentation for the case study can be made as there are many 
factors which can influence the launch performance of a subsidiary, which may 
not be related directly to interdependent headquarter-subsidiary relationships. 
There may be factors that may have a greater influence on the outcomes of 
the subsidiary than the interdependent relationship per se. For example, if the 
third-party payers in a country are not willing to reimburse Xarelto® or place 
severe restrictions on reimbursement, like high co-pays for patients or volume 
restrictions for Xarelto®, the launch success will be affected. This may have a 
greater influence on the subsidiary performance as interdependent working 
relationships. These factors may also need to be considered and better 
understood for the benefit of interdependence to potentially have on the 
success of a global product launch.  
 
The strength of a case study is the possibility to understand complex social 
phenomena (Yin, 2003). To increase the understanding of the phenomena, 
using mixed methods can effectively help to capture a more holistic picture 
(Jick, 1979). Additionally, it has been argued that using different data collection 
methods, can increase the validity of the findings (Jick, 1979; Yin, 2003; 
(Eisenhardt and Graebner, 2007). This has been a point of criticism in solely 
qualitative case studies and is addressed in this research by including 
observations, survey methods and interviews.  
The combination and usage of this multi-method approach can best bet 
described as “triangulation” which has the advantage that the weakness of one 
data collection method is offset by the other (Morvaradi Behrooz, 2004). A 
multi or mixed method study is defined as: “Involving the collection and or 
 68 
analysis of both quantitative and or qualitative data in a single study in which 
the data are collected concurrently or sequentially and are combined at one or 
more stages in the research” (Hurmerinta-Peltomäki and Nummela, 2006). 
 
An important point of differentiation to the research described in the literature 
review is that this exploratory case study uses real outcomes and performance 
measures.  
 
A systematic assessment of the influence of interdependence of the subsidiary 
and subsidiary performance has been conducted in this research, by collecting 
baseline information on the interdependence the subsidiaries exhibited at 
launch and then exploring the subsidiary outcomes in detail. The benefit of 
using multiple methods is that it can lead to new insights by applying mixed 
methods in the integration or implementation phase (Hurmerinta-Peltomäki 
and Nummela, 2006).  
 
Furthermore, it helps to capture a more holistic picture of subsidiary 
interdependence and outcomes, which quite nicely overlaps with the potential 
advantages of case studies (Jick, 1979).  
 
In conclusion, for the complex nature of this research the use of different 
research methods in the same research was warranted to help obtain critical 
insights in subsidiary interdependence and outcomes. 
 69 
 
4.3 Theoretical Research Environment 
 
 
The research has been embedded in the social network theory (Nahapiet and 
Ghoshal, 1998). This is appropriate when we look at interdependent 
relationships within the Bayer organisation. It is important to highlight the 
origin of the company as it followed a more patriarchal development which is 
not uncommon with European based multinational organisations. The 
subsidiaries are directly reporting to corporate headquarters, the subsidiaries 
are relatively autonomous, informal personalised relationships exist with 
headquarters, and there is a division according to product and technology 
characteristics (Hedlund, 1984; Franko, 1975). 
Its strategy can therefore be characterised as: "Building a strong local 
presence through sensitivity and responsiveness to national differences" 
(Bartlett and Ghoshal, 1989; Hedlund, 1984). Local differentiation and the 
capability to respond to differences in distinguished national markets have 
been the key strategies for local subsidiary success. This is important because 
as there is a good network structure within the organisation, this may be 
different from organisations who have followed a more centralistic or 
multinational approach (Perlmutter, 1969; Enright, 2005; Kono, 1984).  
 
With the growing size of the organisation and the acquisition of Schering A.G., 
the product diversity has increased and the organisation moved into a regional 
management structure (Bayer Press Release, 2007). This makes the 
organisation more complex and there is a move away from a pure paternalistic 
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structure with its personalised relationships and independent subsidiaries 
(Malnight, 1996) towards a more integrated and interdependent organisational 
network (Doz and Prahalad, 1991; Nohria and Ghoshal, 1997; Gupta and 
Westney; 2003; Inkpen and Tsang, 2005).  
 
This research environment provided us with an excellent opportunity to 
conduct this exploratory case study. It allowed for an in-depth analysis to find 
out if the theoretical arguments on the benefits hold up in a real world empirical 
setting. In addition, we can confirm some of the counter pressures and provide 
insight into how successfully build and sustain interdependent relationships 
and how these are linked to successful product launch outcomes. 
With the launch of Xarelto® taking place within Bayer and the headquarter 
organisation coordinating the global launch with their subsidiaries provides a 
research environment to investigate how interdependence can contribute to 
launch success. 
 
4.4 Empirical Research Environment 
 
 
The international marketing organisation of Bayer went through several 
changes during the research period. This may have influenced to the research 
and the potential outcomes. Before the merger between Schering A.G. and 
Bayer Healthcare A.G., in 2006, Bayer had a centralized marketing structure, 
whereby regional marketing colleagues were paid by their region were 
physically part of the global team at the Bayer Healthcare headquarter 
organisation in Wuppertal, Germany. Brand strategies were centrally 
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developed and cascaded out directly from the global team to the countries by 
the regional colleagues, who were responsible for the implementation in their 
respective regions. The clear advantage of this structure is that the global 
strategy and know-how are directly carried over into the regions and the 
regional marketing colleagues, who are part of the central group, have all the 
strategic knowledge and are capable of transferring this know-how (figure 6).  
 
 
Figure 6: Centrally Driven Marketing Structure - Bayer Model 
 
Schering worked with a regional marketing structure. Rather than having larger 
global teams, they worked with smaller global team who just set the strategy, 
branding and implementation, which was completely regionalised for the 
different global regions. Here the regional teams were larger and had quite 
some autonomy with regard to branding, messaging and marketing roll out. 
The advantage of this structure is a closer alignment to the needs of the region 
and being able to tailor the marketing materials accordingly (figure 7). 
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Figure 7: Regionally Driven Global Marketing Structure - Schering Model 
 
With the merger between Bayer Healthcare and Schering in 2006, these two 
structures co-existed next to each other in the newly formed Bayer Schering 
Pharma A.G. It was at this time the research was conducted, a further 
refinement to the global-country structure was made, namely the 
establishment of a global brand leadership team with direct connection to the 
global group. The main countries are part of the global brand leadership team 
and meeting in person or virtually to make relevant decisions on the brand 
(figure 8). 
Figure 8: Integrated Global Marketing Structure 
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This was thought to have the benefit of the countries having direct influence on 
the brand strategy and foster collaborative global-country interaction.  
 
Another organisational change occurred in the spring of 2008, when Xarelto®, 
which was originally part of the Specialty Medicine Group, moved into the 
General Medicine group. As a consequence, several marketing colleagues in 
the countries continued with other responsibilities for other products within the 
Bayer Healthcare Portfolio. For the global marketing group, this meant a rapid 
re-establishment of working relationships with the country colleagues, as this 
change happened nine months before the first countries were launching.  
 
This section may have provided some of empirical circumstances and 
background in which the research took place. In the next section the scientific 
context of the research is explained. 
 
4.5 Research Philosophy: Scientific Realism 
 
 
The objective of this research is to explore the theory of interdependence in a 
case study approach within the Bayer Healthcare organisation. The 
applicability of the theory of interdependence will be assessed in an empirical 
environment. This section will highlight some the theoretical knowledge 
approaches and associated research methodologies used, as well as the 
epistemology during the different phases of this research.  
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In the survey section, the implicit underlying assumption is that corporate 
behaviour can be objectively observed, collected and measured. “Positivistic 
approaches assume that things can be studied as hard facts and the 
relationship between these facts established as scientific laws” (Smith, 1998).  
 
The observations made, take place in an open system as opposed to a closed 
system, much like a laboratory where the researcher can control the 
experiment free of outside influence (Sayer, 1992). Therefore it is important to 
acknowledge the states of complexity and that the research is open to 
multiple, causal influences (Hodson, 2004). Also, the observed marketing 
managers within Bayer may behave different in different situations, based on 
their intrinsic properties. When observing the subsidiaries, we may find certain 
patterns of behaviour in dealing with interdependence. This assumes a 
positivistic stance, since the behaviour may be observable and is anticipated 
to happen with empirical regularity (Smith, 1998). This process of knowledge 
development is called induction, which is the recognition of patterns and 
establishing a tentative ideas or hypothesis (Hodson, 2004).  
As previously outlined, the research will be enhanced by conducting in-depth 
interviews to explore these patterns. Social behaviour of the subsidiary is 
observed and studied, in particular, the collective behaviour of individuals in 
an organisation in a certain industry across different cultural regions and 
countries. Therefore, one can argue that using interviews as part of the 
research methodology, the knowledge gathering is more on the other side of 
the epistemological spectrum called ‘phenomenalism’, which defines that only 
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knowledge gained through observed experience can be taken seriously 
(Smith, 1998).  
As both marketing and business executives are interviewed within the Bayer 
Healthcare organisation, a “sense” or an “experience” from the company will 
be obtained. The knowledge and insight cannot be separated from that 
experience. The solely positivistic stance is too abstract and simplistic to 
encompass our research conclusions solely based on a positivistic stance 
(Smith, 1998). Also the interviews, one of the primary research methodologies 
used, in this exploratory case study do not particularly support the positivistic 
approach as it can be criticised for lacking scientific rigor (Hodson, 2004). This 
is due to the fact that it is hard to measure interview data factually and 
objectively. “Invisible factors” and interpretation of the interview results do 
support a phenomenalistic approach.  
  
The best epistemological approach that combines both viewpoints yet 
includes enough of the more empirical approach to make some predictions, 
and includes an understanding of causal relationships and intangible aspects 
is called, social realism. The realism is defined as “ a standard set of concepts 
for describing the operation of any social system. (Pawson and Tilley, 1997) 
and social systems “comprise the interplays of individuals and institution, of 
agency and structure and of micro and macro processes” (Pawson and Tilley, 
1997).  
This epistemological concept best describes and fits with the underlying 
assumptions of the research that was conducted. A “realist emphasises the 
ways in which all social structures are ultimately related to concrete practices 
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of members of a society” (Smith, 1998). If society in this case is defined as an 
organisation, like the Bayer Healthcare organisation, this definition by Smith 
also fits very nice with the realm in which this research takes place. It 
balances the focus on experience and the constructivist approach; “truth and 
meaning are created by a person’s interaction with the world, therefore, 
knowledge and meaning are created, not discovered” (Hodson, 2004). Hence 
the realist view is the prevailing stance here and contrasts well to the positivist 
view. The realist view has the following characteristics, which fit very well with 
the research methodologies used in this thesis (Sayer, 1992; Hodson, 2004): 
 Seeks explanations in particular situations; this research was conducted in 
organisations that are operating in a rapidly changing global environment.  
 Complex structuralism;  this research measured organisational behaviour 
across different cultures 
 Agents are embedded; many factors influence choice and action 
 
After comparing the two opposing viewpoints, empiricist and phenomenalism, 
the social realist view best defines the claim to “truth” that we will try to convey 
from this research. 
 
4.6 Phase I: Background Survey of the Bayer Subsidiaries 
 
The first phase of the research explains the setup and conduct of the survey 
with the Bayer subsidiaries to capture baseline data and important subsidiary 
characteristics as well as an assessment of various relational aspects. 
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The aim of the survey was to obtain an unbiased picture at launch of the 
headquarter-subsidiary relationships, and measure the interdependency levels 
of the Bayer subsidiaries.  
The survey was sent to the marketing and business managers in all Bayer 
Healthcare subsidiaries, where there were pre-marketing activities on-going at 
the time. 
An eight question interdependency score previously validated in the research 
by (Subramaniam and Watson, 2006) has been used to categorise and map 
interdependency levels of all the subsidiaries within the Bayer Healthcare 
organisation. The same questions will be used to capture the interdependence 
levels of the subsidiaries and will be explained in more detail in the next 
section. 
 
4.6.1 Model of Interdependence 
 
Subramaniam and Watson (2006), have used a configurational approach to 
study interdependent relationships looking at 115 headquarter subsidiary pairs 
in their research and confirmed that the subsidiaries of a multinational 
company vary in terms of scope, directionality and level of interdependence 
and as such they correspond to the profiles of “lone stars”, “passive stars”, 
“dominant stars” or “constellation stars” (Subramaniam and Watson, 2006; 
O'Donnell, 2000).   
The lone stars are subsidiaries characterised by a low degree and narrow 
scope of interdependence, with no significant influence directed at another 
subunit. These subsidiaries would primarily be sales organisations in a 
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country, products & marketing concepts are provided by the headquarter 
organisation. Therefore there is little need for interdependency. A moderate 
degree of interdependence which is narrow in scope, typically limited to 
headquarters indicates a passive star, however passive stars exhibit bi-
directional interdependence with headquarters (Subramaniam and Watson, 
2006). From an agency theory perspective, passive stars can be viewed as 
agents of the parent organisation (Roth, 1995). Dominant stars on the other 
hand are characterised as having a moderate degree of interdependence, 
which consist of a broad scope and unidirectional influence to other 
subsidiaries and to headquarters (Roth, 1995). These are subsidiaries, which 
have some special competencies or entrepreneurial capacities and can make 
contributions to headquarters or to other subsidiaries (Birkinshaw et al., 2005). 
Finally, constellation stars are subsidiaries characterised by a high degree of 
interdependence and a broad scope and multidirectional influence, with 
influence also flowing from other subunits (Roth, 1995). This would be typical 
of a subsidiary in the transnational organisation and is consistent with other 
empirical studies (Bartlett and Ghoshal, 1986; Enright, 2005). 
 
Subramaniam and Watson (2006) used and eight item scale based on the 
work form O’Donnell (2000) that asked the questions associated with direction 
and level of interdependence between the headquarter and subsidiary pairs 
and subsidiary to other subsidiaries. The focus of this research is primarily on 
headquarter and subsidiary interdependence. For completeness all eight 
questions were included in the survey, which can be found in appendix A.  
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In the survey a short introduction to the interdependence section was to 
ascertain the mutual dependence on headquarters and other subsidiaries for 
their success in the launch preparation of Xarelto®. The participating country 
respondents were asked on a five point likert scale how they rated their 
dependence on the headquarter organisation for the pre-launch activities of 
Xarelto® in the following questions: 
1. Subsidiary depends on the effective functioning of headquarters to keep 
performing its task effectively 
2. The activities of headquarters influence the outcomes of the subsidiary 
3. Headquarters depends on this subsidiary to effectively perform its tasks 
in order to continue to perform its tasks effectively 
4. The activities of this subsidiary influence the outcomes of headquarters 
 
The next four questions related to the mutual dependence on other 
subsidiaries: 
 
5. This subsidiary depends on the effective functioning of other foreign 
subsidiaries to keep performing its tasks effectively 
6. The activities of other foreign subsidiaries influence the outcomes of 
this subsidiary 
7. The activities of this subsidiary influence the outcome of other foreign 
subsidiaries 
8. Other foreign subsidiaries depend on this subsidiary to effectively 
perform its tasks in order to continue performing its tasks effectively 
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The focus of questionnaire was on launch preparation tasks, so this measure 
seems appropriate as it highlights the interconnectedness of the headquarter 
activity in the launch preparation of the subsidiaries.  
The coefficient alpha in the literature for this eight item scale was 0.82, 
indicating a high level of internal reliability (Subramaniam and Watson, 2006). 
 
The last four questions of the interdependence scale were repeated but for the 
regional headquarters which had come into existence after the Schering A.G. 
acquisition as described in section 4.3. 
 
4.6.2 Other Survey Parameters 
 
As identified in the literature review, levels of information exchange, frequency, 
complexity and content have played a role as factors affecting 
interdependency (McCann and Ferry, 1979). Therefore questions with regard 
to lateral integration are also included in the survey. 
 
A subjective assessment of the countries’ opinion on the headquarter-
subsidiary relationship is also made, i.e. the question whether the subsidiary is 
satisfied with the headquarter-subsidiary relationship. This is done as a control 
variable to the questionnaire. 
 
Recently published literature has demonstrated that subsidiaries of a 
multinational organisation develop a unique and differentiated set of 
competencies and capabilities due to the different international environment 
they operate in (Birkinshaw et al., 2005). The competitiveness of the 
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organisation as a whole depends on how well it can tap into these valuable 
subsidiary resources and transfer them across the organisation (Bartlett and 
Ghoshal, 1986; Porter, 1990). Therefore a subsidiary competence measure is 
included, measuring the marketing competencies as outlined by Bartlett and 
Ghoshal (Bartlett and Ghoshal, 1986). And to measure how well a subsidiary 
can support managing interdependencies, a three question scale measuring 
this aspect, which was used and validated by Kendall Roth (Roth and 
Morrison, 1992). 
 
 
4.6.3 Survey Sample and Measures 
 
 
Questionnaires were sent to all relevant subsidiaries where business unit 
managers or marketing and product managers were designated to be involved 
or responsible for Xarelto® in their respective country. In total there were 125 
colleagues identified who were sent the survey questionnaire.  
The majority of the survey questions will contain a five point "Likert" scale 
ranging from: fully agree, agree, agree nor disagree, disagree to fully disagree. 
The survey contained the following parameters: 
- The eight-item interdependency questionnaire (O'Donnell, 2000)  
- Country capability and interdependency measures (Bartlett and Ghoshal, 
1986) (Roth and Morrison, 1992) 
- Subjective opinion of the country interactions from headquarters to the 
affiliate  
-  Questions on subsidiary characteristics: 
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 - Size (for revenue classification) 
 - Employees (organisational size) 
 - Standing in market place (ranking)  
 
A sample of the questionnaire can be found in Appendix A. 
 
The aim of using the survey instrument was to obtain baseline variables and 
an interdependency score of each of the participating subsidiaries, as well as 
an assessment from the subsidiaries on their working relationships, their 
capabilities and levels of interaction with other countries. This will facilitate the 
selection of the subsidiaries, for the ensuing in-depth exploratory analysis. As 
seen in the literature, an inverse relationship may exist between marketing 
capability and willingness to interact with headquarters, therefore this 
parameter is also included in the survey (Roth and Morrison, 1992). 
  
4.7 Phase II: Collection of actual launch results from the subsidiaries 
 
The aim was to collect actual launch performance data of the subsidiaries that 
launched Xarelto®. The first country to launch was Canada on September the 
16th, 2008, with the European Medical Agency, EMEA approval following on 
September the 30th with subsequent launches rolling out worldwide (Breum, 
2008).  
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4.7.1 Definition of subsidiary product launch performance measures 
 
As described by Philip Kotler (1984), typical successful marketing outcome 
measures are defined in terms of sales, market share and market share 
growth, as well as message and branding execution. These corroborate nicely 
with an industry study conducted by an industry research organisation, IMS 
health, where 4225 new product launches in the pharmaceutical industry were 
analysed as outlined in the literature section. In this study product launch 
success was defined as follows (MacCarthy and Gascoigne, 2007): 
1. Establishing a prominent place in the market: Successful products took 
a dominant share of sales (first or second place) in the market within 
two years. 
2. Promotional Effectiveness: Gaining superior market share relative to 
their competitive share. 
3. Maximizing Opportunity: Achieving a steep launch curve and deep 
market penetration during their brief launch window. The launch 
trajectory is typically set within the first six month of launch. 
 
The outcome measure used in this research will be along the same criteria as 
used by the IMS group, with some slight modifications.  
The subsidiary product launch outcome measures are end point is:  
 
1. In-country sales results as measured by IMS. The IMS sales result 
was publicly available and measured real in-market sales. 
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o An additional analysis will be conducted with relative sales 
results as many smaller countries were contained in the 
sample  
 
The definition of “sales-uptake” has been modified in the sense that the sales 
results have been be analysed over a period of a minimum of six consecutive 
months. The reason for using this slightly truncated sales data is to be able to 
conduct the research in an adequate timeframe as the launch outcomes. Also 
the launch outcomes are used to determine the selection of the subsidiaries to 
be interviewed and for this purpose the truncated outcome measures would 
suffice. 
 
2. Market Share, measured in percentage of patients who have 
undergone elective hip or knee replacement operations and who 
were put on Xarelto®.  
 
As antithrombotic agents are used for many different indications, market 
shares based on absolute numbers make it very difficult to ascertain the true 
use venous thromboembolic prevention in orthopaedic patients. Therefore the 
patient share, of patients who receive Xarelto® after having undergone these 
elective orthopaedic procedures was the best way of measuring the market 
share.  
 
3. Product market uptake or growth: Based on the IMS research 
(MacCarthy and Gascoigne, 2007).  
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The product or sales uptake data was collected from the countries directly and 
validated by an independent assessor who categorise these on a five point 
scale ranging from low to very fast. This was done by the regional marketing 
colleagues and not by the researcher himself to avoid bias and increase the 
validity of this outcome measure.  
 
4.8 Phase II: Combining the Survey Outcomes with the Subsidiary 
Product Launch Results  
 
 
The next step in the research process was exploring the existence of patterns 
between the interdependence scores and the outcome variables. As identified 
by Subramaniam and O’Donnell (2006) there was a relationship between the 
level of interdependency and the fit with the organisational type. In this 
research this relationship will be explored using real outcomes data on a 
subsidiary level. Several influencing factors described in the literature, such as 
size, age and competency of the marketing colleagues in the subsidiary will be 
cross correlated. The strength of the exploratory nature is that there is a wealth 
of data in the survey responses and the launch outcomes, that other aspects, 
such as the level of marketing capabilities in the country and lateral integration 
can be explored. In the literature this aspect was negatively correlated (Roth, 
1995). Such potentially opposite effects will be investigated. 
 
As previously described, this is a multi-method exploratory study. After the 
survey, countries were specifically selected based on interdependence levels 
and launch outcome parameters for in-depth interviews to obtain a more 
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robust insight into the drivers between interdependence and launch 
performance. The interviews were used to explore any potential relationships.  
 
4.9 Subsidiary Interviews 
 
 
Interviews were conducted with the marketing managers across the 
continuum from the best performing countries with high interdependent 
scores and high outcomes scores to the worst performing countries with low 
interdependent and low interdependence scores, included medium 
interdependence and performance levels. Also countries were selected 
where interdependence was high and the performance was low and vice 
versa, where interdependence was low and performance high. Ten in-depth 
interviews were conducted to obtain an understanding of the patterns found 
in the survey and the causal relationships of interdependence and product 
launch outcomes as previously described. The individual interviews were 
conducted using the findings from the questionnaire and investigated if there 
is potential evidence that these results were attributable to interdependent 
headquarter and subsidiary relationships. This enabled an in-depth analysis 
of the how and why behind interdependency of the subsidiaries and launch 
success within the Bayer organisation.  
 
4.9.1 Interview Questions 
 
The questions in the interviews were aligned with the questions from the 
interdependence scale (Subramaniam and Watson, 2005) in an attempt to 
 87 
investigate the factors that play a role in the interdependence performance 
relationship as outlined in the guiding theoretical background. The first 
question focused on understanding the country marketing colleague’s 
interpretation of the concept of interdependence. A subsequent question 
explored the rationale for their interdependence scores they gave in the 
quantitative survey. This provided a confirmation of the understanding of the 
concept of interdependence by the subsidiary managers and obtained their 
estimation of the headquarter-subsidiary interdependency levels. 
  
The next set of questions were formulated to understand how the support 
from the headquarter organisation had been perceived by the subsidiary 
marketing managers and which materials and initiatives the subsidiary 
marketing managers felt they were most dependent on to receive. These 
questions specifically focused on the subsidiary’s dependence on the 
headquarter organisation and were related to the first two questions in the 
interdependence scale from Subramaniam and Watson (2005). It could also 
highlight their levels of autonomy (O’Donnell, 2000), indicate their willingness 
to obtain knowledge from the headquarter function (Watson and Hewitt, 2006) 
as well as leverage global materials (Kogut 1985). 
 
The following questions focused on the subsidiary’s perceived contribution 
towards the global launch success. This was question was intended to explore 
the contribution of the subsidiary to the headquarter organisation. It would 
also uncover any goal incongruence and responsiveness of the marketing 
managers as outlined by McCann & Ferry (1979).  
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The next question was formulated to investigate factors where the interaction 
between the headquarter and subsidiary organisations did not work well, or 
where certain aspects could have been better. Factors such as resources 
needed to maintain the relationship O’Donnel (2000) and employee turnover, 
which were outlined as risks to interdependence Roth (1995) could be 
uncovered. 
 
The following questions investigated the factors important for building and 
maintaining interdependent relationships. These questions were often omitted 
in the literature. This research offered the ability to get more insights into what 
conditions need to be fulfilled to build and maintain these interdependent 
relationships, and in particular, how these interdependent relationships 
contributed to overall brand success. With these questions, the potential 
contributing factors in the interdependence performance relationship could be 
validated. 
 
The complete country interview guide containing the actual interview 
questions can found in appendix D. 
 
 
4.9.2 Interview Feasibility and Limitations 
 
The interviews were “open-ended” so any follow-up or clarifying questions 
could be asked  (Gillham, 2000). Also their answers may lead to greater insight 
into the subject and they may be probed to explain causal relationships.  
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The researcher has contacts with business unit management and marketing 
“experts” within the company subsidiaries, therefore it was realistic to obtain 
permission and time to conduct such interviews.  
 
One of the limitations of the interviews could be that the researcher is part of 
organisation and therefore an organisational bias cannot be excluded. 
Especially in case when the respondents have worked with the researcher, 
they may have formulated their answer to what the researcher may want to 
hear. The researcher had changed positions in the company during the 
conduct of the interviews and was no longer part of the global marketing group 
but working in a country organisation. This may have eliminated part of the 
bias, as the researcher was now part of subsidiary organisation and may have 
been perceived as such by colleagues when conducting the interviews. 
 
4.10 Methodology Summary 
 
This case study research project employs a multi-method approach using a 
country survey combined with actual real-world market data and follow-up 
surveys, using the Xarelto® launch as a case study. It is unique in using actual 
outcomes data, rather than subjective country management feedback, which 
was previously identified as a gap in the literature.   
By conducting the survey before the interviews with the country subsidiaries, 
interdependence and its relationship on product launch outcomes can be 
analysed without bias of launch results. Specific countries were selected 
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depending on the outcome of the survey and actual market results for further 
explorative interviews into supporting and detracting factors of the 
interdependence launch performance relationship. 
 
In the next chapter, the set-up and results of the quantitative country survey 
will be presented. 
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5. SURVEY RESULTS 
 
 
5.1 Introduction 
 
 
The results of the country survey will be presented in this chapter. In the first 
section, the survey set-up and the survey responses are presented and 
discussed, including, aspects which are relevant to the interdependent working 
relationships, such as country experience, interaction with headquarters, and 
the country’s opinions with regard to headquarter support.  
 
In the next section, the interdependence capability of the subsidiaries and the 
scores of the eight item interdependency questionnaire will be reviewed, 
followed by the captured product launch outcomes data from the countries. 
Relevant explorative analysis between the subsidiary responses and 
outcomes data will be presented, as well as an analysis of the 
interdependence score and the outcome measures.  
 
The aim of this chapter is to explore any relevant relationships between 
interdependence and the subsidiary launch data and to provide relevant 
information for the country selection for the follow-up interviews.  
 
5.2 Survey Set-up 
 
 
In December 2008, 125 surveys were sent out via the company intranet to the 
Xarelto® marketing and business management colleagues in 68 countries 
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around the world. A specific subsidiary in a country could receive multiple 
surveys as they went to Business Unit Heads, Senior and Junior Brand 
Managers in that subsidiary. For the quantitative data analysis having higher 
numerical response is desirable, therefore all the colleagues connected with 
the launch of Xarelto® were included in the survey. The survey was 
accompanied by an introductory letter, which introduced the nature and the 
reason of the survey and included assurances of anonymity. This was 
achieved by omitting any names from the respondents and by aggregating 
data presentations, so that the results could not be backtracked to one specific 
country individual. A full copy of the letter can be found in appendix B. 
 
5.2.1 Survey Sample 
 
The recipients of the survey were either the business and or the marketing 
managers who had significant involvement in the on-going marketing activities 
for the preparation of the launch of Xarelto® in their respective country, and 
who were on the weekly communication list for updates on Xarelto®. The list 
was updated to include only those subsidiary and marketing managers. Any 
other functions, for example, Country Pharmaceutical Division Heads or 
country Managing Directors, were screened out. 
 
The company intranet e-mail system, Lotus Notes®, was used to send the 
survey to the country business and marketing managers. As this on-line intra-
company system is generally used to reach the subsidiary marketing and 
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business unit colleagues it is an accepted method of communication with the 
subsidiaries.  
 
5.2.2 Survey Validation 
 
Before the survey was sent out to the marketing and business managers in the 
subsidiaries, the survey was piloted with several internal marketing colleagues 
and colleagues from the Bayer Market Research department. This activity was 
done prior to ensure comprehension of the questions and identify any 
misinterpretations.  Several editorial suggestions were provided and particular 
comments were made to avoid or eliminate bias in the questions asked. In 
addition the researcher received suggestions to provide a rationale and 
explain each of the sections so the context in which the questions were posed 
was better understood.  
 
5.2.3 Data Capture 
 
An external online survey programme, survey monkey tm, was used to field the 
survey and collect the results from the participating colleagues. The reason for 
using an on-line survey, rather than a paper based survey, is a potential higher 
response rate from the marketing and business colleagues as they can easily 
click the response buttons online. Another added benefit is the fact that the 
data is automatically captured, thereby eliminating data transfer errors as the 
data is directly captured from the respondent’s in a downloadable electronic 
file. As this survey is sent around the world, the electronic route is the faster 
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and a more cost efficient method and therefore deemed most appropriate for 
conducting this survey. 
 
The survey stayed open for one year. 99% of the responses were collected in 
the first 60 days after the e-mail was sent to the participants. One e-mail was 
sent out to marketing and business unit managers soliciting feedback. The 
choice to participate was up to the respondents in the survey; therefore the 
feedback contains a random response sample. It needs to be mentioned that 
the researcher was a part of the global marketing team at the time and had 
frequent interaction with many of the countries. This could have influenced the 
choice of the marketing and business management colleagues to participate. 
A specific non-response analysis will be conducted later in the chapter to 
investigate if this has influenced the results. 
 
5.2.4 Database Coding 
 
 
The responses captured in Survey MonkeyTM, were downloaded on-line into an 
Excel® spreadsheet in December of 2009. The spreadsheet was reviewed and 
the results spot checked with the on-line results to ensure congruency and to 
confirm that no mistakes had happened during the data transfer.  
The statistics programme SPSS Version 16, Student edition was used for the 
data analysis. In order for SPSS to be able to read and identify the data, each 
of the columns had to be recoded with appropriate titles for automatic entry 
into SPSS.  
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The SPSS manual (SPSS, 2007) also stated that missing variables should be 
recoded with 999. This was initially done, but led to aberrant scatter plots as 
the graphs included the numbers 999 along with the five point Likert-scale 
outcomes. Other manuals (Pallant, 2001) recommended to leave these open 
or be filled with a dot. Initial analysis conducted found outcome results which 
were false. The data again was manually verified, recoded and the raw data 
tables locked for exploratory analysis, which now produced correct scatter 
plots. 
 
 
5.3 Survey Response 
 
5.3.1 Country Survey Response Rates  
 
 
Fifty six (56) subsidiaries responded from the one hundred and twenty (125) 
surveys that were sent out, representing a response rate of 44%, which is 
quite good for an in-house survey. In a recent comparative survey conducted 
by the HR function within the company, looking at HR processes the response 
rate of a similar magnitude where 43% of the employees surveyed responded 
(Groh, 2011).  
 
Of the fifty-six survey respondents, three respondents did not provide a 
complete response to the questions asked and only partially filled in the 
survey. It was prudent to omit these country responses completely from any 
further analysis and therefore, fifty-three (53) surveys were deemed eligible for 
the descriptive statistical analysis.  
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In the survey table there were occasional data omissions, and therefore all the 
variables may not always add up to 53 in the descriptive analysis. It is 
suspected that one of the reasons for the omissions of data may be the 
sensitive nature of some of the questions, or respondents did not want to 
comment on specific questions such as headquarters competency, interaction 
and benevolent measures.  
 
5.3.2 Evaluation of Non-Response Bias 
 
 
Since the researcher was potentially known to the respondents as the survey 
was conducted in the same organisation where the research takes place,  it is 
important to ascertain if there is a difference between the responses from the 
respondents and the non-respondents as it may influence the validity of the 
findings (Lambert and Harrington, 1990). Data from non-respondents was not 
and could not be collected. Researchers have addressed this challenge in 
recent studies, by comparing the early responders with the late responders 
and if there is no difference found in the results, then by inference any later 
respondents would be expected not to differ from the initial cohort (Winter et 
al., 2005).  
Therefore, the data from the respondents was split into two groups, by 
response date. The first half of the respondents was allocated to the early 
response group and the second half to the late response group. Both groups 
were compared to each other using the ANOVA one tailed test. This 
methodology was used in a large sample studies using determinants and 
outcomes, very similar to this study (Winter et al., 2005). If no significant 
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differences are observed between the two groups, then an absence of  a non-
response bias is inferred (Lambert and Harrington, 1990). 
 
The ANOVA test did not reveal a significant difference in any of the variables 
in the survey including the outcome variables and it is safe to assume that 
there is no apparent response bias in the study. 
 
5.3.3 Country Survey Response Distribution  
 
The next section explores the descriptive statistics of the survey data. It is 
important to know, however whether a representative sample of subsidiaries 
was contained in the responses received. To evaluate this, the subsidiaries 
responses are organised by size in terms of total annual revenue and number 
of employees.        
 
The distribution by annual turnover is presented in the following graph: 
 
Figure 9: Turnover distribution by Bayer subsidiary 
 
If the histogram graph is overlaid with the normal distribution curve, there was 
a good overlap; however the data is slightly negatively or left skewed (- 0.468) 
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was found in the data sample, indicating the presence of more smaller 
subsidiaries. 
This would reflect the Bayer corporate reality because there are approximately 
10 large subsidiaries, which are responsible for the majority of the sales. 
Therefore, it is not unexpected that there are more subsidiaries with smaller 
sales levels contained in the survey responses.  
 
 
Figure 10: Turnover of Bayer in Subsidiary Country 
 
When the same analysis was conducted based measured in terms of number 
of employees, the data is less skewed with a 0.078 outcome. Therefore the 
distribution of subsidiaries of different organisational size in the sample is 
deemed to be adequate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Total number of employees in your country’s Bayer organisation 
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5.3.4 Descriptive Statistics of Survey Response 
 
In this section, the descriptive statistics of the survey will be presented first 
graphically followed by an in-depth discussion on the data. This overview will 
provide an insight into the country respondents, marketing experience, lateral 
integration, frequency of contact with headquarters, involvement in marketing 
meetings, competency rating of the headquarter and their own organisation. 
This information is relevant as it provides relevant information that may impact 
the interdependence performance relationship.  The descriptive analysis 
conducted: 
 
 
Figure 12: Length of work in the pharmaceutical industry 
 
 
 
Figure 13: Length of work in marketing function 
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Table 1 : Length of work in marketing function 
 
 
Figure 14: Personal contact with headquarters 
 
Figure 15: Personal contact with subsidiaries 
 
 
 
Figure 16: Seeking advice from headquarters 
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Figure 17: Participation at international marketing meetings 
 
 
Figure 18: Part of project or marketing team to coordinate decision making 
 
 
Figure 19: Quality of advertising material received from headquarters 
 
 
Figure 20: Global marketing quality of service and support 
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Figure 21: Subsidiary competency compared to other groups at Bayer Healthcare 
 
 
In the first descriptive analysis, the majority, 72% (n=38) of the respondents 
were in marketing, 26% (n=14) were in the business management function, 
and one respondent in the category ‘other’. The distribution of the time the 
respondents spent in the Pharmaceutical industry is evenly divided, whereby 
most of the respondents had ten to fourteen years of pharmaceutical industry 
experience (figure 12), which signalled that the respondents have considerable 
industry experience as well as marketing experience. The majority of the 
respondents, almost 60%, had seven or more years of marketing experience 
(figure 13), which established an experienced group of respondents within the 
company who participated in the survey. 
Most of the respondents, 66%, never had any ‘out of country experience’, 20% 
had been at least in one international assignment, and 13% had two or more 
international assignments. Less than 10% of respondents had any 
headquarter experience. Therefore this aspect is less accountable for lateral 
integration, however, this may be overcome by frequent contacts to the 
headquarter organisation as this forms the basis for interdependent 
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relationships (O’Donnell, 2000). The majority of the respondents do have daily 
or weekly contact with headquarters. This is a relevant finding and indicated 
that the subsidiary organisations were willing to bear the cost and the effort of 
maintaining ties with the headquarter organisation (figure 14). There is less 
evidence of frequency of contact with other subsidiaries (figure 15) potentially 
highlighting a more centrally driven approach to obtain knowledge and 
information from the centre of the organisation, as aspect that was highlighted 
in literature as a factor relevant to interdependence (Watson and Hewitt, 
2006).  Another related aspect, is seeking advice from headquarters, which 
demonstrates the interaction with the headquarter organisation. Here, only 
15% of the respondents stated never or very rarely seeking advice (figure 16), 
which supports the frequent obtainment of knowledge by the subsidiary 
organisations. 
 
Participation in international marketing meetings was questioned since face to 
face meetings may influence the formation of lasting relationships. One-third of 
the respondents were very frequently or frequently present at international 
marketing meetings, and more than two-thirds of the respondents have been 
present at the meetings. As the sample is representative in terms of subsidiary 
size and turnover, it is important to note that it is most likely the majority of all 
subsidiaries did have an opportunity to interact directly with the global 
marketing group at these international marketing meetings (figure 17).  
 
The results pertaining to further integration, in terms of involvement in project 
teams and being part of the global decision making, shows a slightly different 
picture. The responses are more equally distributed, indicating that a smaller 
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group of countries felt that they were included in the decisions affecting the 
Xarelto® brand. However, 40% of the respondents were frequently or very 
frequently part of the project team involved in the decision making with regard 
to the brand (figure 18), indicating local buy-in to decisions made, which may 
have relevance for the interdependence score as indicated in the literature and 
the guiding theoretical framework, (Roth and Morrison, 1992).   
 
The competency of the global marketing group, with regard to the quality of the 
marketing materials was assessed. It is understood that countries are only 
willing to leverage global materials, if they perceive them to be of high 
qualitative value. Standardised materials are part of the work packets 
associated with interdependence that the countries would be dependent on to 
receive from headquarters (O'Donnell and Jeong, 2000). The respondent 
answered very positively. The majority of the respondents, 66% rated the 
materials they received from the global group above average or far above 
average. This may indicate the willingness to rely on the global marketing 
group to receive the necessary branding materials and messages (figure 19). 
 
A similar result is found for the levels of support from the global marketing 
group, where the majority, 68% of the respondents, rated the level of quality of 
service and support as far above average and above average compared to 
other business units in the organisation (figure 20) indicating a good level of 
perceived support from the global organisation by the subsidiaries. 
Questioning the subsidiaries competency delivered interesting results, 
whereby the subsidiary rated their competency higher than the other groups 
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within the marketing organisation. It is important to note that the subsidiaries 
are confident in their own marketing abilities, since 75% rate themselves 
above and far above average in their competency compared to other groups 
within the Bayer organisation (figure 21).  
 
So for several of country background information has been analysed as well 
as several of the aspects from the guiding theoretical there has not been any 
aspect that would have strong moderating impact on the interdependence 
performance relationship. One moderating factor which was highlighted as 
critical in this relationship was collaborative intent and trust (Tasoluk et al., 
2006). For this reason a trust and benevolence scale was included in the 
questionnaire to evaluate this point this will be presented in the next 
paragraph.  
 
5.3.5 Trust and Benevolence Feedback  
 
This section will attempt to obtain insight, whether aspects of trust and 
benevolence were evident between the headquarter and subsidiary 
organisations. As this may play a role and potentially influence the analysis 
between interdependence and product launch outcomes later in the chapter. 
The trust and benevolence scale is made up of five questions (Mohr and Puck, 
2005).  
 
The result of each question will be presented and discussed individually.  
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For the first question, more than 81% of the responded agreed or strongly 
agreed with the statement that the global marketing group has an interest in 
helping subsidiaries to achieve their countries goals.  
 
Figure 22: The global marketing group has an interest in helping to achieve your country's goals 
 
A similar result is found for that statement that the “Global Marketing Group 
actually helps the subsidiary achieve its goals”. 85% of the respondents 
agreed or strongly agreed with this statement. When queried whether the 
global marketing group actually had the capability to successfully launch 
Xarelto®, the majority (72%) still agreed or strongly agreed.  
 
 
The last two statements on the trust and benevolence score pertain to making 
the appropriate decisions and adhering to them. In both instances, the majority 
of the respondents (78%) strongly agreed or agreed with the statement that 
global marketing takes appropriate decisions with regard to the management 
of Xarelto® and that the Global marketing group was adhering to agreements 
made. Here also, the majority of the respondents (69%) agreed or strongly 
agreed. 
 
 107 
This indicates general level of trust and benevolence from the subsidiary 
organisations towards the headquarter organisation as well as the majority of 
the countries stating that they believe the global organisation has the 
capabilities to support them. Trust was identified as one of the potentially 
negative moderating factors, this does not seem to be an issue that could 
affect the analysis between headquarter and the product launch performance 
in a negative way. 
 
 
5.3.6 Summary Results – Descriptive Statistics 
 
A substantial response was received to the electronic survey, the 44% 
response rate compared favourably to other internal surveys and those in the 
literature (Hurmerinta-Peltomäki and Nummela, 2006; Groh, 2011). Also the 
mix of respondents from the small to larger size companies was balanced and 
fell within a normal distribution range. The majority of the respondents were 
familiar with the pharmaceutical industry with ten to fourteen years of industry 
experience as well as marketing experience of seven years or more. The out-
of-country or international experiences were limited, however.  
It was observed that the majority of the respondents have regular contact with 
the headquarter organisation, mostly weekly with the global marketing group. 
In terms of interaction with the headquarter organisation, participation in 
international marketing meetings scored well with the majority of the 
respondents having participated in global marketing meetings and or being 
part of international project meetings to coordinate  decision making. Therefore 
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it was also noted that many subsidiaries felt they had input into the global 
decision making. The quality of marketing materials from the global 
organisation were accredited by the subsidiaries as generally above average 
and the competency was rated in the same manner, but not as high as the 
subsidiary competency, the latter may have been a leading question. 
Overall, there was positive feedback on the trust and benevolence statements 
regarding the Global Headquarter Organisation. It has become evident from 
the survey that there is relatively frequent and participatory interaction between 
headquarter organisation and the majority of the subsidiaries. 
No apparent factors could be identified that could have a potentially 
detrimental impact on the interdependence performance analysis and that 
would need be controlled for or taken into consideration when analysing the 
quantitative analysis on the interdependence and product launch performance 
in the next section.  
 
5.4 Subsidiary Interdependence  
 
In this section, the subsidiary capabilities and the interdependence questions 
from the interdependence questionnaire (O'Donnell, 2000; Subramaniam and 
Watson, 2006) will be explored. Subsequently, headquarter and subsidiary 
interdependence scores will be combined into one variable in order for it to be 
matched with the country launch outcomes data.  
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5.4.1 Subsidiary Interdependence 
 
First several questions were asked with regard to interdependence capability 
(Roth and Morrison, 1992). As can be seen from the responses to the question 
if subsidiary managers exploit interdependence between related products, this 
may provide an indication that independence exists across product groups and 
potentially the organisation. The responses are almost equally divided, 
whereby 25% say that exploiting interdependencies between products is 
characteristic for their subsidiary behaviour. There is no normative data for 
these results, but seem to be lower when compared with the responses seen 
in the previous section majority of the respondents. 
 
 
 
Figure 23: Subsidiary managers exploit interdependence between products 
 
 
Another factor related to potential interdependence is linking best practices 
across divisions. Looking across the subsidiaries, the result is very similar as 
the previous question, with a relatively small proportion, less than 20% of the 
respondents, linking best practice across division as portrayed in figure 25.  
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The responses could be markers for general interdependence and provide an 
indication for linkages across other products and divisions. The results indicate 
that this is generally less characteristic for the subsidiary respondents.   
 
 
 
Figure 24: Subsidiary managers link best practice across divisions 
 
 
5.4.2 Subsidiary - Headquarter Interdependence Scores 
 
The interdependence questionnaire adapted from O’Donnell (2000), which 
Subramaniam and Watson (2006) used in their research, contains an eight-
item questionnaire. Four variables determine the dependence in terms of 
direction and resource flow of headquarter on the subsidiary and four variables 
determine the dependence and resource flow of the subsidiaries on other 
subsidiaries in the organisation. In this research, we are particularly interested 
in headquarter subsidiary interdependence.  
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The first question relates to the subsidiary’s dependence on headquarter for a 
successful launch of Xarelto®. The majority of the respondents (42%) only feel 
that this is the fact to some extent, as indicated in the graphical representation 
of the data below. There is group of 35% who state that they are: “to a great 
extent or very great extent” dependent on headquarters. The results are 
slightly skewed towards this group if we look at the overall distribution of the 
responses, which is not unexpected as there are larger subsidiaries which are 
less dependent on headquarters, and there are many smaller subsidiaries, 
which may indicate a higher dependency. Noteworthy, is the large middle 
group that is to some extend is dependent on HQ.  
 
 
 
Figure 25: Subsidiary depends on headquarter for the launch of Xarelto® 
 
The next question asked to what extend the activities of the headquarter 
organisation influence the outcome of their subsidiary? 
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This aspect of interdependence is recognised by almost all the respondents. 
The majority, 54%, agree to a great extent or a very great extent with this 
statement. 
 
Figure 26: Activities of headquarters influence the outcome of the subsidiary 
 
 
In the graphical representation above, this would indicate some connection 
with the headquarter organisation.  
The reverse question is asked, whereby headquarters is dependent on the 
subsidiaries. This seems to find less recognition among the respondents. 
Almost two-thirds, (65%) stated that this was true to a very little or only some 
extent.  
 
Figure 27: Headquarters depends on the subsidiary for effective functioning 
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The response could potentially be explained by the fact that many of the 
respondents were of smaller countries as presented in the descriptive statistics 
section. Because of their smaller size and sales impact, they may feel that 
their impact on the global organisation is less evident. Further exploration will 
have to confirm this possible explanation. 
 
The results are even more evident when respondents were asked about the 
impact subsidiaries have on headquarter outcomes. Here almost three 
quarters of respondents deemed the influence to be very little, little or only to 
some extend an influence. This needs further investigation to understand the 
reason for this.  
 
 
Figure 28: Activities of subsidiaries influence headquarter outcomes 
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5.4.4 Aggregating Subsidiary - Headquarter Interdependence Scores 
 
The concept of interdependence in this exploratory analysis with the product 
launch outcomes data is multidirectional and multilevel. The four variables, just 
described that pertain to the headquarter-subsidiary relationship, were 
combined into a single score using a factor analysis. A similar methodology 
was used by Subramaniam and Watson ( 2006). The reason this was done is 
for the correlations to be calculated encompassing an average of all the 
dimensions of interdependence in one score. This variable will be matched 
with the subsidiary launch data in an exploratory analysis. 
The coefficient alpha for the aggregation was .81 for these four weighted 
items, indicating a good level of internal reliability. 
 
The descriptive statistics of the combined scores have a mean of 2.42 and a 
standard deviation of 0.776, which is distributed more towards lower 
interdependence as demonstrated in the graph below. 
 
Figure 29: Distribution of aggregated interdependence score 
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5.5 Capturing the Subsidiary Product Launch Data 
 
5.5.1 Sales and Relative Sales Data 
 
 
Unique to this research is that it is based with real in-market outcomes data. 
Sales data from IMS, a third-party provider of wholesaler to pharmacy and 
hospital sales data, was collected from the moment of first launch of Xarelto® 
in Germany on the 2nd of October 2008, until December of 2009.  
This provides more than a years’ worth of real in market data of the countries 
that launched and was deemed sufficient to conduct an exploratory analysis of 
the launch uptake. Ideally a longer timeframe should be analysed, but that 
would go beyond the timeframe for this thesis. In this period from October 
2008 until December of 2009, 55 countries launched, and outcomes data, in 
terms of sales were captured from IMS data. This was coded as YTD sales. 
In addition a relative sales figure sales will be calculated and will be used for 
an extra analysis. As many smaller countries contributed sales data, a 
relative sales analysis allows correcting for the country’s relative size. The 
Xarelto® sales will be expressed as ratio of total country sales, collected in 
the survey background data, and used in the respective analysis.  
 
5.5.2 Patient Shares 
 
 
Patient shares were calculated and provided by the regional marketing 
colleagues. As explained in the methodology sections, the market share 
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definition for the anticoagulation market is often compromised in the countries 
due to the different therapy regimens, which distorts the comparability between 
markets as different anticoagulants with different indications make up the 
market definitions. In order to solve this issue, the regional marketing 
colleagues calculated a patient share by calculating the number of cases that 
were treated with Xarelto® for the prevention of venous thromboembolism 
(VTE) in patients, after elective hip or knee replacement surgery, divided by 
the number of cases in the country on an annual basis. These patient shares 
were captured and incorporated in the statistical analysis. 
 
5.5.3 Market Uptake Data 
 
 
Sales and market share developments over the launch period from October 
2008 until December 2009 were analysed for the countries that launched. As 
described in the IMS study by MacCarthy and Gascoigne (2007) the product 
growth or uptake was mentioned as one of the criteria for successful launch 
outcomes. The product uptake was categorized from low to very fast, and 
adjudicated by independent regional marketing colleagues of the respective 
regions. Thirty-seven countries had enough sales or market data to be able to 
make an estimate of the market uptake in their respective markets. This data 
was captured and also incorporated in the statistical analysis.  
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5.6 Subsidiary Product Launch Data and Interdependence Score  
 
5.6.1 Combining the Subsidiary Product Launch Data with Interdependence 
Scores 
 
 
The survey data from the countries who responded to the survey was matched 
with the actual in-market launch data described in the previous chapters. 
However, some adjustments needed to be made as not all the survey results 
could be matched with market data. Three of the respondents in the survey 
were regional business managers, who had regional responsibility. Since the 
launch data is country specific it was decided that they would be excluded from 
the launch data analysis. Furthermore, two respondents of the respondents did 
not list a country response, and there were several responses missing to the 
eight question Interdependence score by O’Donnell (2000). In the end the data 
set contained forty five (45) eligible country responses.  
 
These responses where then matched with the country sales and marketing 
data. When this was conducted, there were in total thirty seven (37) country 
survey and outcomes pairs that were available for an exploratory analysis, as 
not all countries who participated in the survey had launched Xarelto® or 
generated sufficient sales data. These country pairs were analysed in several 
statistical analysis, which will presented in the next section. 
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5.6.2 Exploratory Analysis Interdependence and Subsidiary Product Launch 
Data 
 
The first analysis matched the headquarter dependency score with the 
absolute sales the country organisations achieved since launch until 
December of 2009. 
 
This result of this analysis was flat and even had a slightly negative 
relationship. The correlation coefficient between subsidiary dependence on 
headquarters and year to date sales was slightly negative (r= -0.68), not 
significant (p= 0.691).  
 
An additional analysis was performed using weighted data with relative sales 
using the annual turnover as the country weighting. This analysis provided a 
similar result with the correlation coefficient coming out slightly negative  
(r=-0.20), not significant (p = 0.121). 
 
The analysis conducted with the patient shares, resulted in a similar outcome 
as the one for absolute sales: a slightly negative relationship with a correlation 
coefficient of -0.107, which was not significant (p= 0.595). 
 
When matching the interdependency scores with the adjudicated market 
uptake measure, no correlation was found (r= 0.068) and the relationship was 
not significant (p=0.694).    
 
The findings are a bit surprising. The literature suggests a positive link, but 
this could not be confirmed by the analysis just conducted. Especially the 
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negative relationships between the aggregated interdependence scores and 
the absolute sales and patient shares numbers suggest a slightly inverse 
relationship. Brand uptake was minimally positive and not significant; 
therefore, a closer look is warranted in all three cases. 
 
The brand uptake distribution was analysed by a representation of all different 
brand uptake levels contained in the sample to gain an understanding of the 
distribution of the different brand uptake levels and to investigate if the data 
was concentrated or skewed in a certain direction. In the graph, presented on 
the next page, each category has a similar frequency of occurrence. 
Therefore the data is not skewed towards a low brand uptake that could have 
potentially explained the negative results in the correlation analysis. 
 
 
 
 
Figure 30: Distribution of brand uptake levels 
 
 
Another concern could be that the aggregation of the interdependence 
questions into one score, which was undertaken in the previous section, could 
be responsible for the result found. In a separate analysis conducted on each 
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of the individual head-quarter subsidiary interdependence questions, none of 
the questions individually had any significant correlations with any of three 
outcome measures, sales, brand uptake and patient shares.  
Therefore the aspect of the aggregation of the interdependence score is not 
responsible for the non-significant outcomes found. 
 
In order to obtain more clarity on the interdependence and brand uptake, the 
scores of the individual countries and their respective brand uptake during the 
launch period of October 2008 until the end of 2009, as adjudicated by the 
regional business groups, have been plotted in a scatter plot to obtain a better 
perspective of which countries may drive the outcomes of this exploratory 
analysis.  
 
Figure 31: Scatter plot of interdependence score and in-market brand uptake 
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France and Mexico have particularly high interdependence scores and high 
brand uptake, while Hungary, Portugal and Germany are on opposite side of 
the spectrum, with lower brand uptake and low interdependence scores. Then 
there are several countries with high interdependence scores but low brand 
uptake, like Ukraine and South Korea. Having stated this, both countries 
actually launched a little bit later in 2009 and may still have been early in the 
brand uptake cycle, which may be in part responsible for their lower brand 
uptake. Then, finally, there is a cluster of countries, with fast brand uptake, 
such as, Australia, Switzerland and the United Kingdom, including Ireland, 
who scored low on the interdependence score. These responses are quite 
surprising as all of these countries were early launch countries, who were in 
regular contact with the headquarter organisation and therefore these results 
warrant further investigation. 
 
5.7 Discussion 
 
The finding of a flat and in some cases even slightly negative relationship 
between the interdependence score and the three marketing outcome 
measures was surprising. These findings could not confirm the ideas 
postulated in the theoretical framework and do not seem to be supported in the 
analysis.  
Review of the sample size, or responses being skewed, which could have 
explained the outcomes were conducted and found not to be of relevance.  
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The result could potentially be explained by confounding factors influencing the 
outcome measures such as;  the launch timing of the individual countries and 
the amount of product launch information collected. The data set is relatively 
small and this may have had an influence as well, however it is more likely that 
other factors are responsible for the results found and it is therefore necessary 
that this is further investigated with the respondents of the survey.  
 
5.8 Summary Remarks 
 
In summary, it can be stated that the data set was substantial and a forty four 
percentage response rate on an internal electronic survey invitation was in-line 
with other surveys conducted within the company. Overall, the descriptive 
statistics provide a good variety of respondents, in terms of size and turn over, 
as well as industry and marketing experience. The responses indicated a 
frequent interaction between the subsidiaries and the headquarter organisation 
and participation in decision making and international marketing meetings. In 
general the materials and the quality of the marketing materials from 
headquarter organisation were rated favourably by the subsidiary 
organisations. 
 
A unique aspect of this research is the fact that it is conducted with real-world 
outcomes data from the product launch of Xarelto®. Actual in market sales, 
patient shares and adjudicated brand uptake were captured in a period from 
first launch year in October 2008 until December 2009. In total thirty-seven 
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(37) countries, who also responded to the survey had relevant launch data for 
analysis. 
 
The findings on the exploratory analysis of interdependence and market 
outcomes data were inconclusive and could not confirm the concept of 
interdependence contributing to subsidiary launch success in this quantitative 
analysis. It has to be pointed out that the correlation analysis performed, only 
captured simple linear relationships.  
 
Data aspects, such as the sample size and potentially distribution of sample 
were thought to be explanatory factors, however, further analysis were not to 
be able to confirm this. Confounding factors on the outcomes data as well as 
other factors in the interdependence performance relationship may help to 
explain the results found. 
 
Therefore, further analysis needs to be conducted to investigate what 
interdependent factors drive performance and which factors detract from 
performance. Associated factors to interdependence described in the 
theoretical framework, such as headquarter subsidiary interactions, seeking 
advice from headquarters, being part of project team, participating in global 
marketing meetings, exploiting interdependencies across products and 
divisions, were all present for the majority of the responding subsidiaries in the 
quantitative analysis. The quality of the perceived support and marketing 
materials from the global organisation were deemed above average or far 
above average, however, the quality of these headquarter-subsidiary 
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interactions was not reflected in the surveys, as well as other unknown factors 
that may have played role in the inconclusive results found. 
 
Follow-up interviews were needed to explore this further. As discussed in the 
methodology section, interviews with subsidiary organisations allowed for an 
in-depth analysis to uncover factors that positively influence or detract from the 
interdependence and outcomes relationship that were not highlighted in the 
quantitative survey. 
 
The selection of the subsidiaries for the interviews, as well as the conduct and 
the results of the interview with the subsidiary representatives will be 
presented in the next two chapters. 
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6. COUNTRY INTERVIEWS  
 
 
6.1 Introduction 
 
 
From the findings in the previous chapter a case was made for interviewing 
countries on the concept of interdependence, to investigate potential reasons 
for the inconclusive correlations found between product launch outcomes and 
levels of interdependence using the adapted interdependence score from 
Subramaniam and Watson (2006).  
 
Interviews with the country participants are very well suited to ask the 
countries directly about potential determining factors in the interdependence 
performance relationship.  
 
In this chapter, the country selection for the interviews, the interview set-up, 
the data capture and coding methods are discussed and presented.  
 
6.2 Country Selection for Interviews 
 
For the selection of the countries for interviews, the scatter plot, where the 
results of the brand uptake and country score has been plotted against the 
interdependency scores of the country. This has been enhanced with the lines 
of the median scores. The deviations from the median scores can now be 
seen and an assessment can be made which countries may be best identified 
for interviews to further explore some of the results found in the exploratory 
analysis.  
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Figure 32: Country interdependence and brand uptake 
 
 
The selection of subsidiaries for interviews is based on the following criteria:  
1. Absolute score of interdependence 
2. Brand uptake 
3. Deviation from the modus 
4. Organisation size 
5. Willingness to participate in a one to one interview 
 
Based on these criteria, four clusters have a high interdependence, high brand 
uptake, high interdependence and low brand uptake, low interdependence and 
high brand uptake and low interdependence and low uptake. 
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Interviews were conducted with the small size subsidiaries and larger 
subsidiaries from each of the quadrants in order to obtain a balanced picture. 
Also, two subsidiaries in the middle of the scatter plot will be selected for 
interviews, since they are on the continuum of the interdependence and 
outcome parameters ranging from low to high. Using this approach all the 
different combinations of high/low interdependence and sales uptake will be 
covered and the subsidiaries are diverse and differentiated enough to obtain 
varied responses to the survey questions. In the quantitative analysis no 
correlation could be found, therefore subsidiary pairs with low 
Interdependence and high sales as well as subsidiary pairs with low 
interdependence and high sales will be queried to uncover factors that may 
have contributed to the results found in the previous chapter. 
 
Identifying a small and a large subsidiary from each section, will aid to 
minimise potential bias, which may come in the form of country size and 
turnover. Countries along the interdependence – brand uptake axis low/low to 
high/high, including the countries in the middle ground will be included as 
these tend to confirm the theoretical model. These will be contrasted with the 
country pairs that deviate from this, the low high and the high/low country 
pairs. Therefore, the countries ideally suited for the interviews, based on the 
criteria stated, would be: 
 
High interdependence, High uptake  France and Mexico 
High interdependence, Low uptake  Italy and Ukraine 
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Low interdependence, High uptake  UK and Switzerland 
Low interdependence, Low uptake  Germany and Hungary 
Medium Interdependence, Medium Uptake Spain and Australia 
 
A graphical representation of the country selection can found below. 
Having an adequate representation in each of the interdependence sales 
categories and different countries of different size and regions should 
provide us with insights in the interdependence concepts 
 
Figure 33: Country selection for interview 
  
Ten interviews with countries in different geographical regions and different 
size and background should provide adequate insights to explain the 
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results from the survey data and to further explore interdependent 
relationships and its meaning for the subsidiary outcome. If needed, 
additional interviews can be conducted to collect additional data. 
 
6.3 Conducting the Interviews 
 
The advantage of interviews is the fact that the researcher can probe and ask 
follow-up questions. This will help to get a clear picture of the situation and the 
interdependence performance relationship and it can be verified whether the 
findings are in line with the theory. The interview questions were open-ended 
so causal relationships could be explored. 
 
The interviews were conducted with the marketing colleagues from identified 
countries, who participated in the survey, as they were directly involved in the 
launch of Xarelto®. In the case of Italy, multiple candidates responded to the 
survey, however the results were not different, therefore the interview, with one 
of the product managers responsible for the launch of Xarelto® provided the 
respective country viewpoints.   
 
The aim was to conduct the interviews in person, as there were opportunities 
during international marketing meetings for face-to-face interviews. An 
invitation letter to the country colleagues, inviting them to participate can be 
found in Appendix C. 
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In total, five of the interviews were held in person, either at international 
marketing meetings in New York and Berlin or at the office in Newbury, UK. 
The countries for which interviews were conducted in person were with 
France, Australia, UK, Spain and Switzerland. The other five interviews were 
conducted by telephone, because the countries were located further away 
from headquarters, or they were not directly accessible. These countries were: 
Ukraine, Mexico, Hungary, Germany and Italy.  The interviews commenced in 
with Switzerland in December of 2010 and the last interview was conducted in 
April with the Ukraine and the interviews lasted approximately 20 minutes 
each.   
 
As the researcher works in the same company and knows the interviewees, 
they share the same bias of reality. They are conditioned the same way by the 
company environment to some extent and therefore a true outside or objective 
view may not be completely possible. The interview results may contain this 
bias.  
 
6.4 Interview Questions 
 
In the previous chapter, some subsidiaries confirmed the theoretical 
expectation that overall interdependence correlates to marketing outcome, but 
others did not. That is why the questions in the interviews were open ended to 
comprehend factors driving interdependence – performance relationship.  
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The interview questions were initially formulated prior to the interviews and 
were outlined section 4.8 in the methodology chapter. As mentioned 
previously, sales and sales results are multifactorial, therefore the reason for 
the sales results was queried to provide insights if other factors than 
interdependence were driving the Xarelto® product launch outcome results.  
This was a question that was only included after the first interview with 
Switzerland as this question was originally not in the survey guide, but needed 
to be included to uncover any factors that significantly affected the sales 
outcome in a subsidiary. A scripted interview guide, which was used with the 
interviewees to standardise the interview as much as possible, containing all 
the questions can be found in appendix D. 
 
The aim of the interview was to explore all these factors and then compare 
and contrast the responses with other country clusters and with the concepts 
in the literature to identify those responsible for the subsidiary product launch 
success. 
 
Another important objective in this thesis was to examine factors necessary to 
build and maintain interdependent relationships. This was identified as a gap 
in the literature and the interviews offers the ability to get more insight into 
what conditions need to be and how theses may contribute to overall product 
launch outcomes.  
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6.5 Capturing the interviews 
 
 
The interviews were tape recorded. Permission was asked from every 
interviewee prior to the start of the interview and it was explained that the 
transcribed interviews would be sent back to the interviewee for verification 
and correction. The reason for tape recording the interview was to ensure that 
there was accurate data collection (Dearnley, 2004). The names of the 
colleagues who participated are named in the acknowledgment section, but 
will not be referred to in the thesis. It was also explained that if quotes were to 
be used, in the thesis, permission was sought from the interviewee.  
 
The interviews were transcribed by the researcher and by a departmental 
colleague. All the interviews were again cross checked for accuracy after 
transcription to ensure that the interview was captured correctly as the 
interviewees were from multinational backgrounds and English is often not 
their first language. 
 
In general there was a spontaneous willingness from the countries to 
participate, most likely helped by the fact that the interview was for 
independent academic research, which may be shared within the company but 
not conducted directly by a headquarter function.  
 
The interviews were collated into one large document containing one hundred 
and six pages of transcribed interviews containing over 28,000 words.  
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The next step was to review the text contained in this document, categorising 
and highlighting themes for cross-referencing and quoting in the thesis 
(Gillham, 2000).  
 
 
6.6 Interview Analysis Approach 
 
To analyse the interview data, a procedure suggested by Miles and Huberman 
(1994) was to code and organise the interview transcripts. Coding analysis 
was relevant as it forms: “A meaningful dissection of documents whilst keeping 
the relations between the parts intact” (Miles and Huberman, 1994). Initially the 
codes were sentences or sentence structures and they were categorised 
according the emerging themes.  
“A code in qualitative inquiry is most often a word or short phrase that 
symbolically assigns a summative, salient, essence-capturing, and/or 
evocative attribute for a portion of language-based or visual data” 
(Saldana, 2009).  
 
In this analysis of the data, an “non - a priori” approach was chosen for the 
analysis as the essence from the answers were captured after each interview 
question (Dearnley, 2004, Saldana, 2009).  
 
Relevant themes which were provided as answers by the interviewees, were 
organised by country, and by interdependence and brand uptake score per 
question, and these were captured in a matrix (Miles and Huberman, 1994). A 
data matrix was built in an Excel® spreadsheet programme. The essence of 
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the relevant passages were coded in a descriptive manner, so “descriptive 
coding” was applied in a first cycle approach (Saldana, 2009). The transcripts 
were examined for information categories and these were described. This way 
patterns in the answers may become visible and similar answers and topics 
could be identified as well as answers which differ and are incongruent. 
 
In a second cycle, a cluster analysis of the answers by interdependence score 
and brand uptake was conducted to explore if there were any differences or 
similarities in the answers, as it may help to provide a rationale for the findings 
in chapter five. “Second cycle coding methods is fitting categories with one 
another to develop a coherent synthesis of the of the data corpus” (Saldana, 
2009).  
The different categorical answers were systematically linked for a 
comprehensive analysis. According to the literature this approach appears to 
warrant the greatest explanatory relevance (Strauss and Corbin, 1998). 
 
The coding was done manually, with ten interviews that this was the most 
feasible approach. Although the researcher was familiar with a qualitative 
software analysis NUD*IST, now called NVivo, the data volume was such that 
entering the results, coding and analysis could be done manually and a 
software approach was not needed. It may have unnecessarily complicated 
the analysis and potentially detracted from answering the research questions. 
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6.7 Chapter Summary 
 
This chapter attempted to provide a rationale for the country selection for the 
interviews. Different country pairs with different levels of interdependence and 
different brand uptake levels were selected for interviews. The answers from 
each of the pairs can be compared and contrasted with each other. The 
interviews were tape recorded, transcribed and coded for data analysis, which 
will be presented in the next chapter. 
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7. INTERVIEW RESULTS  
 
 
 
In this chapter the results of the subsidiary interviews will be presented and 
discussed.  
 
In the first part of this chapter, the themes which emerged from the interviews 
with the subsidiaries on the interdependence-performance relationship with the 
global headquarter organisation will be described. The central question of this 
explorative research project was to uncover if and how interdependence can 
contribute to better product launch outcomes. This will be presented per 
cluster described in the previous chapter, following a two-step process.  
 
The focus of the first step is to identify similarities and differences in the 
themes that emerged in the interviews with the marketing managers of 
subsidiaries within each of the five analysed clusters. This analysis aims to 
provide insight into factors that influence the relationship between 
interdependence and performance.  
 
In a following step, explorative comparisons across the five different subsidiary 
groups will be conducted. However, not all factors were mentioned by all of the 
subsidiaries in the different clusters during the interviews. This required follow-
up interviews with subsidiary managers in order to shed light on particular 
themes that were not raised during the original interviews with subsidiaries in 
particular clusters. These had been appropriately identified as themes that 
played a role across the different subsidiary clusters. The similarities and 
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differences of the themes which emerged were then explored for their role as 
positive or negative moderators within the interdependence-performance link. 
 
This was done by comparing factors across the clusters and establishing if 
they were congruent or different, and whether they potentially contributed to 
performance as the clusters were ranked by performance and 
interdependence levels. For example, why did some subsidiary clusters show 
high performance despite low interdependence, whereas other in clusters high 
interdependence did not lead to high performance. Each of the factors 
identified in the first step will be presented and discussed individually and 
compared across the clusters in the second part of this chapter.  
 
The first question of the interview relating to the meaning of interdependence 
was answered similar across the country interviews and therefore there was 
not a large diversion in interpretation that needs be controlled for. Therefore 
the interview results, identifying the emerging factors that may be relevant in 
the interdependence performance link, can now be presented. 
 
7.1 Interdependence and Launch Outcomes by Country Cluster 
 
This section will commence with the high interdependence and high product 
uptake cluster, followed by the high interdependence low uptake cluster, after 
which the remaining clusters will follow. 
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7.1.1 Country Cluster: High Interdependence/High Uptake (France and 
Mexico) 
 
 
One of the key aspects highlighted in the literature for interdependence and 
consequently leading to better performance is the exchange of information 
between interdependent organisational units. The interviews in this cluster with 
the high interdependence and high outcome country subsidiaries, confirms 
some of the findings in the literature, where a high degree and bilateral flow of 
information forms the basis of an interdependent relationship (McCann and 
Ferry, 1979; Bartlett and Ghoshal, 1989; Watson and Hewitt, 2006). The 
marketing managers of the two subsidiaries in this category provided support 
for this argument, for example, the Mexican Product Manager stressed the 
importance of the flow or exchange of information for a successful product 
launch: 
 
“That there is a relationship between the global and local structure and 
they need each other, because they have a common responsibility to 
launch with success the product [In order to do this] There is a bilateral 
flow [of information], to provide information and to receive information”. 
 
It was felt that sharing global materials and marketing campaigns, made it 
easier for the countries to undertake certain local promotional activities as the 
countries start from a good base of ideas and this was thought to lead to better 
performance. For high interdependence to lead to better performance and to 
maximise the use of global materials or initiatives, and adapt them locally, is a 
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theme mentioned in this cluster. The countries save time and financial 
resources since they do not have to start from scratch. Resources can be 
better invested to drive product uptake, which is especially true if resources 
are tight in the country. Along the same lines, by avoiding duplication 
resources can be saved, which can in turn be used to drive product uptake in 
the market. This was highlighted in the literature by Kogut, (1985) and 
O'Donnell and Jeong (2000) and exemplified by the French Product Manager:  
 
“If you start not from the start [the beginning] but from an intention 
basis, you save time. The philosophy is to grow perhaps further in terms 
of fine tuning the materials because we start from a very strong basis 
proposed by global”.  
   
“It was important to have a clear view of what can be delivered by 
global, because we are in the philosophy, of getting all the best 
materials from global.” 
 
“The philosophy of maximising what was done globally, because local 
resources were limited”.  
 
This is supported by the Mexican product manager. He acknowledged a 
similar type of support, including the relevance of data provided by the global 
organisation and avoiding duplication. He went a step further and indicated 
that this formed the basis in terms of their partnership with the global 
organisation. 
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“The feeling of the local team is that the product is important, so if the 
push comes from global, for local it is to understand the priority of the 
project. We receive information about market scope, the disease, the 
buying process, the pipeline trials [and] the value dossier. We receive 
all [this] information that of course is important partnership information 
to start the project”.     
 
This leads to next topic that evolved from the interviews; close cooperation, 
since close cooperation allows for expertise and knowledge transfer. The 
better the global materials are tailored to local market conditions, the less 
reinvention needs to occur and more resources are available to drive market 
uptake. In the words of the French Product Manager: 
 
“My feeling is that the very close cooperation between us and the global 
colleagues is important, and the closer it is the better the expertise can 
be cascaded locally, and the more fine-tuned the marketing material 
avoiding reinvention”. 
 
The effect of this knowledge transfer and its contribution to performance is 
best highlighted in the following example from Mexico. They needed a lot of 
help from the global regulatory group dealing with local medical authority 
requests in order to receive a local marketing authorisation to go and 
commercialise the product. Different information packages and data analysis 
 141 
were provided by the global organisation, which contributed to a positive effect 
on performance. 
 
“I think that locally we were not prepared to launch a block buster. So 
when we [were] facing all the challenge[s] of the market we saw that we 
need more support from the global office…as we were facing a lot of 
difficulties with the [local regulatory] authorities and the change in 
regulatory issues, we needed to go back to the global [organisation] 
and ask for different information, [it was a] a different situation, that we 
couldn’t see before”.  
 
Without the interdependent linkage to the global headquarter organisation, 
there would have most likely not been a rapid response and, as a result, they 
would have had potential delays with their market authorisation by the local 
regulatory authorities. The market would have been delayed and Mexico would 
have not performed as well as they did. Therefore, responsiveness and 
timely delivery emerge as relevant factors for interdependence to be able to 
contribute to performance. The countries need to be able to rely on the global 
organisation that the materials will be delivered on time. The French Product 
Manager emphasised this succinctly as well:  
 
“We take the best what is developed by global; therefore we are very 
dependent on this material which is supposed to be delivered on time”. 
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A further potential moderator that emerged as potentially important, if 
interdependence is to lead to increased performance, is trust between a 
subsidiary and the headquarter organisation. The interviewed manager of the 
French subsidiary highlighted the importance of trusting that the materials are 
delivered in a high standard and on time, as otherwise they would have to 
produce these materials themselves negating the beneficial effects of the 
interdependent relationship.  
In this regard, it was also mentioned by the high/high cluster respondents that 
the preparedness of the global team is an important factor in building trust for 
them. The global organisation needs to be ahead of the local countries with 
the planning and the development of the materials. According to the French 
product manager: 
 
“I very strongly believe the global team is the face of the brand and for 
sure if [the] brand [team] gives an image which is not so well prepared 
internally, then you can become sceptical”.   
 
In this cluster, sharing of knowledge, making use of global materials, 
avoidance of duplication, close cooperation and responsiveness were 
mentioned as topics or moderators in the interdependence performance 
relationship. Case examples of global responsiveness and timely delivery of 
value dossiers, regulatory packages, global branding materials, buying 
process, marketing materials, seemed to have helped to country to getting 
better prepared to enter the market and drive the sales of Xarelto®, and 
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ultimately may have contributed to the good uptake and absolute brand sales 
in their respective markets. 
 
Critical remarks were provided on the timeliness of delivery of materials and 
trust, which were mentioned as key factors for the interdependent performance 
relationship to exist.  
 
7.1.2 Country Cluster High Interdependence/Low Uptake (Italy and Ukraine) 
 
The subsidiaries in this category showed high levels of interdependence, 
however the brand uptake performance did not materialise. Interviews were 
focussed in how far the performance was associated with factors that have 
been identified within the high interdependence cluster in the previous section, 
as well as identifying reasons for low uptake despite having high levels of 
interdependence. 
 
The factors that emerged from Italy were the early involvement in the global 
market preparation and sharing of information.  
 
“When we were invited, we had first product training and we received all 
information, which we could [potentially] need. So it was provided from 
the very beginning”.  
 
A reference was made to the close alignment with the global organisation to 
ensure that the same message was used globally and avoiding brand 
 144 
fragmentation. Something that was detrimental for the launch performance 
with Levitra (Salz, 2008), was that different messages and campaigns were 
used around the world. This led to an inconsistent brand positioning of what 
the product represented and could contribute medically in the minds of the 
customers. From the perspective of the Italian Product Manager, alignment 
was an important outcome of the interdependent relationship with the global 
organisation: 
 
“One example of this kind of close alignment is also [seem] from the 
visual branding and the brand vision; we had absolutely the same 
message”. 
 
According to Italy’s brand manager, the result of interdependence was early 
involvement, global guidance, and alignment, which helped them to prepare 
appropriately for their market entry and, thereby, be well prepared to launch, 
which in turn should have led to a good uptake. 
 
Ukraine’s perspective was similar in terms of avoiding duplication and 
sharing of resources, which saved capacity and led a better preparation for 
launch, which in turn supported better launch outcomes: 
  
“We were saving the capacity of countries and also the money, 
because, it is easier to [than] create one or adapt another. It costs 
almost nothing”. 
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“When I was launching I had a lot of things being done, so when I was 
[busy] in time of preparation of the brand or the market, I could find 
everything what I would need, and in comparison with even other drugs 
in Bayer [that we were] launching we were quite good prepared”.   
 
Ukraine had one important addition, which were the personal relationships 
with other parts of the organisation and headquarters. This was mentioned as 
a business driver as it provided them the platform to allow them to interact and 
share information and drive performance:  
 
“Personal relationships are really important and in this case good 
personal relationships will help business 100%”.  
 
“We are sharing much more information, materials, key opinion leaders, 
we are participating together in conferences, so we are more in 
contact”. 
 
The personal relationship aspect was even further highlighted in the context of 
international marketing meetings which were regularly held. It was felt that they 
also helped with alignment and network building as evidenced by one of the 
particular comments made by the Italian Product Manager:  
 
“The global meetings are absolutely important for many reasons, for the 
topics, for the alignment [of] what you have for the content, but also 
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from a relationship point of view”, both alignment for the common 
objective, but more so for the relationship and network building”.   
 
In both countries negative moderating factors were mentioned in the form of 
clarity of roles and market dynamics, which may have affected the 
interdependence performance link. 
 
If the roles were not clear, the country subsidiary colleagues did not know with 
whom to build their personal relationship network and, therefore, the benefits 
of interdependence could not materialise. This notion was mentioned by the 
Hungarian product manager:  
 
“It is very important in big organisations like this that everybody knows 
how global or headquarters is build up, like an organogram 
[organisational chart or overview]. Everybody should know who is doing 
what and who belongs to whose team, who is the head of which team, 
that is something important first of all and then of course you have to 
get to know the people”.   
 
The second detracting factor according to the brand managers had not much 
to do with the interdependent interaction with the headquarter organisation but 
more to do with local market dynamics and in particular reimbursement.  
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In Italy, limitations with regard to market access significantly slowed down the 
brand uptake and this had a larger impact on the brand uptake. In words of the 
Italian product manager:  
 
“It is completely a question of market access, of environment, and 
classification of the drug. We only have a hospital classification and the 
hospital classification, means all the expenses of the drug are related to 
the regions and they just have no money anymore to list any new drug”.  
 
In the Ukraine the brand uptake was rather slow also due to market 
circumstances. The market was relatively small as the Ukraine has a low 
number of hip and knee surgeries, and therefore, initial sales were slow:  
 
“We can’t really sell a lot because we really have a small number of 
hips and knee operations each year”. 
 
From the interviews in this cluster, factors evolved that may have an effect on 
either interdependence or performance, which caused the interdependence 
performance relationship not to be the main contributor for performance. In 
both cases in this country cluster, local market circumstances have had a 
bigger influence on the sales uptake than the contribution of the headquarter-
subsidiary interdependent relationship. 
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7.1.3 Medium Interdependence/Medium uptake (Australia and Spain) 
 
The country cluster in the middle of the spectrum lies along the continuum 
from low/low to high/high interdependence and brand uptake, and it is 
therefore warranted to analyse this segment to explore if there is any evidence 
confirming or detracting from the interdependence brand performance 
relationship.  
 
This is an interesting cluster, because both Spain and Australia developed a 
leadership position in their respective regions. Spain was a conduit for a lot of 
the materials to be converted to Spanish and to be franchised to Latin 
America. This is also true for Australia, who became the lead subsidiary in the 
Asia-Pacific region.  
 
As mentioned in the previous clusters, the topics of avoidance of duplication 
and achieving greater efficiency with limited resources emerged as themes, 
exemplified by the Product Manager in Spain:  
 
“We are a reference for the LATAM [Latin American country] community 
and we try to be in constant contact with them and exchange issues, for 
example, easy translations, because [of] the cost”. 
 
Additionally, transfer of Information/knowledge, i.e. solving problems quickly 
and efficiently also contributed to performance as evidenced by both Product 
Managers: 
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“I think it is easy for me that with all the people I know now, it is easy 
with a phone call or a text message or something like this: ‘Marco’ 
[researcher previously active in the global organisation] I have a 
problem”. 
  
“I think for me is that exchange of ideas, when you can sit down [and] 
have quality time talking to fellow colleagues, no matter what you learn, 
you gain experience”. 
 
It was this experience that really helped Australia, which was relatively 
removed from the mainstay countries, to prepare themselves locally.   
 
“I think I do put it down to a number of things: there was a good basis 
from Global in terms of what they would be messaging and I also think 
there was very good latitude in terms of being able to tailor that to the 
needs of the country and testing that out in your own individual market. 
So I actually know what the overarching key objectives were and 
leveraging those”. 
 
Optimally leveraging global materials for launch performance emerged as a 
theme here as well.  
 
The Australian Product Manager acknowledged a form of reciprocity, sharing 
ideas in an interdependent manner and making contributions back to the 
centre, seems to have a motivational aspect for the country subsidiary: 
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“I think it was also the sense of where you see interdependency back, 
there are no stupid ideas and even if something was not completely 
taken up, it was how it was handled, which was extremely professional 
and I think this gets you motivated”.  
 
A nice case study example of an interactive working relationship was the co-
development of the clot man campaign between the global organisation and 
Australia, where the global organisation shared branding files to create 
strategic brand reminders such as the clot man suit which was used very 
successfully at a local congress and was subsequently shared throughout the 
world after usage in a global marketing meeting. The global organisation was 
actually able to tap in the local Australian resource networks to have these 
suits made for the rest of the world. This case example is described in more 
detail in appendix F.  
 
Reasons for not having a high interdependence high uptake relationship in this 
cluster can potentially by explained by a sense of asymmetry in the 
interdependence performance relationship.  This was driven by the perception 
of the size of the contribution the Australian subsidiary could make to the 
global organisation.  
 
“At the time when we were going through this, there was very much a 
high interdependency I think, probably more and more swept my way in 
terms of information we wanted interdependence levels. I had more 
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interdependency from you [the researcher active in the global 
organisation] than you did from the other way around”.  
 
In the literature interdependence is often moderated by the typology of the 
subsidiary as was the case in the analysis conducted by Subramaniam and 
Watson (2006). However, this case study demonstrates that even the small 
countries can make a very impactful contribution which can lead to 
performance enhancement globally. 
 
  7.1.4 Country Cluster Low interdependence/ high uptake (UK Switzerland) 
 
 
The subsidiaries in this category showed high levels of performance despite 
having low levels of interdependence. It will be interesting to explore how far 
high performance was associated with the factors that have been argued to 
follow from the high interdependence/high performance clusters, and identify 
the reasons for high levels of performance despite the absence of 
interdependence. 
 
The United Kingdom and Switzerland were in the cluster of low 
interdependence and high uptake. In both interviews the countries indicated 
that they depend on the global organisation for the overall brand strategy, 
brand direction, value proposition, pricing and publications. This highlights the 
sharing of information and strategic alignment as relevant factors. The 
countries go one step further and acknowledge that all support need to be in 
the correct order to be successful. In the words of the UK Brand Manager:  
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“We are dependent overall for the strategy and direction and the value 
and the pricing, the publications and all the things we need to be right in 
order to be successful”. 
 
In evaluating the interdependence performance relationship, again the themes 
of avoidance of duplication or the leveraging of global materials emerged as 
having supported the countries in this cluster. The UK and Swiss Product 
Managers acknowledged: 
 
“First thing I would do before we did anything or if we were thinking of 
going into a new direction or producing a new piece of material was to 
speak to the global marketing team and ask them” 
 
“They [the global team] gave the layout, the image of the brand, more 
the look and feel of the brand and then the information I got, gave me 
an idea of the brand that I could translate to the market” 
 
However, their opinion with regard to dependence on headquarters is 
interesting to highlight. The sense of autonomy both countries have or 
experienced seemed to have played a role. Both countries commented:  
 
“We need to take from global what we need to take, follow the global 
strategy, utilise some of the materials, as many materials as we can, 
but still have the independence to tailor stuff to our own market 
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conditions, to develop new materials to support specific some specific 
issues that we need to address”.  
 
“We are not totally dependent on each other, because we have a 
degree of flexibility and the budget to implement some stuff that we 
create ourselves”.  
 
The importance of higher flexibility or autonomy was also highlighted by the 
product manager of the subsidiary in Switzerland who compared the local 
organisation to his experiences working in other companies:  
 
“At Bayer you have much more freedom or you can much more do what 
you want in the countries. Compare it to Pfizer. It is like this”.  
 
The countries themselves acknowledge that sharing their local materials with 
global and other countries, which is completely in line with the literature on 
interdependence (Victor and Blackburn, 1987), as the countries have some 
form of reciprocity. An example of this factor was provided by the Swiss 
product manager, who acknowledges that he provided local materials which 
were franchised out all over the world: 
 
“So if brand uptake is one of the [global] goals, we contributed this year 
with the sales we have and we also have some best practices which 
you [global] shared with other countries, these were the advisory board 
minutes and the dosage card, for example”. 
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A possible reason why the UK and Switzerland were successful, despite low 
levels of interdependence may be due to the fact that they had high levels of 
local resources and, therefore, there was little dependence on other 
subsidiaries or the headquarter organisation for resources. These resources 
allowed them to conduct their own pre-marketing activities and share them 
back with the global organisation. 
 
Trust and transparency were mentioned by the respondents in terms of an 
open knowledge exchange, the countries could be entrusted with data and 
constructively criticise the global organisation on their activities and materials 
that were being developed. Trust is most likely seen in the context of mutual 
respect and understanding as mentioned by the product manager of 
Switzerland:  
 
“I meant, with the criticism part, you can criticise each other that it is a 
very important fact. I can criticise you and you can criticise me and trust 
me”.  
 
In this cluster, close links to global and transparency on global deliverables, 
are mentioned as relevant factors for properly leveraging the global information 
to drive local performance, in the words of the Swiss product manager: 
 
“Compare this with the old working world, where there was a much 
bigger distance between global and the countries and thanks to the 
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close relationships I had a lot of information early and at the origin of 
the information and I felt that at all times I had the best information I 
could have and it was very transparent”. 
 
Responsiveness was also mentioned multiple times as a prerequisite for 
building and maintaining interdependent relationships. The UK Product 
Manager probably stated it best:  
 
“If I asked for something, people came back to me with an answer. It 
might not be the one I wanted, but people came back with an answer”. 
 
Responsiveness predisposes that the countries send inquiries to the global 
team. This was also mentioned by multiple respondents as they felt that the 
global group was very approachable as evidenced by the UK Brand leader:  
 
“The unquantifiableness that the brand team were all very 
approachable, there were no barriers”. 
 
A detracting factor to the interdependence performance relationship did 
emerge from the interviews. Delays in decision making and multiple rounds 
of discussions were seen as having a negative effect on the interdependence 
performance link. As decisions are delayed countries cannot continue with 
their market preparation:  
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“That is something, discussion and the next time we discussed again 
and that was something I would criticise. That’s it. The bigger ‘Xarelto’ 
[team] got [in the global organisation], the slower the decision making 
became. In the beginning the team was very quick and dynamic and I 
think we slowed down”. 
 
In summary, the interdependence between headquarters and the countries 
was evident not only in leveraging materials, from the global organisation, but 
also having reciprocity in terms of sales contribution and local materials that 
were disseminated to the other countries, was confirmed.  
 
The local autonomy, in terms of flexibility and ability of adapting global 
materials or creating their own, combined with budgetary independence 
seemed to have played a mediating role. Having protracted discussions or 
delays in decision making does seem to detract from the interdependence 
performance relationship because both the global and the country groups are 
not moving forward towards a successful launch. 
  
7.2.5 Low interdependence/low uptake (Germany and Hungary) 
 
 
In the interviews, Germany stated that they did not see brand leadership from 
the global team and as one of the first countries launching, they did not see the 
brand materials being delivered on time. Timeliness of global deliverables 
seemed to be a clear negative factor in the interdependence performance link. 
As a consequence, Germany needed to be more reliant on themselves, hence 
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their dependence on global organisation was low and they did not have the 
benefit of leveraging the global materials for enhanced country performance:  
 
“The local subsidiary heads have task to think ahead of things, because 
the deliverables from global were not, simply didn’t come through in 
good time”.  
 
Hungary had a similar situation as they could not really leverage headquarter 
subsidiary interdependent relationship benefits due to lack of contact with the 
global organisation due to local personnel changes in the country:  
  
“Because there was no real communication, because of personnel 
reasons”.  
 
In this country cluster headquarter subsidiary interdependence was deemed 
supportive to their country launch outcomes by solving local problems, e.g. 
leveraging knowledge efficiently and the early involvement with the brand.  
 
“I think it that is absolutely contributing in a positive way, so it is very 
important for us to know who to find if I have a particular problem. So 
that saves time, makes things go easier”.  
 
“Those people do start early to think about the strategies and 
implementation. Who were early involved in the piece [brand and 
marketing materials], are thinking about the future two or three years 
prior to launch and then started local activities, therefore, they are 
performing better than those who only start at the start. That is what you 
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call market preparation and you are all in the know, you are involved in 
an early stage the better you perform”. 
 
 
In the German interview the point was made that the relationship build-up with 
the countries should be initiated early, and then launch performance can be 
enhanced as countries then have adequate time to prepare the brand for 
launch. Therefore, building interdependent relationships early with countries 
can contribute to launch uptake when the relationship and network building is 
done early enough in the pre-launch phase so the true benefits of the network 
can be adequately leveraged.  
 
A similar point is made by Hungary that the early involvement and building 
interdependent networks can have beneficial effects on performance. The 
countries to start exchanging information and getting the countries involved 
in the strategy, product and disease education can lead to a better market 
preparation. This is supported by the Hungarian Product Manager: 
 
“We had first product training and we received all information, which we 
could need. So it was provided from the very beginning”. 
 
“Global is not a country, they are not selling to the other countries, so I 
think the information that we might give and what we see, that is the 
most important that we can give to global”. 
 
The product managers of the subsidiaries in this category highlighted the 
importance of providing local market information to the headquarter 
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organisation. This confirms the reciprocity, which is in line with the literature 
that argues that interdependence leads to bilateral information flows and 
therefore to higher performance (Bartlett and Ghoshal, 1989). The feedback 
from the countries ensures that the materials, support knowledge transferred 
to the countries has relevance and is usable. 
 
In this cluster aspects of enhancing performance are recognised, however, 
they could not be fully exploited due to the late arrival of materials or the 
absence of a personal relationships with the headquarter organisation. The 
argument could be made that if the materials had been delivered on time, 
leveraged properly, and the Hungarian Product Manager known they existed, 
a potentially better performance could have been realised.  
 
7.1.6 Summary Table of potential moderating factors   
 
Factors that are supportive of the interdependence and performance 
relationship as well as factors that detract in this relationship have been 
identified by the country clusters in the interviews. In total, twelve different 
factors were identified.  
 
The first two themes which evolved from the interviews were support from 
headquarters and global responsiveness. It was demonstrated in the case 
of high interdependence and high performance cluster that these factors 
contributed to an earlier and better launch preparation and country 
performance. This is in confirms the concept of interdependence as outlined 
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by O’Donnell (2000), who defines interdependence, as: “The reliance of the 
multinational corporation, including head office on other sub-units for its 
operations”. Clearly this can only come into existence if there is general 
support from head office to the country subsidiaries and a good level of 
responsiveness. These are important antecedents for interdependent 
relationships to exist and for interdependence to have potential contribution as 
identified in the literature (Victor and Blackburn, 1987; O’Donnell, 2000; 
Subramaniam and Watson, 2006) 
 
The next theme is the exchange of knowledge, sharing of expertise and 
solving problems. All three themes have been highlighted in the different 
interviews with the country clusters. These have been summarised as one 
factor in the summary table for the cross reference analysis as they appeared 
similar in meaning throughout the different interviews. These aspects were 
highlighted in the guiding conceptual framework and empirically confirm the 
literature that leverage of knowledge can enhance the capabilities of the 
subsidiary (Birkenshaw et al., 2005) and that cumulative knowledge can be 
leveraged world-wide (Doz et al., 2001; Watson and Hewitt, 2006). 
 
This is followed by avoiding duplication and leveraging global materials 
mentioned by several clusters as key drivers in the performance 
interdependence relationship. These confirm suggestions in the literature that 
supporting countries along the value chain (Kogut, 1985) is beneficial for 
subsidiary performance. In addition a certain level standardisation of global 
materials, applicable in high-tech industry can save time and money for the 
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subsidiaries as outlined by (O’Donnell and Jeong, 2000). This aspect is also 
included in the table.  
 
Similarly, building networks or being part of Xarelto® network has been 
identified as potentially relevant for the interdependence performance link and 
ties in with the network and social capital literature (Nahapiet and Ghoshal, 
1998; Kostova and Roth, 2003; Birkinshaw et al., 2005). All arguing that the 
network is an antecedent for interdependence to exist and can lead to new 
intellectual capital, enhanced subsidiary capabilities and increased value to the 
organisation which in the literature could lead to enhanced subsidiary 
performance. 
 
Next, clarity of roles and responsibilities within the global organisations for 
the countries were identified by the countries as necessary for 
interdependence to exist and to drive performance. For network actors to exist 
in the network, they need to gain centrality according to Bouquet and 
Birkinshaw (2008) only if the actors are known can they participate in an 
interdependent manner and exert any influence in the organisation. This 
empirically supports the authors in their argument that even low-power actors, 
such as Australia in the case example described can gain influence in the 
global organisation and contribute to organisational outcomes. 
 
Timely delivery has been mentioned in several of the interviews, this has 
been combined with delays in decision making. Both have been identified as 
detracting factors in the subsidiary’s launch performance, as materials cannot 
 162 
be leveraged and the country risks was therefore at risk of not being 
adequately prepared to launch successfully. These aspects have been 
identified in the literature and were captured in the guiding conceptual 
framework under incongruence of outcome and responsiveness and were 
pointed out by McCann and Ferry (1979). 
 
Trust was mentioned combined with transparency. This emerged from the 
interviews with regard to delivery of global materials and launch preparedness 
of the global team, as well as the ability to provide constructive criticism both 
ways, to ultimately achieve better and more impactful campaigns and 
marketing strategies. In the literature, collaborative intent and the development 
of trust can be seen as important antecedents to a productive collaboration 
between headquarter and subsidiaries (Tasoluk et al., 2006). “Convincing both 
parties of the expertise of the other party” is deemed essential for effective 
collaboration (Tasoluk et al., 2006) and suggests that trust and transparency 
are key variables in collaboration between headquarters and subsidiary to 
ensure proper reciprocity is given by both parties.  
 
Local autonomy and availability of local resources were mentioned to 
enable countries the freedom to adapt global campaigns better to local 
circumstances and therefore allow for better performance. However, this could 
also have a potentially negative effect when countries have ample resources 
available. They may not need to use global material and could do everything 
on their own however this will duplicate efforts, which could potentially detract 
from performance as the local funds could have been invested to drive brand 
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uptake in the market by funding local marketing initiatives. Both aspects were 
also captured in the literature as potentially negative moderating factors, cost 
of maintaining the interdependent relationship may not be feasible if the 
availability of local resources is limited (Frost et al., 2002; O’Donnell, 2000; 
Van der Vegt et al., 1999) and if local autonomy is high (Tasoluk, 2006).  
 
A theme very central to the concept of interdependence is reciprocity. This 
was highlighted by Thompson (1967) and Roth and Morrison (1992) From the 
country subsidiary perspective in this research, being able to provide feedback 
was not only deemed motivational, but also essential to provide feedback to 
the headquarter organisation on the practical applicability of the global 
campaigns and messaging. By enhancing these and making them better, the 
subsidiaries world-wide could benefit and have more impactful marketing 
campaigns, which would in turn enhance performance.  
 
Strategic alignment emerged as a theme in multiple clusters. The central 
idea was that messaging and product campaigns are aligned, a unified global 
concept of the Xarelto® brand emerges. If, for example, healthcare 
professionals from the UK were to go to a scientific congress elsewhere in 
Europe, they see the same branding and messaging. This reinforcement of the 
brand image and the brand message with the healthcare professionals would 
then support the brand uptake in their respective countries. This aspect can be 
interpreted as a product launch outcome in line with literature on marketing 
performance as outlined by Aaker (1990), building and sustaining a unified 
brand image and by Rust (2004) where improved customer thoughts, feelings 
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and knowledge about the product are central. Establishing these on a world-
wide basis would clearly contribute to product launch success for the 
organisation. 
 
The factors described above were mentioned in all or multiple of the country 
clusters. However, this may not explain the difference in uptake or 
interdependent levels found in each of the clusters. For example, it was 
possible for a particular factor to appear in both the high and low uptake 
cluster. 
 
The results of the interviews were collated in a summary table below. In order 
to do this, the transcripts of the original interviews were used, but also follow-
up interviews were carried out as not all subsidiary clusters mentioned the 
same factors in their respective interviews.  
 
These secondary interviews were conducted to explore the role and level of 
topics and moderators in subsidiaries that the countries may not have 
particularly addressed in order to make comparisons across the clusters. The 
follow-up interviews were conducted in person or by telephone. The 
information collected in the second round of interviews is marked with a (2) in 
the cross comparison table on the next page. 
 
As outlined in the beginning of the chapter, the summary table, on the next 
page provides the overview for the secondary analysis, which is the 
comparison across the clusters to identify those factors which are directly 
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moderators in a positive or negative manner in the interdependence 
performance relationship.  
 
 
 
Cluster1 
(France, 
Mexico) 
Cluster2 
(Italy, 
Ukraine) 
Cluster 3 
 
(Spain, 
Australia) 
Cluster 4 
 
(UK, 
Switzerland) 
Cluster 5 
 
(Germany, 
Hungary) 
Interdependence1 High High Medium Low Low 
Performance1 High Low Medium High Low 
      
Perceived HQ support  High Low 
(Italy), 
Very high 
(Ukraine) 
High High High 
Perceived HQ 
responsiveness  
High High High High Low 
(Ukraine) 
High  
Germany 
Exchange of 
information/ knowledge 
exchange and sharing 
of Expertise 
High Medium Medium High Low 
 
Avoiding duplication/ 
Leveraging Global 
Resources 
High High Medium2 Medium2 Low (due to 
timeliness) 
Network of inter-
personal relationships / 
Early involvement 
High Low 
(Ukraine) 
High 
(Italy) 
High High Low 
Clear roles and 
responsibilities  
High High Medium2 Low2 Low2 
Close Cooperation High Low Medium2 High  Low 
(Ukraine) 
High  
Germany  
Timely delivery and 
decision making 
High High High Low Low 
Trust/Transparency High High2 High2 High High2 
Local autonomy/ 
availability of local 
resources 
Low Low2 Low High High 
Reciprocity High Low2 Medium2 High Low 
Strategic Alignment High High High2 High High2 
 
Table 2: Factors in the interdependence and performance relationship 
 
                                                          
2 Signifies responses captured from second interviews 
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7.2 Emergent Moderators across Subsidiary Clusters  
 
In this section the role of particular emergent factors across the subsidiaries 
are investigated and discussed, in particular, whether they are moderators 
which have a direct effect in the interdependence performance relationship. 
 
The factors that emerged from the interviews in the previous section are 
evaluated in order of appearance in the table, across the subsidiary clusters to 
assess their comparative roles. This allows for a better assessment of the 
importance of different potential moderators identified in each of the clusters.  
 
This comparison presents a clearer picture of the role that some of the factors 
play for the nature of the relationship between interdependence and 
performance across subsidiary clusters. While a factor may appear to be a 
moderator in one or some of the subsidiary clusters, further interviews had 
been conducted to investigate whether it played a similar role in the other 
subsidiary clusters. For example, if communication seemed to be a relevant 
factor for high interdependence to lead to high performance in the high 
interdependence and high performance country cluster, but communication 
was also high in the country cluster with high interdependence and low 
performance, communication may not have been a deciding factor in the 
interdependence performance relationship. 
 
In the next section, each of the twelve factors from the summary table will be 
reviewed individually. 
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7.2.1 Perceived support from headquarter organisation 
 
Perceived support from headquarters was the first factor that evolved from the 
interviews. In the cross-comparison table, the support was deemed high 
across the different clusters with a slight variation in the high interdependence 
low performance cluster.  
Since there was not a notable differentiation across the different clusters, a 
relevant conclusion with regard to whether perceived support may be a 
contributing or detracting factor cannot be made. The results indicate that 
headquarter support was high across the subsidiary clusters and in the 
quantitative data section headquarter interest and support was rated high by 
the majority of the respondents, which indicates a similar result. Therefore, 
perceived headquarter support could be seen as a prerequisite, but not directly 
be attributed as a moderator in the interdependence performance relationship.   
 
7.2.2 Perceived Headquarter Responsiveness 
  
Perceived headquarter responsiveness was high across the country clusters 
with a minor variation in the low/low country cluster. Ukraine rated 
responsiveness as low, but this could potentially be explained by the lower 
levels of perceived interaction Ukraine had, in part as a result of personnel 
changes in the country, as mentioned in the interview data in the previous 
section.  
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Since perceived headquarter responsiveness is high in each of the clusters 
with no real differences notable across the different country clusters, therefore 
perceived responsiveness can also not be directly attributed as a moderator in 
the in the interdependence performance relationship. 
 
However, responsiveness may be a relevant factor in building and fostering 
interdependent networks but it appears to be similar across different clusters. 
A rationale for this finding could be the fact that the global organisation was 
consistent in their responsiveness across all the countries. 
 
7.2.3 Exchange of Information/knowledge exchange and Sharing of Expertise 
 
 
One of the main factors that emerged in the interviews as having a potential 
positive effect of interdependence on subsidiary performance is information 
exchange.  
The findings for the subsidiary clusters high/high and low/low support the 
moderating effect of knowledge exchange and sharing of expertise. This 
finding is in line with the role prior research has attributed to knowledge 
exchange in multinational organisations (Birkinshaw et al., 2005) and which 
has been regarded as the basis for interdependent relationships (Bartlett and 
Ghoshal, 1989). As reviewed in the literature, levels of information exchange, 
frequency, complexity and content have been identified as factors moderating 
interdependency (McCann and Ferry, 1979).  
Furthermore, against this background, the literature would suggest that 
improved knowledge exchange and expertise between headquarters and 
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subsidiaries may allow firms to avoid the pitfalls associated with launching a 
product in multiple countries and provide a foundation for improved subsidiary 
performance and therefore improved launch outcomes (O'Donnell and Jeong, 
2000).  
  
However, the subsidiaries in the low interdependence and high outcomes 
cluster indicate that exchange of information/knowledge and sharing of 
expertise may lead to improved performance irrespective of the level of 
subsidiary interdependence. Several additional moderating factors on 
interdependent relationships can be rationalised. The first one is imperfect 
information (McCann and Ferry, 1979), when the subsidiary is not aware of the 
potential benefits of the relationship, or perceived the benefits as very different, 
they may not be willing to support these interdependent relationships.  
The argument can be made that information exchange allows the headquarter 
to communicate the benefits of interdependence to the subsidiaries and as 
such it might create a “buy-in” of the subsidiaries increasing on benefits such 
as sharing of expertise and resources and reducing resistance to loss of 
autonomy. This holds true across all clusters, since information exchange is 
high in the country cluster where there was a high degree of autonomy in the 
low interdependence and high performance cluster.  
 
Having stated this, the level of exchange of information and knowledge sharing 
across the clusters seems to differ across the clusters as described in the 
previous section. 
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In the low/low category, information was shared and good ideas delivered to 
save time in the market preparation. This holds true across the continuum of 
the country clusters but the intensity of information exchange seemed to have 
increased from just sharing information to exchanging best practices in the 
medium county cluster category, to an incorporation of a philosophy of 
leveraging and maximising global materials and ideas in the high 
interdependence and high performance cluster. Accordingly, the cluster 
performance also increased across the same continuum from the low/low via 
the medium/medium to high/high cluster. Therefore, the evidence emerges 
that the countries can benefit from sharing ideas and knowledge, but that 
performance was really enhanced if this was conducted in a fully cooperative 
and integrated manner by both parties, almost as ‘modus operandi’ between 
headquarter and subsidiaries and formed the basis for  leveraging each other’s 
resources. Therefore information exchange was both mechanistically involved 
in building interdependence as well as a moderating factor between 
interdependence and performance as it formed the basis for sharing and 
leveraging knowledge and avoiding duplication. 
 
7.2.4 Avoiding duplication / Leveraging Global Resources 
 
Avoiding duplication and leveraging global materials has been mentioned by 
several clusters as key drivers in the performance interdependence 
relationship. A cross cluster comparison identifies these factors as moderators 
in the interdependence performance relationship. The quantitative analyses in 
chapter four highlights the importance of leveraging global resources and the 
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evidence from the country interviews in the high/high cluster indicates that high 
levels of interdependent relationships and high levels of performance are 
associated with high levels of avoidance of duplication and leveraging of 
resources. This was less evident in the low/low country cluster and their 
associated performance was low as well. There seems to be, a relationship 
associated with the leveraging of resources and the levels of interdependence 
and performance across all country clusters.  
This supports the argument made by (O'Donnell and Jeong, 2000), that a 
certain amount of standardisation coming from headquarters would save 
duplication of efforts as just minor adaptations need to be made instead of the 
development of new marketing materials developed from the ground up. It also 
supports arguments made by Kogut (1985) where subsidiaries can save 
resources along the value chain. When concepts are worked out at the global 
level and not duplicated in the countries, resources can be saved or put to 
better use in the market and more funds are available to shape the customer 
perception of the superior benefits of the brand and increase the brand equity 
(Aaker, 1991) in local markets, and as evidenced in this case study, lead to 
higher performance. 
 
Avoiding duplication and leveraging global resources emerges as a 
contributing moderating factor in the interdependence performance 
relationship.  
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7.2.5 Network of Interpersonal Relationships 
 
Building networks or being part of the Xarelto® network or group was identified 
as a relevant factor. From the interviews in the high interdependence and high 
performance cluster, this was defined as a fully integrated collaborative 
relationship. In contrast, in the low interdependence, low performance cluster, 
interpersonal relationships were deemed partially present and generally 
identified as poor.  
 
For interdependence to really work, the argument can be made that networks 
and social capital need to be created and utilised for the benefit of the 
subsidiary (Bartlett and Ghoshal, 1989; Kostova and Roth, 2003; Nahapiet and 
Ghoshal, 1998). This was also highlighted by Bouguet and Birkinshaw (2008), 
where the aim of the subsidiary is to gain centrality within the organisation. The 
authors specifically make the point that it is equally important to consider how 
well connected the actors are to other units within an organisational network. 
This is related to the social network theory, which was previously discussed, 
whereby the main objective of the subsidiary should be to gain influence within 
the strategic networks where the multinational corporation is embedded 
(Bouguet and Birkinshaw, 2008).  
 
Networks with the headquarter organisation need to be created for 
interdependence to work. From the interviews, early involvement is deemed 
essential as the process of creating networks takes time and effort. In this case 
study investments in global marketing meetings and country visits have been 
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made to build these networks. Countries who did not invest the time, for 
examples to due personnel changes, to build these networks, were less likely 
to benefit from interdependent working relationships and therefore 
interpersonal networks is a contributing moderating factor in the 
interdependence performance relationship. 
 
In this case study, an example of building cooperative networks has been the 
participation of the countries in global marketing meetings. From the interview 
responses, these meetings also demonstrated the dedication from the global 
group and the level of preparedness, which provided them with energy, 
motivation and ideas to raise their own efforts in their respective countries and 
hence their own performance.  
 
A more detailed description of these meetings and how they were conducted 
can be found in appendix E.  
 
7.2.6 Clarity of Roles and Responsibilities 
 
Clarity of roles and responsibilities has been mentioned as important factor in 
the interdependence performance relationship. Some country clusters 
identified deficiencies here and felt that clear roles and responsibilities were 
not always present, which prevented them from reaching out and interacting 
with the global organisation. In the cross comparison across the country 
clusters, the clarity of roles and responsibilities seemed to be linked to the high 
interdependence and high outcome country clusters and was distinctly lower in 
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the low performance and low interdependence clusters. Therefore this factor 
can be identified as a moderator in the interdependence performance 
relationship.  
This provides some support for a finding in the literature between 
interdependence and employee turnover, where unmanaged interdependence 
leads to higher employee turnover (Roth, 1995). Employee turnover and 
reorganisations can have a detrimental effect on obtaining clarity of roles and 
relationships. In this case study, there may have been role confusion after the 
Bayer Schering merger and the change of business units, from the specialty 
business unit into the General Medicine business unit as described in the 
introductory chapter. 
 
For interdependence to be able to contribute to high performance this should 
be avoided, or a conscious effort needs to be made to clarify roles and 
responsibilities and to re-establish the network structure after such changes. 
 
7.2.7 Close Cooperation 
 
Close cooperation, a theme that evolved in the high performance cluster has 
been included separately as it forms the basis for the sharing of resources and 
avoiding duplication. This is one of the factors that were probed in the second 
round of interviews with the various country clusters. 
In the cross cluster analysis, close cooperation was evident in the high 
performance high interdependence cluster. It became clear that close 
cooperation fostered the sharing of information, materials and best practices 
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that have been identified as drivers for performance. The level of cooperation 
was different across the clusters. In the low category it pertained to just 
sharing information, which delivered good ideas and saved time in the market 
preparation, which in turn led to the country being better prepared to face the 
market and the competition and launch results were thus improved. This holds 
true across the continuum of the country clusters because the intensity of the 
cooperation increased and so did the performance across the country clusters 
from low to high. In the medium category the cooperation pertained to sharing 
of best practices and exchange of ideas. In the high performance and high 
interdependence cluster the cooperation was fully integrated and geared 
towards completely leveraging global materials.  
 
Close cooperation seems to match the responses from the exchange of 
information and from the evidence above it was a positive moderator in the 
interdependence performance relationship.  
 
7.3.8 Timely Delivery and Decision Making 
 
Timely delivery had been mentioned in several of the interviews. This had 
been combined with delay in decision making, as both highlight late delivery or 
delay on progress and were deemed detracting from the interdependence 
performance relationship.  
Multiple rounds of discussions, delayed decision making, and lack of follow-up 
in the interdependent network seemed to be influencing performance in a 
negative way. All three factors seemed to delay the launch preparation. Three 
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of the early launch countries, including the UK, Switzerland and Mexico were 
contained in both clusters.  The requirement for more information was a result 
of slower decision making, which was likely to be more costly to the 
subsidiaries as they could not optimally benefit from the global materials as 
they came late and therefore had to be local produced. Cost was associated 
as a detracting factor in the literature (Frost et al., 2002, Van der Vegt et al., 
1999) as it may divert resources and investments necessary to ensure the 
subsidiary’s competitive strength and its performance.  
 
Timely delivery of materials and resources as well as timely decision making 
could therefore be identified as detracting or negative moderators in the 
interdependence performance relationship. 
 
7.3.9 Trust and Transparency 
.  
Our analyses also highlighted the importance of other factors, such as trust.  
In the interviews, there was also mention of transparency, but placed in a 
context of trust in terms of an “open knowledge exchange”. The countries 
could be entrusted with data and they could criticise the global organisation, 
“without it coming back to you”. This is different from the trust scale used by 
Mohr and Puck (2005), which has a benevolence aspect. The responses 
indicated a different aspect of trust, which confides in the countries, and is 
open to factual and critical dialogue without it getting political or emotional. A 
contributing aspect to transparency was a clear role definition which was 
outlined previously within the headquarter team, as to who does what and who 
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was responsible for which items. This also helped the countries to address the 
right person for their specific questions or problems. 
 
The trust and transparency levels were high across all country clusters, 
therefore this factor is noted for its importance, but does not offer explanation 
to the differences in the interdependence performance relationship.  
 
7.3.10 Local Autonomy / Availability of Local Resources 
 
Similarly, local autonomy and or the availability of local resources were raised 
by several clusters as having affected the performance relationship. The high 
performance, high interdependence countries scored low on this factor, in 
contrast to the low performance and low interdependence countries which 
scored high. This was similarly true for the low interdependence and high 
performance country cluster. Interdependence seems to be diminishing with 
the increased availability of local resources.  
The countries that scored high on local autonomy attributed this to the fact that 
they themselves had adequate resources available and felt that they had 
enough freedom or flexibility to do what they needed to do for a successful 
launch. In that sense the countries felt that they were not dependent on global 
for input.  
 
Several country clusters showed good results despite low levels of 
interdependence, but they had sufficient local resources. This relates to the 
suggestions of Subramaniam and Watson (2006), that some subsidiaries can 
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remain independent and an increase in interdependence i.e. leveraging global 
materials may not increase performance as they have the means themselves 
to do what is needed to successfully enter the market.  
 
The desire or need for interdependence may be diminished if the capacities 
and budgets are available locally in the countries. While the country cluster low 
interdependence and high performance were successful despite little 
interdependence because of their local resources, the low/low cluster 
subsidiaries had no such local resources available and in the cross cluster 
analysis were less successful. This could mean that interdependence may be 
more relevant because countries are motivated to take what is provided as a 
substitute for local resources, which was one of the main arguments for the 
positive effect of interdependence in the previous section. 
There was evidence for a negative moderating effect of local resources in the 
literature as subsidiaries with high capabilities  and resources were less likely 
to work on an interdependent level as they deem themselves to be more 
autonomous and less in need to headquarter assistance or support (Roth, 
1995).  This seems to be confirmed in this case study as well. 
 
7.3.11 Reciprocity  
 
Reciprocity has been defined as a key aspect of interdependent relationships 
(Thompson, 1967). The concept was based on mutual dependence rather 
than resource transactions, i.e. materials, resources and people going back 
and forth between headquarters and subsidiaries.  
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In the comparison across the country clusters, reciprocity was high in the high 
performance, high interdependence cluster and low in the low performance, 
low interdependence cluster as well as in the medium cluster. Therefore, there 
was a pattern that identified this aspect as a moderator in the interdependence 
performance relationship. This is logical as mutual dependence assumes a 
level of mutual interaction and exchange of resources. From the interviews, it 
is perceived that the global organisation is not a local sales organisation, so in 
order be effective there needed to be a level of reciprocity, either with 
feedback, local knowledge and ideally materials and ideas that can be 
franchised worldwide. 
 
However, the high interdependence, low performance cluster had low 
reciprocity and the low interdependence, high performance cluster had high 
reciprocity, this was a bit juxtaposed and not in line with the literature that 
assumes a high degree of reciprocity with high interdependence (Bartlett and 
Ghoshal, 1989; O'Donnell, 2000). This could potentially be explained by 
language issues, e.g. franchising Italian and Ukrainian materials was deemed 
more difficult than Swiss and English materials. An alternative explanation 
could be the potential opportunistic behaviors of the subsidiary cluster, 
whereby they take part in the transactions, but do not reciprocate to the same 
level or at all (Watson and Hewitt, 2006). This could have a multitude of 
reasons, like size and location, which was mentioned by Australia in this case 
study. Another reason could be the level of autonomy, which was indicated by 
UK and Switzerland.  
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Reciprocity, nevertheless, was identified as key part of interdependent 
relationships and having a moderating effect in this case study. Only if there is 
a substantial level of reciprocity, can the global support be tailored to the local 
markets and can interdependence be beneficial in supporting the subsidiary 
outcomes. 
 
7.3.12 Strategic Alignment. 
 
Strategic alignment was high across all the country clusters and therefore it did 
not seem to be a determining factor for the interdependence performance 
relationship.  
The expectation was that the country clusters who worked interdependently 
with the headquarter organisation would adopt the same strategy, messaging 
and branding in the launch of Xarelto® as they would be using the global 
branding and messaging. Conceptually, in the high interdependence cluster, 
materials and resources are not only shared but capacity as well. In this case 
several countries worked simultaneously on similar projects with the global 
organisation. Case examples were provided in the interviews such as the set-
up of a non-interventional study with Germany or patient brochures supplied 
by Switzerland, both which subsequently distributed or implemented by the 
global organisation.  
It was foreseen that the countries that worked in this manner had to adopt the 
strategy and branding as they are conducting projects on behalf of the global 
group.  As the alignment was high in all the analysed country clusters, this 
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factor could not be confirmed as a moderator in the interdependence 
performance relationship.  
 
The strong global mandate on harmonised branding and messaging, which 
was clearly articulated in many of the global marketing meetings, may have 
had its effect and led to overall country adherence, whereby no differential in 
strategic alignment was apparent and the impact in the interdependence-
performance relationship could therefore not be assessed.  
 
7.3 Chapter Summary  
 
Knowledge exchange, avoiding duplication and close cooperation were clearly 
identified as key moderators in the interdependence and launch performance. 
When the headquarter organisations and subsidiaries really work together in a 
fully mutual supportive and collaborative relationship, the benefits of 
knowledge exchange and avoiding duplication can drive enhanced subsidiary 
performance.  
 
This allowed the countries to leverage the global materials and expertise or 
translate them and in certain cases franchise them out regionally. The 
interdependent relationships allowed for leveraging economies of scale by 
global purchasing and mutual problems solving abilities. Both led to enhanced 
local capabilities in terms of funding and expertise to be better prepared for the 
product launch and thereby enhanced brand performance. The interdependent 
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relationship laid the platform for objective knowledge exchange and buy-in to 
ensure strategic alignment and buy-in to the global concepts.  
 
Autonomy, lack of timely delivery and delays in decision making had a 
negative moderating effect. It became clear that the countries are only willing 
to give up their autonomy if the global organisation delivers the materials in a 
timely fashion. Lack of follow-up, multiple discussion rounds and slow decision 
making were all detracting from the interdependence performance 
relationships.  
 
Other influencing factors evolved from the interviews which may have a larger 
impact on the brand performance than the interdependence levels, such as 
local reimbursement, and local market dynamics. This does not discard the 
interdependence performance link, but it does point out the difficulty in 
establishing this relationship. Both the headquarter and subsidiary 
organisations can have a high interdependent relationship and all the 
prerequisites for a good market entry are fulfilled, however,  if unforeseen 
market events occur such a limited reimbursement in a country this affects 
brand  and subsidiary performance.   
 
Factors that were relevant for interdependent relationships to be able to make 
a positive contribution were identified as perceived responsiveness, support 
from headquarters followed by trust, transparency and strategic alignment 
between headquarters and subsidiaries. These factors however could not be 
identified as moderators in the interdependent performance relationship. 
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Global marketing meetings were identified as an important prerequisite to 
obtain country involvement and build interdependent networks. In addition, it 
was almost unanimously mentioned by the countries that these meetings 
provide a basis for knowledge exchange and an opportunity to address their 
issues and solve their problems. The global marketing meetings were also 
deemed highly motivational and help them with ideas, and provide drive and 
energy to take back to their respective countries. 
 
From the interviews it is clear that an interdependent relationship can enhance 
brand or launch performance, provided that certain market access parameters 
are controlled for. The interdependent relationships can be beneficial provided 
that the global organisation delivers marketing materials in a timely fashion 
and with the right quality.  
 
The global marketing meetings have proved to be one of the ways to build 
these interdependent relationships and establish open and transparent 
communication to transfer knowledge, leverage global initiatives, avoid 
duplication and accelerate the market preparation for enhanced launch 
outcomes.   
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8. CONCLUDING REMARKS 
 
 
In this chapter the conclusion from the quantitative and qualitative sections will 
be integrated and discussed, as well as the contribution of this research to the 
literature. Practical recommendations for management will also be provided. 
  
8.1 Study Conclusion 
 
 
This explorative multi-method study set out to investigate interdependent 
working relationships between headquarters and subsidiaries and the 
influence of this relationship on new product launch outcomes in the Bayer 
organisation. In the literature, there is theoretical evidence that a high and bi-
directional level of interdependence can contribute to subsidiary performance, 
since it would lead to a better knowledge base for the subsidiary and therefore 
a better competitive position. In addition, avoiding duplication of efforts and 
harnessing the expertise of the whole organisation would enable the 
subsidiaries to attain better launch performance. However, there was no direct 
link established in the literature between interdependence and market 
outcomes or product launch performance data in any of the studies reviewed. 
This research was designed to address this gap.  
 
The objective of this research was to explore whether subsidiaries with a high 
degree of interdependent working relationships between subsidiaries and the 
headquarter organisation achieve better subsidiary product launch outcomes 
and to identify moderating factors that play a role in this interdependent 
performance relationship. 
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The central research question was formulated as follows: 
 
Is the Bayer Healthcare subsidiary’s new product launch performance of 
Xarelto® associated with interdependence between the headquarter and 
subsidiary organisations?  
 
The launch of Xarelto®, a novel oral anticoagulant in the Bayer Healthcare 
organisation provided the empirical environment to obtain factual, local 
subsidiary performance data and established interdependence levels between 
the headquarter and subsidiary organisations using a validated 
interdependence survey questionnaire (Subramaniam and Watson 2006).  
 
This research project was divided into two stages. The first stage commenced 
with a quantitative survey of the subsidiary marketing and business managers, 
collecting background characteristics, communication and integration 
parameters, and most importantly, interdependence capabilities and the 
headquarter-subsidiary interdependence scores. These were then matched 
with the subsidiary’s sales, market uptake data and patient shares achieved in 
the Xarelto® launch timeframe from October 2008 until December of 2009.  
 
From the quantitative analysis, a direct correlation between interdependence 
scores and any of the subsidiary product launch outcome measures could not 
be established.  
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The absence of any significant relationship between the interdependence 
measurements used in the literature and the launch outcomes in the 
subsidiaries is in line with the ambiguous results presented in prior literature.  
There may have been factors at work outside of the interdependence 
performance relationship or factors not consistently applied across the 
subsidiaries, which may explain the insignificant linear correlations found in the 
quantitative analysis. Further research was necessary to explore more in-
depth with which factors would affect or moderate the nature of the 
interdependence-performance relationship.  
 
The survey data was used to categorise the subsidiaries for the interviews and 
they were allocated to five clusters along the interdependence and brand 
uptake parameters, ranging from low to high. From each cluster a small and a 
large subsidiary were selected for individual interviews.  
 
The interviews with the subsidiaries revealed twelve factors that may have a 
potential moderating role in the interdependence performance relationship. To 
adequately assess this, the factors were placed in a comparative grid and 
each factor was cross compared to determine its potential influence on 
performance. There were several instances where subsidiaries had not 
specifically mentioned certain factors. In those cases, follow-up interviews 
were conducted to obtain an assessment from the subsidiary organisation at 
the level which this factor or aspect played in the relationship.  
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As evidenced from the results, highly interdependent and cooperative 
headquarter subsidiary relationship can contribute to better launch outcomes 
and interdependence has to be managed in relation to these moderating 
factors.  
 
From the interviews, it became clear that product launch outcomes are 
maximised in the subsidiary if there is a fully integrated and supportive 
relationship between headquarter and subsidiary organisations.  
It is only then that knowledge transfer, resource sharing, exchange of country 
expertise occurs and duplication of effort is avoided. In line with the literature 
this brings the organisation to a better knowledge base and leaves it with 
resources which can be invested to drive the brands locally. In this research, 
better market uptake occurred in those subsidiaries where fully integrated and 
supportive relationships existed. The concept of interdependence extends 
further than just sharing and franchising information and work packets as 
outlined in the literature. The findings in this empirical research suggest that a 
fully, globally networked marketing team, working collaboratively together 
towards a successful launch of Xarelto® drives improved product launch 
outcomes in the local subsidiary. 
 
The results from this research would indicate that interdependence between 
headquarter and subsidiaries is more likely to have a positive effect when 
there is clarity of roles and responsibilities and a timely delivery of materials, 
resources and expertise sharing from both headquarter and subsidiary 
organisations. Dependence from the countries on the headquarter 
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organisation and relinquishing their own independence is facilitated when the 
materials and work packets are delivered on time and there are clear 
expectations and no incongruence. Otherwise there is the risk that the 
countries may return to their autonomous ways and start producing everything 
locally as they want to avoid not being ready to launch. 
 
Relationship network aspects seem to play a bigger role for building and 
maintaining headquarter and subsidiary interdependent relationships, which 
are currently not part of the interdependence questionnaire in the literature. 
The empirical example that stood out is the participation in the global 
marketing meetings, which provided the subsidiaries with an opportunity for 
the product managers to build their network on which they exchange 
information, ideas and best practices. Without the foundation of such a 
relationship network, the establishment of interdependent relationships was 
less evident in this research. Also, sympathy or empathy seems to play a key 
role in this relationship build-up. When there is willingness to work together for 
a common purpose (i.e. a product launch), the global partners and countries 
go out of their way to accommodate each and work together towards a 
common objective, this would empirically support the literature on social capital 
(Kostova and Roth, 2003), which will be further outlined in the next section. 
 
 
8.2 Contribution to Theory 
 
The initial contribution of this research to the theory was to take the concept of 
interdependence and apply it in a practical setting using empirical outcome 
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data. In the literature there is an implicit assumption made that headquarter 
and subsidiaries should work together in an interdependent manner and it is 
argued that this should lead to better outcomes. Prior research of 
Subramaniam and Watson (2006) found that if the appropriate level of 
interdependence was matched with the role of the subsidiary that subjective 
subsidiary performance was improved. In this research it was demonstrated 
that even small subsidiaries can have a larger influence or role and gaining 
centrality and influence in the organisation despite their relatively small size. 
Australia, Mexico and Ukraine all became lead subsidiaries in the region 
because of the launch sequence of Xarelto®. This would support the 
suggestions made by Bouquet and Birkinshaw (2008) that there is potential 
dynamic action, which may change the subsidiary status from a simple sales 
organisation to regional player. This dynamic action is currently not considered 
in the interdependent framework used by Subramaniam and Watson (2006) 
and future research should be focussed on a more dynamic subsidiary status 
of subsidiaries and which factors drive these, in this case study, regional 
leadership in a product launch and associated expertise. 
The interdependence framework may need to be extended to take into 
consideration the potentially changing roles of subsidiaries.   
 
The main contribution from this research is that relationship aspects seem to 
play a larger role in the concept of interdependence than is currently stated in 
the literature. Relationship aspects, in particular social capital is not reflected in 
current interdependence framework, as it focuses mainly on the level and 
direction of work packets and resources going back and forth between 
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headquarter and subsidiary organisations as well as their respective levels of 
mutual dependence (McCann and Ferry, 1979; Harzing, 2000). The evidence 
in this research would support the literature by Victor and Blackburn (1987) 
which focused more on relationship aspects, such as coordination and 
cooperation rather than resource transaction units. The findings would suggest 
enhancing the interdependence scale with aspects of social capital and 
revalidating the interdependence.  
 
Twelve factors have been identified in the interview data which were 
associated with the interdependence performance relationship. The identified 
moderating factors; exchange of knowledge and sharing of expertise, 
avoidance of duplication, interpersonal relationship network aspects, close 
cooperation and clear roles and responsibilities strengthened the 
interdependence performance relationship. Delay in delivery of materials and 
decision making, as well as high local autonomy i.e. availability of local 
resources detracts from the interdependence performance relationship. 
 
As contribution to the theory, a practical framework is generated that captures 
the insights from the qualitative study. This framework is limited to the 
feedback from the country interviews in this case study of a pharmaceutical 
product launch. It shows the factors that were just described and how they play 
a role in the interdependence between headquarter and subsidiary 
relationships as portrayed on the next page. 
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 Figure 34: Headquarter – Subsidiary Interdependence: A framework for a product launch 
 
 
Several factors, such as trust, transparency, reciprocity, headquarter support, 
responsiveness and strategic alignment may have an influence on either 
interdependence or outcomes but could not be directly linked in the 
interdependence performance relationship in this study. 
 
An important finding in this study is that an interdependent cooperative 
network is central to the interdependence performance relationship. Along 
these networks, knowledge, materials and resources are transferred to the 
countries. They in turn provide feedback to the global organisation with regard 
to the practical applicability of the concepts and initiatives locally. The global 
organisation in turn, responds, in a timely manner to the countries with 
updated concepts, materials and resources. Through this mechanism 
duplication is avoided and global resources are leveraged. The early build-up 
or existence of interpersonal collaborative networks is a key aspect and it is 
therefore of importance that roles and responsibilities in the global team are 
well defined as well as designated assignees are identified in the countries 
who are responsible for the product in the early stages of the product 
Interdependence Launch 
Outcomes
+ Exchange of /Information knowledge
+ Avoiding duplication /Leveraging global resources
+ Early involvement/ Interpersonal relationships
+ Clear roles and responsibilities
+ Close cooperation
⁻ Timely delivery and decision making
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development. When this exchange functions well, the local organisations seem 
to trust the organisation for inputs and support, although this was not a 
moderator in the interdependence performance relationship. Only then are the 
countries willing to give up their authority and rely on the global organisation 
for marketing concepts and brand support. This will have the benefit of 
avoiding duplication, increased efficiency, which can be used to drive the 
brand uptake.  
 
This practical framework provides insights on interdependent working 
relationships and in part confirms what Bartlett and Ghoshal (1989) described 
in their transnational organisational model. The concept of interdependence 
can be further explored in further academic studies using the positive and 
negative moderating factors of the interdependence-performance link identified 
in this empirical research study. 
 
8.3 Contribution to Practice 
 
This research hopes to contribute to the company and to the wider 
management literature by providing suggestions for improved launch 
outcomes. Since many pharmaceutical companies have  a good pipeline with 
multiple products in late stage development, results from this research can be 
taken into consideration during the pre-launch and launch phase of these 
compounds (Divac, 2011). 
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Many companies, including Bayer invest resources in marketing excellence 
and building global and local marketing capabilities, however, the global 
launch implementation and headquarter subsidiary relationship aspects are 
often overlooked.  
In a personal discussion with Dr. Joerg Reinhardt, the current Bayer 
Healthcare CEO, pertaining to this research project, he welcomed any initiative 
centred around increasing efficiency, enhancing mutual confidence in each 
other (headquarter and subsidiary colleagues) and increasing overall 
competence.    
 
This research offers several practical recommendations to management 
practice that may increase efficiency in any pharmaceutical organisation about 
to launch new products on how to potentially improve their product launch 
outcomes: 
 
1. Early country involvement and launch planning. It was clear that the 
countries which started early could build an interdependent network 
with the global organisation and benefit from the global expertise and 
resources.  
 
2. Assign marketing colleagues to the brand locally. This is necessary to 
provide valuable feedback to initial brand profile, value proposition and 
branding elements. In this research, a local infrastructure for the brand 
was not immediately built-up, but having feedback from assigned 
colleagues in the subsidiaries to ensure that the global organisation 
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develops the product with the correct end-points, health economic data 
and messages relevant for commercialisation locally. 
 
3. Build a close cooperative network. The global marketing meetings in 
this research were instrumental in building global-subsidiary 
relationships. In addition, they have been able to show a contributory 
effect to absolute sales levels and sales uptake in a post-hoc analysis. 
 
4. Obtain country buy-in for globally developed concepts and campaigns 
early. This requires a certain level of reciprocity from the country 
organisations. 
 
5. Ensure global preparedness. The global organisation should ideally be 
a year ahead of the countries and needs to be forward thinking. As one 
of the main detractors of trust and local country dependence on the 
global team was the fact that materials and projects were not delivered 
on time for use and adaptation in some of the countries. It is essential 
that the global marketing group harnesses and funnels the knowledge 
from the extended global group, including Global Clinical Development, 
Medical Affairs, Clinical Pharmacology, Regulatory, and Health 
Economics and Outcomes Research to the countries. The global 
marketing group has the advantage to be dedicated to the brand, which 
is often not the case in the smaller countries, where Product Managers 
are responsible for multiple brands.  
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6. Leverage global materials. By avoiding duplication of efforts and 
resources the whole launch implementation process becomes more 
efficient and impactful. 
 
7. Avoid rapid personnel changes. Once the networks are built, personnel 
changes as evidenced in this research detract from the interdependent 
relationships, as they have to be rebuilt with new colleagues. In a 
launch phase, it is important to limited personnel changes due to 
reorganisations and keep restructuring to a minimum.  
 
8. Establish frequent, open and transparent communications between the 
headquarters and the countries. The countries appreciate honest and 
objective communications. A balanced perspective on the product and 
the profile is requested from the countries, especially any potential 
drawbacks that may be criticised through academic scrutiny of the 
clinical product data. It is important that the countries are adequately 
prepared to handle those objections scientifically and practically, 
thereby enhancing their confidence of the product in the market. 
 
9. Strong global brand guidance: In this research the countries universally 
accepted the global brand guidance and found that the delivery of 
marketing materials helped their launch preparations, provided that 
these were delivered in a timely manner as previously described. 
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10. Organise, high energy, motivational global marketing meetings 
containing workshop style interactions. Although this was not a 
prospective study, there was a clear direct correlation between 
participation in the global marketing meetings and better brand uptake 
as well as absolute sales. It is suggested that at these meetings the 
interdependent networks are built. The countries found it useful to 
discuss their issues and problems and obtain solutions, as well as 
sharing best practices, successes and aligning with each other. It is 
then through these networks, that the lead countries for the regions 
become defined and a mutual dependency is fostered. 
 
When these recommendations are put into practice an optimal manner in 
which the headquarter organisations and subsidiaries are working 
interdependently together could become possible. This could be envisioned 
working as follows: A smaller nuclear global team networked with the 
subsidiary countries, jointly working on launch preparation. Results of any work 
get franchised around the world in a truly an integrative and efficient manner. 
Lead countries could be identified who co-produce global materials with the 
guidance and resources from the global organisation negating a top down 
approach. The key suggestions from this research could enable the 
organisation to implement such a framework and enhance future product 
launch outcomes in terms of absolute sales and sales uptake. 
 
As product launches are universal in the pharmaceutical industry these 
suggestions may have wider implications across the industry and potentially 
in other high-tech industries. The research investigated factors in global 
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launch execution between the headquarter and subsidiary organisations of a 
globally operating pharmaceutical company and therefore these findings may 
have applicability beyond the pharmaceutical industry. Further research will 
need to investigate if similar factors play a role in the interdependent 
headquarter subsidiary relationships how these are then linked to subsidiary 
performance and product launch performance in particular.  
 
8.4 Limitations  
 
This study has limitations, but it can serve as a stepping stone for further 
research. It is based on just one case study within the Bayer organisation and 
was also specifically related to a launch product within this organisation. 
Therefore, the generalisation of the results in this empirical case study remains 
to be further assessed, for example, potentially with other products within the 
organisation and or in future product launches.  
It was deemed necessary to focus on a product launch within a Business Unit 
within one company to explore the causal and dynamic relationship of the 
headquarter-subsidiary interdependence and performance.  
The merit of using a multi-method approach in a case study research has been 
recognised in the international business literature to generate further 
theoretical insights (Hurmerinta-Peltomäki and Nummela, 2006; Eisenhardt 
and Graebner, 2007), however there remain limitations around the 
generalisability of the findings to other parts of the organisation, and to the  
pharmaceutical industry in general.   
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One of the main limitations of this study is that performance is measured by a 
specific product launch performance and that this does not automatically imply 
overall subsidiary performance or organisational performance. There is an 
assumption made that when a subsidiary is launching new products, the 
lifeblood of the pharmaceutical industry, that they will be successful, business 
wise and in the long term. Therefore, most of this research implicitly assumes 
that performance of the subsidiaries relates to the overall organisation’s 
performance, as it assumes that the result of the subsidiaries aggregates to 
the total organisational performance. However, this may not always be the 
case and as such needs to be taken into consideration.  
 
The limitation however remains that this case study focuses on just one 
product launch, not multiple and these product launches are multifactorial. The 
external environment has not been taken into consideration. Key external 
issues were excluded from the research as it focused primarily on the 
interdependent headquarter subsidiary relationship and factors that 
contributed to product launch outcomes. Several external factors were 
mentioned during the interviews and highlighted such as reimbursement for 
the medicine in the local subsidiary countries. For example, if market access is 
not granted in a country then is it very difficult to generate sales, irrespective of 
the high interdependent support the subsidiary may have received from the 
headquarter organisation. Therefore interdependence between headquarter 
and subsidiary organisation should not be seen as a condition for success, 
rather it can enhance success when distorting external factors are managed or 
controlled for. There may have been one or many of these factors on-going in 
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the background, when this research was conducted and this could be one of 
the explanations why the quantitative analysis was inconclusive. To correct for 
external factors was not really feasible in this research project and represents 
a limitation of this study.   
 
Another limitation is interdependence focused on the headquarter subsidiary 
relationships. Interdependence between subsidiaries is only has not been 
considered in interdependence performance evaluation as it was not the focus 
of this research and may present an opportunity for future research. 
 
Furthermore, this research focused on a product launch, where product 
knowledge was at the centre in the global marketing and clinical development 
departments. For successful launch implementation the countries were 
dependent on the headquarter organisation for knowledge transfer and the 
actual finished product as they all originate from Germany. Therefore, this 
research may have limited relevance to product later in their lifecycle or other 
products which are produced and marketed regionally. 
 
The results have not been specified by culture and the cultural background of 
the respondents has not been taken into consideration. Culture has been 
demonstrated in international studies to be of influence (Hofstede 2005). This 
may need to be taken into consideration when interpreting the results. 
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8.5 Suggestions for Further Research 
 
If follow-up studies are to be considered, it would be a valuable exercise to test 
the importance of the moderators identified in this on a larger scale in order to 
verify if these hold true in other studies. This can potentially be achieved 
through a larger prospectively designed study, preferably across the 
pharmaceutical industry. 
 
A key opportunity for academic theory is to find ways to enhance the 
interdependence questions with the relationship aspects found in the network 
and social capital literature. A synthesis of the resource flow and its direction, 
and focus on work related projects combined with the relationship aspects 
from the network and social capital literature could potentially provide an 
enhanced and more encompassing interdependence scale, which contains 
both elements resource flows as originally outlined in the interdependence 
literature (Victor and Blackburn, 1987; McCann and Ferry, 1979). The current 
scale does not seem to include the latter and this research points to integrated 
collaborative relationship between headquarter and subsidiary organisations 
as one of the main factors for interdependence to contribute to product launch 
success. This new scale, comprising of both resources and relationship factors 
could then be validated in empirical research for further use in larger 
confirmatory studies. 
 
Another suggestion is to conduct an experimental research approach, by 
deliberately devolving central power to the country organisation and making 
them responsible for part of the global launch deliverables, which the countries 
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have to send back to headquarters, thereby establishing an independent 
relationship. A qualitative, focus group research could be conducted with the 
participants to ascertain and confirm the moderating factors identified in this 
research. This would approach the topic in a different manner and may 
highlight additional aspects in the headquarter-subsidiary interdependence 
relationship.    
Meanwhile the results hold practical value for academic researchers, as well 
as pharmaceutical companies which are about to embark on future product 
launches.  
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Appendix B: Survey invitation to Bayer Colleagues 
 
 
 
Dear Colleagues,  
 
Currently, I am conducting independent research for my DBA at the University of Bradford in 
association with the NIMBAS institute. My special interest is headquarter subsidiary 
relationships, in particular, how we can come to mutual information exchange and improved 
launch performance.  
 
The research is exploratory in nature and is being conducted within the Bayer Schering 
Pharma organisation as a case study. This is not set up to make any determined statements, 
but more to help explore prerequisites for good subsidiary headquarter interaction that could 
help support future launches in the future indications.  
 
In this regard, I would kindly ask you to fill out a short survey which captures background 
data on your local organisation, the rating of the knowledge sharing and interactions with 
headquarters, regions and other subsidiaries, as well as our capabilities and your perceived 
level of trust as it pertains to the pre-launch preparations of 'Xarelto'.  
 
The survey will only take 10 minutes and will cover twenty one questions which are multiple 
choice or have a rating scale. The responses will be held confidential and only be presented 
in aggregated format. Upon request, I will be happy to compare the combined responses 
from your country with overall response rates in the survey, if you are interested in any of the 
outcomes.  
 
I thank you in advance for your time and your help with the survey. Please click on the link 
below and you will automatically be guided through the survey.  
 
 
http://www.surveymonkey.com/s.aspx?sm=u6dx2vtGtVc3fJE0e2rKhg_3d_3d  
 
 
If you have any questions regarding the survey, please do not hesitate to contact me.  
 
Best regards,  
 
Marc van Unen  
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Appendix C: Invitation E-Mail for Country Interview 
 
 
 
Dear ,..., 
 
In the past, you or your country colleagues have kindly participated in a survey to explore 
subsidiary headquarter interactions and the prerequisites for good a successful launch of 
'Xarelto' in Orthopedic Surgery.   
 
The survey captured background data of your local organisation, the rating of the knowledge 
sharing and interactions with headquarters, regions and other subsidiaries, as well as our 
capabilities and your characterization of the relationship with the global group as it pertains 
to the pre-launch preparations of 'Xarelto'.  
  
The results have been analysed and compared with in-market outcomes and in this regard, I 
would kindly ask for your help to answer a couple of interview questions to help explain 
some of findings that have come up from this analysis. The research period is the pre-launch 
and launch period of Xarelto in 2008 and 2009 and since you were involved with the launch 
at this period in time, you would be the ideal candidate 
 
The interview will take approximately 30 minutes and will cover six major questions, 
regarding headquarter subsidiary interdependence, support received from the headquarter 
function, what could have been in improved, how did your country contribute to global launch 
success, what are the prerequisites for good interdependent working relationships between 
headquarter and subsidiary organisations.  
 
The interview will be transcribed and send back to you for review. If direct quotes are used, 
your permission will be asked in advance.  
 
I thank you in advance for your time and your help with the interview. Please let me know if 
you would like to participate, I have availability coming Wednesday, the 20th of April, please 
let me know if this is convenient for you.   
 
If you have any questions, please do not hesitate to contact me. 
 
With kind regards, 
 
 
 
Marc van Unen 
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Appendix D: Interview Guide for Country Interviews 
 
 
 
 
Dear Colleague, 
 
Thank you for participating in this interview. The interview will probably last 
about 15 minutes and is related to the survey you filled out a while ago and 
how you felt you were prepared for the launch of Xarelto®.  
 
There are initial questions on what your understanding is of interdependence 
and the rationale for your score in the survey and the sales result of Xarelto® 
in your country: 
1. What is your understanding of headquarter subsidiary 
interdependence? 
2. Why did you score the way you did? (the country score will be 
explained via the telephone) 
3. Can you explain the brand uptake or absolute sales outcome in your 
country? 
 
The next question is to understand in particular what was helpful for you in 
your prelaunch preparation followed by a question relating to aspects you 
depend on from headquarters or global marketing, as we are inquiring about 
your dependence on the central function: 
4. How has headquarters/global marketing supported you with your pre-
launch and launch preparations? 
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5. What is for you the most important to receive from headquarter/ global 
marketing? 
a. What do you as a country depend on to receive from 
headquarter/global marketing? 
 
What you believe your contribution towards headquarter/global marketing is? 
In a way I am asking you what you believe global marketing depends on from 
your country. 
6. How do you did support or contribute to the overall success of Xarelto® 
and helped to achieve global goals? 
 
The next question is a practical one, important for our organisation but also to 
understand areas related to interdependence 
7. What could headquarter/global marketing have done better for the pre-
launch and launch of Xarelto®? 
 
The next question is one of the key questions in the thesis, which asks about 
the factors important for building and maintaining interdependent 
relationships.  
8. What In your mind is relevant for an open, interactive (high frequency, 
bi-directional) working relationship with global marketing? 
9. How do you see this contributing to better overall success of the                 
brand Xarelto®?  
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Appendix E: Global Marketing Meeting  
 
 
As outlined in the research global marketing meetings were held in order for 
the countries prepare their initial launch plans. The meetings provided more in-
depth background information on Xarelto® to the countries to conduct proper 
forecasting and expected resource planning. 
 
The first global marketing meeting was held in Düsseldorf, two and years 
before the anticipated launch of Xarelto®. These meetings continued to be 
conducted on a bi-annual basis. In the run up to the launch, these meetings 
were themed: “Go to Launch” “Go for Growth”, “From Two to Five” during the 
pre-launch and launch period. 
 
The “Go to Launch” meeting was seen as vitally important because the 
Xarelto® launch materials were handed over to the countries for local 
adaptation and implementation. 
 
In addition, these meetings were very strongly branded, line with the evolving 
or finalised product branding. The agendas were directive and contained 
workshop sessions on strategic decisions, where the participants were able to 
share their knowledge and part-take in the decisions.  
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Figure 35: Go-to-Launch Meeting Room Set-Up 
 
The aim of the global marketing meetings was to transfer knowledge from the 
centre to the subsidiaries and provide strategic guidance local implementation 
and activities as well as global deliverables to the country 
 
The country feedback to these meetings were quite positive in terms of 
providing energy, spirit, motivation, excitement, drive and being part of 
something transformational for the company.  
 
This is supported by the findings in the quantitative section, where participation 
in the global marketing meetings correlated positively with having personal 
contact with headquarters, sharing best practices and exploiting 
interdependencies across the division. Therefore the global marketing 
meetings make the establishment of interdependent networks possible.   
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Appendix F: Interdependent Working Example - Clotman 
 
 
An interesting example is the development of the clotman concept; this was 
artwork that was linked to the branding of Xarelto® as portrayed in the global 
advert template below: 
 
Figure 36: Xarelto(r) global advertising example 
 
 
The Australian colleagues requested high resolution artwork from the global 
group for one of their initiatives. They had a vendor who used it to make a 
clotman suit for an acrobat to wear to draw attention to their exhibit stand in 
Australia. Due to established interdependent network a similar suit was 
delivered to the global group, where the researcher used it successfully in a 
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global marketing meeting. Other subsidiaries subsequently also used the 
same concept in local or regional conferences to increase their brand 
recognition and promotional effectiveness, which in the literature is directly 
linked to improved product launch outcomes. 
 
Figure 38: Interdependent Journey of the clotman concept 
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